0001712463 --12-31 2020 Q3 false P20D P30D P20D P30D P20D P30D P20D P20D P30D P30D P5Y P5Y P2Y P1Y P3Y P1Y 800000 pack:AdjustmentToCorrectErrorInSuccessorPeriodsMember pack:AdjustmentToCorrectErrorInSuccessorPeriodsMember 0001712463 2020-01-01 2020-09-30 xbrli:shares 0001712463 us-gaap:CommonClassAMember 2020-11-04 0001712463 us-gaap:CommonClassCMember 2020-11-04 iso4217:USD 0001712463 pack:PaperMember 2020-07-01 2020-09-30 0001712463 pack:PaperMember 2019-07-01 2019-09-30 0001712463 pack:PaperMember 2020-01-01 2020-09-30 0001712463 pack:PaperMember 2019-06-04 2019-09-30 0001712463 pack:PaperMember 2019-01-01 2019-06-02 0001712463 2020-07-01 2020-09-30 0001712463 2019-07-01 2019-09-30 0001712463 2019-06-04 2019-09-30 0001712463 2019-01-01 2019-06-02 0001712463 us-gaap:ProductAndServiceOtherMember 2020-07-01 2020-09-30 0001712463 us-gaap:ProductAndServiceOtherMember 2019-07-01 2019-09-30 0001712463 us-gaap:ProductAndServiceOtherMember 2020-01-01 2020-09-30 0001712463 us-gaap:ProductAndServiceOtherMember 2019-06-04 2019-09-30 0001712463 us-gaap:ProductAndServiceOtherMember 2019-01-01 2019-06-02 iso4217:USD xbrli:shares 0001712463 2020-09-30 0001712463 2019-12-31 0001712463 us-gaap:CommonClassAMember 2020-09-30 0001712463 us-gaap:CommonClassAMember 2019-12-31 0001712463 us-gaap:CommonClassCMember 2020-09-30 0001712463 us-gaap:CommonClassCMember 2019-12-31 0001712463 pack:OrdinaryClassAMember 2019-06-03 0001712463 pack:OrdinaryClassBMember 2019-06-03 0001712463 us-gaap:AdditionalPaidInCapitalMember 2019-06-03 0001712463 us-gaap:RetainedEarningsMember 2019-06-03 0001712463 2019-06-03 0001712463 pack:OrdinaryClassAMember 2019-06-04 2019-06-30 0001712463 2019-06-04 2019-06-30 0001712463 us-gaap:CommonClassAMember 2019-06-04 2019-06-30 0001712463 us-gaap:CommonClassCMember 2019-06-04 2019-06-30 0001712463 us-gaap:AdditionalPaidInCapitalMember 2019-06-04 2019-06-30 0001712463 pack:OrdinaryClassBMember 2019-06-04 2019-06-30 0001712463 us-gaap:RetainedEarningsMember 2019-06-04 2019-06-30 0001712463 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-04 2019-06-30 0001712463 us-gaap:CommonClassAMember 2019-06-30 0001712463 us-gaap:CommonClassCMember 2019-06-30 0001712463 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001712463 us-gaap:RetainedEarningsMember 2019-06-30 0001712463 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001712463 2019-06-30 0001712463 us-gaap:CommonClassAMember 2019-07-01 2019-09-30 0001712463 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001712463 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001712463 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0001712463 us-gaap:CommonClassAMember 2019-09-30 0001712463 us-gaap:CommonClassCMember 2019-09-30 0001712463 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001712463 us-gaap:RetainedEarningsMember 2019-09-30 0001712463 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0001712463 2019-09-30 0001712463 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001712463 us-gaap:RetainedEarningsMember 2019-12-31 0001712463 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001712463 us-gaap:CommonClassAMember 2020-01-01 2020-03-31 0001712463 2020-01-01 2020-03-31 0001712463 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001712463 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001712463 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001712463 us-gaap:CommonClassAMember 2020-03-31 0001712463 us-gaap:CommonClassCMember 2020-03-31 0001712463 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001712463 us-gaap:RetainedEarningsMember 2020-03-31 0001712463 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001712463 2020-03-31 0001712463 us-gaap:CommonClassAMember 2020-04-01 2020-06-30 0001712463 2020-04-01 2020-06-30 0001712463 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001712463 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001712463 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001712463 us-gaap:CommonClassAMember 2020-06-30 0001712463 us-gaap:CommonClassCMember 2020-06-30 0001712463 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001712463 us-gaap:RetainedEarningsMember 2020-06-30 0001712463 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001712463 2020-06-30 0001712463 us-gaap:CommonClassAMember 2020-07-01 2020-09-30 0001712463 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001712463 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001712463 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001712463 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001712463 us-gaap:RetainedEarningsMember 2020-09-30 0001712463 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001712463 us-gaap:CommonStockMember 2018-12-31 0001712463 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001712463 us-gaap:RetainedEarningsMember 2018-12-31 0001712463 us-gaap:TreasuryStockMember 2018-12-31 0001712463 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001712463 2018-12-31 0001712463 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001712463 2019-01-01 2019-03-31 0001712463 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001712463 us-gaap:CommonStockMember 2019-03-31 0001712463 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001712463 us-gaap:RetainedEarningsMember 2019-03-31 0001712463 us-gaap:TreasuryStockMember 2019-03-31 0001712463 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001712463 2019-03-31 0001712463 us-gaap:CommonStockMember 2019-04-01 2019-06-02 0001712463 2019-04-01 2019-06-02 0001712463 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-02 0001712463 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-02 0001712463 us-gaap:CommonStockMember 2019-06-02 0001712463 us-gaap:AdditionalPaidInCapitalMember 2019-06-02 0001712463 us-gaap:RetainedEarningsMember 2019-06-02 0001712463 us-gaap:TreasuryStockMember 2019-06-02 0001712463 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-02 0001712463 2019-06-02 xbrli:pure 0001712463 pack:RackHoldingsInc.Member 2019-06-03 0001712463 us-gaap:LandMember 2020-09-30 0001712463 us-gaap:LandMember 2019-12-31 0001712463 us-gaap:BuildingAndBuildingImprovementsMember 2020-09-30 0001712463 us-gaap:BuildingAndBuildingImprovementsMember 2019-12-31 0001712463 us-gaap:MachineryAndEquipmentMember 2020-09-30 0001712463 us-gaap:MachineryAndEquipmentMember 2019-12-31 0001712463 pack:ComputerandOfficeEquipmentMember 2020-09-30 0001712463 pack:ComputerandOfficeEquipmentMember 2019-12-31 0001712463 pack:ConvertingMachinesMember 2020-09-30 0001712463 pack:ConvertingMachinesMember 2019-12-31 0001712463 us-gaap:CostOfSalesMember 2020-07-01 2020-09-30 0001712463 us-gaap:CostOfSalesMember 2019-07-01 2019-09-30 0001712463 us-gaap:CostOfSalesMember 2020-01-01 2020-09-30 0001712463 us-gaap:CostOfSalesMember 2019-06-04 2019-09-30 0001712463 us-gaap:CostOfSalesMember 2019-01-01 2019-06-02 0001712463 pack:DepreciationandAmortizationMember 2020-07-01 2020-09-30 0001712463 pack:DepreciationandAmortizationMember 2019-07-01 2019-09-30 0001712463 pack:DepreciationandAmortizationMember 2020-01-01 2020-09-30 0001712463 pack:DepreciationandAmortizationMember 2019-06-04 2019-09-30 0001712463 pack:DepreciationandAmortizationMember 2019-01-01 2019-06-02 pack:segment 0001712463 pack:NorthAmericaSegmentMember 2020-07-01 2020-09-30 0001712463 pack:NorthAmericaSegmentMember 2019-07-01 2019-09-30 0001712463 pack:NorthAmericaSegmentMember 2020-01-01 2020-09-30 0001712463 pack:NorthAmericaSegmentMember 2019-06-04 2019-09-30 0001712463 pack:NorthAmericaSegmentMember 2019-01-01 2019-06-02 0001712463 pack:EuropeAndAsiaSegmentMember 2020-07-01 2020-09-30 0001712463 pack:EuropeAndAsiaSegmentMember 2019-07-01 2019-09-30 0001712463 pack:EuropeAndAsiaSegmentMember 2020-01-01 2020-09-30 0001712463 pack:EuropeAndAsiaSegmentMember 2019-06-04 2019-09-30 0001712463 pack:EuropeAndAsiaSegmentMember 2019-01-01 2019-06-02 0001712463 pack:OneCustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001712463 srt:NorthAmericaMember 2020-07-01 2020-09-30 0001712463 srt:NorthAmericaMember 2019-07-01 2019-09-30 0001712463 srt:NorthAmericaMember 2020-01-01 2020-09-30 0001712463 srt:NorthAmericaMember 2019-06-04 2019-09-30 0001712463 srt:NorthAmericaMember 2019-01-01 2019-06-02 0001712463 pack:EuropeAsiaMember 2020-07-01 2020-09-30 0001712463 pack:EuropeAsiaMember 2019-07-01 2019-09-30 0001712463 pack:EuropeAsiaMember 2020-01-01 2020-09-30 0001712463 pack:EuropeAsiaMember 2019-06-04 2019-09-30 0001712463 pack:EuropeAsiaMember 2019-01-01 2019-06-02 0001712463 pack:NorthAmericaSegmentMember 2019-12-31 0001712463 pack:EuropeSegmentMember 2019-12-31 0001712463 pack:EuropeSegmentMember 2020-01-01 2020-09-30 0001712463 pack:NorthAmericaSegmentMember 2020-09-30 0001712463 pack:EuropeSegmentMember 2020-09-30 0001712463 us-gaap:InProcessResearchAndDevelopmentMember 2020-04-01 2020-06-30 0001712463 us-gaap:CustomerRelationshipsMember 2020-09-30 0001712463 us-gaap:TechnologyBasedIntangibleAssetsMember 2020-09-30 0001712463 us-gaap:InProcessResearchAndDevelopmentMember 2020-09-30 0001712463 us-gaap:CustomerRelationshipsMember 2019-12-31 0001712463 us-gaap:TechnologyBasedIntangibleAssetsMember 2019-12-31 0001712463 us-gaap:InProcessResearchAndDevelopmentMember 2019-12-31 0001712463 us-gaap:TrademarksAndTradeNamesMember 2020-09-30 0001712463 us-gaap:TrademarksAndTradeNamesMember 2019-12-31 0001712463 us-gaap:CustomerRelationshipsMember srt:WeightedAverageMember 2020-01-01 2020-09-30 0001712463 us-gaap:TechnologyBasedIntangibleAssetsMember srt:WeightedAverageMember 2020-01-01 2020-09-30 0001712463 srt:WeightedAverageMember 2020-01-01 2020-09-30 0001712463 pack:RackHoldingsInc.Member 2019-06-01 2019-06-03 iso4217:EUR 0001712463 pack:RackHoldingsInc.Member pack:RackHoldingsInc.Member 2019-06-01 2019-06-03 0001712463 pack:RackHoldingsInc.Member 2019-12-30 2019-12-31 0001712463 us-gaap:TechnologyBasedIntangibleAssetsMember pack:RackHoldingsInc.Member 2019-06-03 0001712463 us-gaap:CustomerRelationshipsMember pack:RackHoldingsInc.Member 2019-06-03 0001712463 us-gaap:InProcessResearchAndDevelopmentMember pack:RackHoldingsInc.Member 2019-06-03 0001712463 pack:RackHoldingsInc.Member us-gaap:TrademarksAndTradeNamesMember 2019-06-03 0001712463 pack:RackHoldingsInc.Member us-gaap:MachineryAndEquipmentMember 2019-06-03 0001712463 pack:RackHoldingsInc.Member pack:ConvertingMachinesMember 2019-06-03 0001712463 pack:RackHoldingsInc.Member us-gaap:BuildingAndBuildingImprovementsMember 2019-06-03 0001712463 pack:RackHoldingsInc.Member us-gaap:LandMember 2019-06-03 0001712463 us-gaap:TechnologyBasedIntangibleAssetsMember pack:RackHoldingsInc.Member 2019-06-01 2019-06-03 0001712463 us-gaap:CustomerRelationshipsMember pack:RackHoldingsInc.Member 2019-06-01 2019-06-03 0001712463 pack:RackHoldingsInc.Member us-gaap:MachineryAndEquipmentMember 2019-06-01 2019-06-03 0001712463 pack:RackHoldingsInc.Member pack:ConvertingMachinesMember srt:MinimumMember 2019-06-01 2019-06-03 0001712463 pack:RackHoldingsInc.Member pack:ConvertingMachinesMember srt:MaximumMember 2019-06-01 2019-06-03 0001712463 pack:RackHoldingsInc.Member us-gaap:BuildingAndBuildingImprovementsMember 2019-06-01 2019-06-03 0001712463 pack:RackHoldingsInc.Member us-gaap:TechnologyBasedIntangibleAssetsMember 2020-04-01 2020-06-30 0001712463 pack:RackHoldingsInc.Member 2019-07-01 2019-09-30 0001712463 pack:RackHoldingsInc.Member 2019-01-01 2019-09-30 0001712463 pack:NeopackSolutionsSASDbae3neoMember 2018-12-30 2018-12-31 0001712463 pack:NeopackSolutionsSASDbae3neoMember 2017-02-28 0001712463 pack:NeopackSolutionsSASDbae3neoMember 2020-04-21 0001712463 pack:NeopackSolutionsSASDbae3neoMember 2020-04-01 2020-06-30 0001712463 pack:NeopackSolutionsSASDbae3neoMember 2020-09-30 0001712463 us-gaap:DomesticLineOfCreditMember pack:FirstLienTermFacilityMember 2019-06-03 0001712463 us-gaap:ForeignLineOfCreditMember pack:FirstLienTermFacilityMember 2019-06-03 0001712463 us-gaap:RevolvingCreditFacilityMember 2019-06-03 0001712463 pack:FirstLienTermFacilityMember 2019-06-01 2019-06-03 0001712463 us-gaap:RevolvingCreditFacilityMember 2019-06-01 2019-06-03 0001712463 us-gaap:DomesticLineOfCreditMember pack:FirstLienTermFacilityMember 2020-09-30 0001712463 us-gaap:DomesticLineOfCreditMember pack:FirstLienTermFacilityMember 2019-12-31 0001712463 us-gaap:ForeignLineOfCreditMember pack:FirstLienTermFacilityMember 2020-09-30 0001712463 us-gaap:ForeignLineOfCreditMember pack:FirstLienTermFacilityMember 2019-12-31 0001712463 us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2020-09-30 0001712463 us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2019-12-31 0001712463 us-gaap:LineOfCreditMember us-gaap:EurodollarMember pack:FirstLienCreditAgreementMember 2020-01-01 2020-09-30 0001712463 us-gaap:LineOfCreditMember us-gaap:EurodollarMember pack:FirstLienCreditAgreementMember 2019-01-01 2019-12-31 0001712463 us-gaap:LineOfCreditMember pack:FirstLienCreditAgreementMember 2020-01-01 2020-09-30 0001712463 us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember pack:FirstLienCreditAgreementMember 2020-01-01 2020-09-30 0001712463 us-gaap:LineOfCreditMember pack:FirstLienTermFacilityMember 2020-09-30 0001712463 us-gaap:LineOfCreditMember pack:FirstLienTermFacilityMember 2019-12-31 0001712463 us-gaap:StandbyLettersOfCreditMember 2020-09-30 0001712463 us-gaap:RevolvingCreditFacilityMember 2020-09-30 0001712463 us-gaap:RevolvingCreditFacilityMember 2020-01-01 2020-09-30 0001712463 2020-02-13 2020-02-14 0001712463 2019-01-01 2019-12-31 0001712463 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2019-01-31 0001712463 pack:InterestRateSwapTwoMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2019-09-25 0001712463 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2019-09-25 0001712463 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2020-03-27 0001712463 pack:InterestRateSwapTwoMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2020-09-30 0001712463 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2020-09-30 0001712463 pack:InterestRateSwapTwoMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2019-12-31 0001712463 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2019-12-31 0001712463 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2020-09-30 0001712463 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2019-12-31 0001712463 pack:FirstLienTermFacilityMember pack:InterestRateSwapTwoMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2020-09-30 0001712463 pack:FirstLienTermFacilityMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2020-09-30 0001712463 pack:FirstLienTermFacilityMember pack:InterestRateSwapTwoMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2019-12-31 0001712463 pack:FirstLienTermFacilityMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2019-12-31 0001712463 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember 2020-07-01 2020-09-30 0001712463 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember 2020-01-01 2020-09-30 0001712463 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember pack:AccruedLiabilitiesAndOtherMember us-gaap:InterestRateSwapMember 2020-09-30 0001712463 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember pack:AccruedLiabilitiesAndOtherMember us-gaap:InterestRateSwapMember 2019-12-31 0001712463 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember us-gaap:OtherLiabilitiesMember us-gaap:InterestRateSwapMember 2020-09-30 0001712463 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember us-gaap:OtherLiabilitiesMember us-gaap:InterestRateSwapMember 2019-12-31 0001712463 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember 2019-07-01 2019-09-30 0001712463 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember 2019-06-04 2019-09-30 0001712463 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember 2019-01-01 2019-06-02 0001712463 2020-09-29 2020-09-30 0001712463 2019-12-30 2019-12-31 0001712463 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001712463 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-31 0001712463 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-09-30 0001712463 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-09-30 0001712463 us-gaap:AccumulatedTranslationAdjustmentMember 2020-09-30 0001712463 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-09-30 0001712463 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-09-30 0001712463 us-gaap:FairValueInputsLevel2Member 2020-09-30 0001712463 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0001712463 us-gaap:FairValueInputsLevel2Member 2019-12-31 0001712463 us-gaap:EarliestTaxYearMember us-gaap:TaxAndCustomsAdministrationNetherlandsMember 2020-07-01 2020-09-30 0001712463 us-gaap:LatestTaxYearMember us-gaap:TaxAndCustomsAdministrationNetherlandsMember 2020-07-01 2020-09-30 0001712463 pack:A2019PlanMember us-gaap:EmployeeStockOptionMember 2020-09-30 0001712463 pack:A2019PlanMember us-gaap:EmployeeStockOptionMember 2020-01-01 2020-09-30 0001712463 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2020-01-01 2020-09-30 0001712463 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2020-01-01 2020-09-30 0001712463 pack:PerformanceBasedRestrictedStockUnitsMember 2020-01-01 2020-09-30 0001712463 pack:PerformanceBasedRestrictedStockUnitsMember srt:MinimumMember 2020-01-01 2020-09-30 0001712463 pack:PerformanceBasedRestrictedStockUnitsMember srt:MaximumMember 2020-01-01 2020-09-30 0001712463 us-gaap:RestrictedStockUnitsRSUMember 2019-12-31 0001712463 pack:PerformanceBasedRestrictedStockUnitsMember 2019-12-31 0001712463 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-09-30 0001712463 us-gaap:RestrictedStockUnitsRSUMember 2020-09-30 0001712463 pack:PerformanceBasedRestrictedStockUnitsMember 2020-09-30 0001712463 us-gaap:RestrictedStockUnitsRSUMember srt:DirectorMember 2020-01-01 2020-09-30 0001712463 pack:DirectorStockUnitsMember 2019-12-31 0001712463 pack:DirectorStockUnitsMember 2020-01-01 2020-09-30 0001712463 pack:DirectorStockUnitsMember 2020-09-30 0001712463 us-gaap:CommonClassBMember 2020-09-30 0001712463 pack:OrdinaryClassBMember 2019-06-01 2019-06-03 0001712463 us-gaap:CommonClassAMember 2019-06-01 2019-06-03 0001712463 us-gaap:CommonClassCMember 2019-06-01 2019-06-03 0001712463 us-gaap:CommonClassAMember pack:SharesSubjectToEarnoutPriceTwelveDollarsandTwentyFiveCentsMember 2019-06-01 2019-06-03 0001712463 us-gaap:CommonClassAMember pack:SharesSubjectToEarnoutPriceTwelveDollarsandTwentyFiveCentsMember 2019-06-03 0001712463 pack:SharesSubjectToEarnoutPriceFifteenDollarsMember us-gaap:CommonClassAMember 2019-06-01 2019-06-03 0001712463 pack:SharesSubjectToEarnoutPriceFifteenDollarsMember us-gaap:CommonClassAMember 2019-06-03 0001712463 pack:SharesSubjectToEarnoutPriceTwelveDollarsandFiftyCentsMember pack:CommonClassAorCommonClassCMember 2019-06-01 2019-06-03 0001712463 pack:SharesSubjectToEarnoutPriceTwelveDollarsandFiftyCentsMember pack:CommonClassAorCommonClassCMember 2019-06-03 0001712463 us-gaap:PrivatePlacementMember us-gaap:CommonClassAMember pack:ForwardPurchaseWarrantsAndPrivatePlacementWarrantsMember 2020-08-06 0001712463 us-gaap:CommonClassAMember 2018-01-17 0001712463 pack:WarrantAmendmentMember 2020-09-01 2020-09-02 0001712463 us-gaap:CommonClassAMember pack:WarrantAmendmentMember 2020-09-01 2020-09-02 0001712463 pack:WarrantAmendmentMember 2020-09-21 0001712463 pack:WarrantAmendmentMember 2020-09-20 2020-09-21 0001712463 us-gaap:CommonClassAMember pack:WarrantAmendmentMember 2020-09-20 2020-09-21 0001712463 us-gaap:CommonClassAMember 2019-01-01 2019-12-31 0001712463 pack:SharesNotSubjectToAnEarnOutMember us-gaap:CommonClassAMember 2020-09-30 0001712463 pack:SharesNotSubjectToAnEarnOutMember us-gaap:CommonClassCMember 2020-09-30 0001712463 pack:SharesNotSubjectToAnEarnOutMember 2020-09-30 0001712463 pack:SharesNotSubjectToAnEarnOutMember us-gaap:CommonClassAMember 2019-12-31 0001712463 pack:SharesNotSubjectToAnEarnOutMember us-gaap:CommonClassCMember 2019-12-31 0001712463 pack:SharesNotSubjectToAnEarnOutMember 2019-12-31 0001712463 pack:SharesSubjectToEarnoutPriceFifteenDollarsMember us-gaap:CommonClassAMember 2020-09-30 0001712463 pack:SharesSubjectToEarnoutPriceFifteenDollarsMember 2020-09-30 0001712463 pack:SharesSubjectToEarnoutPriceFifteenDollarsMember us-gaap:CommonClassAMember 2019-12-31 0001712463 pack:SharesSubjectToEarnoutPriceFifteenDollarsMember 2019-12-31 0001712463 pack:SharesSubjectToEarnoutPriceTwelveDollarsandFiftyCentsMember us-gaap:CommonClassAMember 2020-09-30 0001712463 pack:SharesSubjectToEarnoutPriceTwelveDollarsandFiftyCentsMember us-gaap:CommonClassCMember 2020-09-30 0001712463 pack:SharesSubjectToEarnoutPriceTwelveDollarsandFiftyCentsMember 2020-09-30 0001712463 pack:SharesSubjectToEarnoutPriceTwelveDollarsandFiftyCentsMember us-gaap:CommonClassAMember 2019-12-31 0001712463 pack:SharesSubjectToEarnoutPriceTwelveDollarsandFiftyCentsMember us-gaap:CommonClassCMember 2019-12-31 0001712463 pack:SharesSubjectToEarnoutPriceTwelveDollarsandFiftyCentsMember 2019-12-31 0001712463 pack:SharesSubjectToEarnoutPriceTwelveDollarsandTwentyFiveCentsMember us-gaap:CommonClassAMember 2020-09-30 0001712463 pack:SharesSubjectToEarnoutPriceTwelveDollarsandTwentyFiveCentsMember 2020-09-30 0001712463 pack:SharesSubjectToEarnoutPriceTwelveDollarsandTwentyFiveCentsMember us-gaap:CommonClassAMember 2019-12-31 0001712463 pack:SharesSubjectToEarnoutPriceTwelveDollarsandTwentyFiveCentsMember 2019-12-31 0001712463 pack:SharesSubjectToEarnoutPriceFifteenDollarsMember 2019-06-03 0001712463 pack:SharesSubjectToEarnoutPriceTwelveDollarsandFiftyCentsMember 2019-06-03 0001712463 pack:SharesSubjectToEarnoutPriceTwelveDollarsandTwentyFiveCentsMember 2019-06-03 0001712463 us-gaap:WarrantMember 2019-07-01 2019-09-30 0001712463 us-gaap:WarrantMember 2019-06-04 2019-09-30 0001712463 pack:RestrictedStockUnitsandPerformancebasedRestrictedStockUnitsMember 2020-07-01 2020-09-30 0001712463 pack:RestrictedStockUnitsandPerformancebasedRestrictedStockUnitsMember 2019-07-01 2019-09-30 0001712463 pack:RestrictedStockUnitsandPerformancebasedRestrictedStockUnitsMember 2020-01-01 2020-09-30 0001712463 pack:RestrictedStockUnitsandPerformancebasedRestrictedStockUnitsMember 2019-06-04 2019-09-30 0001712463 pack:OneMadisonGroupLLCMember 2020-07-01 2020-09-30 0001712463 pack:OneMadisonGroupLLCMember 2020-01-01 2020-09-30 0001712463 pack:OneMadisonGroupLLCMember 2019-07-01 2019-09-30 0001712463 pack:OneMadisonGroupLLCMember 2019-06-04 2019-09-30 0001712463 srt:DirectorMember 2020-01-01 2020-09-30 0001712463 pack:SharesSubjectToEarnoutPriceTwelveDollarsandFiftyCentsMember pack:CommonClassAorCommonClassCMember pack:OneMadisonGroupLLCMember 2020-09-30 0001712463 us-gaap:PrivatePlacementMember pack:ForwardPurchaseWarrantsMember 2019-06-01 2019-06-02 0001712463 us-gaap:PrivatePlacementMember pack:ForwardPurchaseWarrantsMember pack:OneMadisonGroupLLCMember 2020-01-01 2020-09-30 0001712463 pack:RhoneCapitalIVLPMember pack:RackHoldingsInc.Member 2019-06-01 2019-06-02 0001712463 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2019-01-01 2019-06-02 0001712463 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2019-06-04 2019-06-30 0001712463 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2019-06-04 2019-09-30 0001712463 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2019-06-30 0001712463 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2019-09-30 0001712463 srt:ScenarioPreviouslyReportedMember 2019-01-01 2019-06-02 0001712463 srt:ScenarioPreviouslyReportedMember 2019-06-02 0001712463 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2019-06-02 0001712463 srt:ScenarioPreviouslyReportedMember 2019-06-04 2019-09-30 0001712463 srt:ScenarioPreviouslyReportedMember 2019-06-03 0001712463 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2019-06-03 0001712463 srt:ScenarioPreviouslyReportedMember 2019-09-30

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2020

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________.

Commission File Number 001-38348

 

RANPAK HOLDINGS CORP.

(Exact name of registrant as specified in its charter)

 

 

Delaware

98-1377160

(State or other jurisdiction of

(I.R.S. Employer

incorporation or organization)

Identification Number)

 

7990 Auburn Road

Concord Township, Ohio 44077

(Address of principal executive offices) (Zip Code)

 

(440) 354-4445

(Registrant’s telephone number, including area code)

 

N/A

(Former name, former address and formal fiscal year, if changed since last report)

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Class A Ordinary Shares, par value $0.0001 per share

PACK

New York Stock Exchange

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

Accelerated filer

Non-accelerated filer

 

Smaller reporting company

Emerging growth company

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

 

As of November 4, 2020, the registrant had 68,999,035 of its Class A common shares, $0.0001 par value per share, outstanding (which includes 6,116,453 Class A common shares that are subject to an earn-out provision as described in Part 1, Item 1 of this report) and 6,511,293 of its Class C common shares, $0.0001 par value per share, outstanding, of which 731,383 Class C common shares are subject to an earn-out.

 


 

Ranpak Holdings Corp.

Quarterly Report on Form 10-Q

For the Period Ended September 30, 2020

 

Table of Contents

 

 

 

Page

Part I – Financial Information

 

1

Item 1. Condensed Consolidated Financial Statements (Unaudited)

 

1

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

29

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

51

Item 4. Controls and Procedures

 

51

Part II – Other Information

 

52

Item 1. Legal Proceedings

 

52

Item 1A. Risk Factors

 

52

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

52

Item 3. Defaults Upon Senior Securities

 

52

Item 4. Mine Safety Disclosures

 

52

Item 5. Other Information

 

52

Item 6. Exhibits

 

53

Signatures

 

54

 


 

PART I – FINANCIAL INFORMATION

Item 1.  Financial Statements

Index to Unaudited Condensed Consolidated Financial Statements

Ranpak Holdings Corp.

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

Successor – for the Three Months Ended September 30, 2020 and 2019, the Nine Months Ended September 30, 2020 and the Period June 3, 2019 through September 30, 2019

Predecessor – for the Period January 1, 2019 through June 2, 2019

Unaudited Condensed Consolidated Balance Sheets – September 30, 2020 and December 31, 2019

Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity

Successor – for the Three Months Ended September 30, 2020 and 2019, the Nine Months Ended September 30, 2020 and the Period June 3, 2019 through September 30, 2019

Predecessor – for the Period January 1, 2019 through June 2, 2019

Unaudited Condensed Consolidated Statements of Cash Flows

Successor – for the Nine Months Ended September 30, 2020 and the Period June 3, 2019 through September 30, 2019

Predecessor – for the Period January 1, 2019 through June 2, 2019

Notes to the Unaudited Condensed Consolidated Financial Statements

 

1


 

Ranpak Holdings Corp.

Unaudited Condensed Consolidated Statements of Operations

and Comprehensive Income (Loss)

(in millions, except share and per share data)

 

 

 

Successor

 

 

 

Predecessor

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

June 3, 2019

 

 

 

January 1, 2019

 

 

 

2020

 

 

2019

 

 

2020

 

 

– September 30, 2019

 

 

 

– June 2, 2019

 

Paper revenue

 

$

64.9

 

 

$

57.0

 

 

$

171.2

 

 

$

72.7

 

 

 

$

88.8

 

Machine lease revenue

 

 

10.4

 

 

 

9.3

 

 

 

28.3

 

 

 

11.8

 

 

 

 

14.4

 

Other revenue

 

 

1.5

 

 

 

2.8

 

 

 

6.8

 

 

 

0.9

 

 

 

 

3.2

 

Net revenue

 

 

76.8

 

 

 

69.1

 

 

 

206.3

 

 

 

85.4

 

 

 

 

106.4

 

Cost of goods sold

 

 

46.6

 

 

 

39.6

 

 

 

122.3

 

 

 

52.6

 

 

 

 

61.2

 

Gross profit

 

 

30.2

 

 

 

29.5

 

 

 

84.0

 

 

 

32.8

 

 

 

 

45.2

 

Selling, general and administrative expenses

 

 

17.8

 

 

 

17.7

 

 

 

58.1

 

 

 

22.5

 

 

 

 

23.8

 

Transaction costs

 

 

-

 

 

 

-

 

 

 

-

 

 

 

0.3

 

 

 

 

7.4

 

Depreciation and amortization expense

 

 

7.7

 

 

 

10.3

 

 

 

22.9

 

 

 

13.3

 

 

 

 

17.7

 

Other operating expense, net

 

 

1.9

 

 

 

0.5

 

 

 

2.9

 

 

 

0.8

 

 

 

 

2.2

 

Income (loss) from operations

 

 

2.8

 

 

 

1.0

 

 

 

0.1

 

 

 

(4.1

)

 

 

 

(5.9

)

Interest expense

 

 

4.9

 

 

 

9.5

 

 

 

16.6

 

 

 

17.5

 

 

 

 

20.2

 

Foreign currency (gain) loss

 

 

3.2

 

 

 

(3.2

)

 

 

3.1

 

 

 

(1.6

)

 

 

 

(2.2

)

Loss before income tax expense

 

 

(5.3

)

 

 

(5.3

)

 

 

(19.6

)

 

 

(20.0

)

 

 

 

(23.9

)

Income tax expense (benefit)

 

 

0.8

 

 

 

(3.7

)

 

 

(1.4

)

 

 

(6.1

)

 

 

 

(4.9

)

Net loss

 

$

(6.1

)

 

$

(1.6

)

 

$

(18.2

)

 

$

(13.9

)

 

 

$

(19.0

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss per share

 

 

 

 

 

 

 

$

-

 

 

 

$

(19,195.40

)

Weighted average number of shares outstanding

 

 

 

 

 

 

 

 

-

 

 

 

 

995

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Two-class method

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.08

)

 

$

(0.03

)

 

$

(0.25

)

 

$

(0.26

)

 

 

 

Diluted

 

$

(0.08

)

 

$

(0.03

)

 

$

(0.25

)

 

$

(0.26

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares outstanding - Class A and C

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

72,396,183

 

 

 

53,871,068

 

 

 

71,401,580

 

 

 

53,870,568

 

 

 

 

Diluted

 

 

72,396,183

 

 

 

53,871,068

 

 

 

71,401,580

 

 

 

53,870,568

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive income (loss), before tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

$

8.4

 

 

$

(11.1

)

 

$

7.9

 

 

$

(6.3

)

 

 

$

(4.0

)

Interest rate swap adjustments

 

 

(0.5

)

 

 

-

 

 

 

(12.2

)

 

 

-

 

 

 

 

-

 

Total other comprehensive income (loss), before tax

 

 

7.9

 

 

 

(11.1

)

 

 

(4.3

)

 

 

(6.3

)

 

 

 

(4.0

)

Provision (benefit) for income taxes related to other comprehensive income (loss)

 

 

0.1

 

 

 

-

 

 

 

(2.1

)

 

 

-

 

 

 

 

-

 

Total other comprehensive income (loss), net of tax

 

 

7.8

 

 

 

(11.1

)

 

 

(2.2

)

 

 

(6.3

)

 

 

 

(4.0

)

Comprehensive income (loss), net of tax

 

$

1.7

 

 

$

(12.7

)

 

$

(20.4

)

 

$

(20.2

)

 

 

$

(23.0

)

 

See notes to unaudited condensed consolidated financial statements.

 

2


 

Ranpak Holdings Corp.

Condensed Consolidated Balance Sheets

(in millions, except share data)

 

 

 

September 30, 2020

 

 

December 31, 2019

 

 

 

(unaudited)

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

31.3

 

 

$

19.7

 

Accounts receivable, net

 

 

42.4

 

 

 

36.1

 

Inventories, net

 

 

13.5

 

 

 

11.6

 

Income tax receivable

 

 

6.2

 

 

 

1.5

 

Prepaid expenses and other current assets

 

 

3.5

 

 

 

2.5

 

Total current assets

 

 

96.9

 

 

 

71.4

 

 

 

 

 

 

 

 

 

 

Property, plant and equipment, net

 

 

126.0

 

 

 

122.5

 

Goodwill

 

 

453.1

 

 

 

448.8

 

Intangible assets, net

 

 

441.8

 

 

 

458.6

 

Other assets

 

 

3.2

 

 

 

3.1

 

Total assets

 

$

1,121.0

 

 

$

1,104.4

 

 

 

 

 

 

 

 

 

 

Liabilities and Shareholders' Equity

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Accounts payable

 

$

21.8

 

 

$

12.3

 

Accrued liabilities and other

 

 

25.6

 

 

 

15.5

 

Current portion of long-term debt

 

 

1.6

 

 

 

1.6

 

Deferred machine fee revenue

 

 

0.8

 

 

 

2.5

 

Total current liabilities

 

 

49.8

 

 

 

31.9

 

 

 

 

 

 

 

 

 

 

Long-term debt

 

 

424.8

 

 

 

418.8

 

Deferred tax liabilities

 

 

115.8

 

 

 

115.0

 

Derivative instruments

 

 

11.3

 

 

 

4.6

 

Other liabilities

 

 

2.0

 

 

 

2.3

 

Total liabilities

 

 

603.7

 

 

 

572.6

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies – Note 13

 

 

 

 

 

 

 

 

Shareholders' equity

 

 

 

 

 

 

 

 

Class A common stock, $0.0001 par, 200,000,000 shares

 

 

 

 

 

 

 

 

authorized at September 30, 2020 and December 31, 2019

 

 

 

 

 

 

 

 

Shares issued and outstanding: 68,991,155 and 64,293,741

 

 

 

 

 

 

 

 

at September 30, 2020 and December 31, 2019, respectively

 

 

-

 

 

 

-

 

Class C common stock, $0.0001 par, 200,000,000 shares

 

 

 

 

 

 

 

 

authorized at September 30, 2020 and December 31, 2019

 

 

 

 

 

 

 

 

Shares issued and outstanding: 6,511,293 at September 30, 2020

 

 

 

 

 

 

 

 

and December 31, 2019

 

 

-

 

 

 

-

 

Additional paid-in capital

 

 

563.4

 

 

 

557.5

 

Accumulated deficit

 

 

(47.3

)

 

 

(29.1

)

Accumulated other comprehensive income

 

 

1.2

 

 

 

3.4

 

Total shareholders' equity

 

 

517.3

 

 

 

531.8

 

Total liabilities and shareholders' equity

 

$

1,121.0

 

 

$

1,104.4

 

 

See notes to unaudited condensed consolidated financial statements.

 

3


Ranpak Holdings Corp.

Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity

(in millions, except share data)

    

 

 

Ordinary Shares

 

 

Common Stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Class A

 

 

Class B

 

 

Class A

 

 

Class C

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Additional Paid-In Capital

 

 

Accumulated Earnings (Deficit)

 

 

Accumulated Other Comprehensive Income (Loss)

 

 

Total

 

Successor

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at June 3, 2019

 

 

2,770,967

 

 

$

-

 

 

 

11,250,000

 

 

$

-

 

 

 

-

 

 

$

-

 

 

 

-

 

 

$

-

 

 

$

16.9

 

 

$

(11.9

)

 

$

-

 

 

$

5.0

 

Forward purchase shares

 

 

15,000,000

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Additional shares purchased

 

 

16,149,317

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Conversion of forward purchase and additional shares

 

 

(31,149,317

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

25,454,282

 

 

 

-

 

 

 

5,695,035

 

 

 

-

 

 

 

267.0

 

 

 

-

 

 

 

-

 

 

 

267.0

 

Shares canceled

 

 

-

 

 

 

-

 

 

 

(3,854,664

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(33.0

)

 

 

-

 

 

 

-

 

 

 

(33.0

)

Convert Class B

 

 

-

 

 

 

-

 

 

 

(7,395,336

)

 

 

-

 

 

 

6,663,953

 

 

 

-

 

 

 

731,383

 

 

 

-

 

 

 

63.4

 

 

 

-

 

 

 

-

 

 

 

63.4

 

Convert public shares

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

14,581,346

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

125.0

 

 

 

-

 

 

 

-

 

 

 

125.0

 

Convert private placement warrants

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

658,051

 

 

 

-

 

 

 

84,875

 

 

 

-

 

 

 

6.4

 

 

 

-

 

 

 

-

 

 

 

6.4

 

Public shares redeemed

 

 

(2,770,967

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Amortization of restricted stock units

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

0.2

 

 

 

-

 

 

 

-

 

 

 

0.2

 

Other

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2.6

)

 

 

-

 

 

 

-

 

 

 

(2.6

)

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(12.4

)

 

 

-

 

 

 

(12.4

)

Other comprehensive income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2.3

 

 

 

2.3

 

Balance at June 30, 2019

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

47,357,632

 

 

 

-

 

 

 

6,511,293

 

 

 

-

 

 

 

443.3

 

 

 

(24.3

)

 

 

2.3

 

 

 

421.3

 

Issue Director shares

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,720

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Amortization of restricted stock units

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1.6

 

 

 

-

 

 

 

-

 

 

 

1.6

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1.6

)

 

 

-

 

 

 

(1.6

)

Other comprehensive loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(11.1

)

 

 

(11.1

)

Balance at September 30, 2019

 

 

-

 

 

$

-

 

 

 

-

 

 

$

-

 

 

 

47,361,352

 

 

$

-

 

 

 

6,511,293

 

 

$

-

 

 

$

444.9

 

 

$

(25.9

)

 

$

(8.8

)

 

$

410.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2019

 

 

-

 

 

$

-

 

 

 

-

 

 

$

-

 

 

 

64,293,741

 

 

$

-

 

 

 

6,511,293

 

 

$

-

 

 

$

557.5

 

 

$

(29.1

)

 

$

3.4

 

 

$

531.8

 

Stock-based awards vested and distributed

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

51,603

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Issue Director shares

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

6,903

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Amortization of restricted stock units

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2.2

 

 

 

-

 

 

 

-

 

 

 

2.2

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(3.6

)

 

 

-

 

 

 

(3.6

)

Other comprehensive loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(11.8

)

 

 

(11.8

)

Balance at March 31, 2020

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

64,352,247

 

 

 

-

 

 

 

6,511,293

 

 

 

-

 

 

 

559.7

 

 

 

(32.7

)

 

 

(8.4

)

 

 

518.6

 

Stock-based awards vested and distributed

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

143,048

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Issue Director shares

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

61,164

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Amortization of restricted stock units

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2.0

 

 

 

-

 

 

 

-

 

 

 

2.0

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(8.5

)

 

 

-

 

 

 

(8.5

)

Other comprehensive income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1.8

 

 

 

1.8

 

Balance at June 30, 2020

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

64,556,459

 

 

 

-

 

 

 

6,511,293

 

 

 

-

 

 

 

561.7

 

 

 

(41.2

)

 

 

(6.6

)

 

 

513.9

 

Warrant exchange

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

4,422,564

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Stock-based awards vested and distributed

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,048

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Issue Director shares

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

10,084

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Amortization of restricted stock units

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1.7

 

 

 

-

 

 

 

-

 

 

 

1.7

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(6.1

)

 

 

-

 

 

 

(6.1

)

Other comprehensive income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

7.8

 

 

 

7.8

 

Balance at September 30, 2020

 

 

-

 

 

$

-

 

 

 

-

 

 

$

-

 

 

 

68,991,155

 

 

$

-

 

 

 

6,511,293

 

 

$

-

 

 

$

563.4

 

 

$

(47.3

)

 

$

1.2

 

 

$

517.3

 

 

See notes to unaudited condensed consolidated financial statements.

4


Ranpak Holdings Corp.

Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity

(in millions, except share data)

 

 

 

Common Stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Additional Paid-In Capital

 

 

Accumulated Earnings (Deficit)

 

 

Treasury Stock

 

 

Accumulated Other Comprehensive Income (Loss)

 

 

Total

 

Predecessor

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2018

 

 

995

 

 

$

-

 

 

$

291.4

 

 

$

(69.9

)

 

$

(1.5

)

 

$

(23.6

)

 

$

196.4

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(3.2

)

 

 

-

 

 

 

-

 

 

 

(3.2

)

Other comprehensive income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(3.4

)

 

 

(3.4

)

Balance at March 31, 2019

 

 

995

 

 

 

-

 

 

 

291.4

 

 

 

(73.1

)

 

 

(1.5

)

 

 

(27.0

)

 

 

189.8

 

Purchase of Ranpak Corp.

 

 

(995

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Issue Director shares

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Amortization of restricted stock units

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(15.8

)

 

 

-

 

 

 

-

 

 

 

(15.8

)

Other comprehensive income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(0.6

)

 

 

(0.6

)

Balance at June 2, 2019

 

 

-

 

 

$

-

 

 

$

291.4

 

 

$

(88.9

)

 

$

(1.5

)

 

$

(27.6

)

 

$

173.4

 

 

See notes to unaudited condensed consolidated financial statements.

 

 

5


 

Ranpak Holdings Corp.

Unaudited Condensed Consolidated Statements of Cash Flows

(in millions)

 

 

 

Successor

 

 

 

Predecessor

 

 

 

Nine Months Ended September 30,

 

 

June 3, 2019

 

 

 

January 1, 2019

 

 

 

2020

 

 

– September 30, 2019

 

 

 

– June 2, 2019

 

Cash Flows from Operating Activities

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(18.2

)

 

$

(13.9

)

 

 

$

(19.0

)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

45.3

 

 

 

20.1

 

 

 

 

26.6

 

Amortization of deferred financing costs

 

 

1.2

 

 

 

0.7

 

 

 

 

7.5

 

Loss on disposal of fixed assets

 

 

1.7

 

 

 

0.2

 

 

 

 

1.0

 

Deferred income taxes

 

 

(0.9

)

 

 

(1.3

)

 

 

 

(7.2

)

Loss on derivative contract

 

 

-

 

 

 

6.4

 

 

 

 

-

 

Amortization of initial value of hedging instrument

 

 

(1.2

)

 

 

-

 

 

 

 

-

 

Currency (gain) loss on foreign denominated debt and notes payable

 

 

3.2

 

 

 

(0.8

)

 

 

 

(2.4

)

Amortization of restricted stock units

 

 

5.9

 

 

 

1.8

 

 

 

 

-

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

(Increase) decrease in receivables, net

 

 

(4.9

)

 

 

(0.8

)

 

 

 

1.8

 

(Increase) decrease in income tax receivables, net

 

 

(4.5

)

 

 

(5.3

)

 

 

 

1.7

 

(Increase) decrease in inventory

 

 

(2.7

)

 

 

2.7

 

 

 

 

(1.3

)

(Increase) decrease in prepaid expenses and other assets

 

 

(1.0

)

 

 

(0.5

)

 

 

 

2.7

 

Increase (decrease) in accounts payable

 

 

8.2

 

 

 

(14.1

)

 

 

 

(2.8

)

Increase (decrease) in accrued liabilities

 

 

6.5

 

 

 

3.1

 

 

 

 

7.1

 

Change in other assets and liabilities

 

 

(0.8

)

 

 

1.4

 

 

 

 

1.0

 

Net cash provided by (used in) operating activities

 

 

37.8

 

 

 

(0.3

)

 

 

 

16.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash Flows from Investing Activities

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital expenditures:

 

 

 

 

 

 

 

 

 

 

 

 

 

Converter equipment

 

 

(21.1

)

 

 

(9.7

)

 

 

 

(9.9

)

Other capital expenditures

 

 

(3.9

)

 

 

(0.8

)

 

 

 

(0.6

)

Total capital expenditures

 

 

(25.0

)

 

 

(10.5

)

 

 

 

(10.5

)

Cash paid for acquisitions

 

 

-

 

 

 

(945.6

)

 

 

 

-

 

Cash withdrawn from trust account

 

 

-

 

 

 

308.1

 

 

 

 

-

 

Patent and trademark expenditures

 

 

(0.5

)

 

 

(0.2

)

 

 

 

(0.3

)

Net cash used in investing activities

 

 

(25.5

)

 

 

(648.2

)

 

 

 

(10.8

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash Flows from Financing Activities

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from issuance of term loans and credit facility

 

 

-

 

 

 

534.6

 

 

 

 

-

 

Proceeds from sale of common stock

 

 

-

 

 

 

314.7

 

 

 

 

-

 

Shares subject to Redemption

 

 

-

 

 

 

(158.3

)

 

 

 

-

 

Financing costs of debt facilities

 

 

-

 

 

 

(12.6

)

 

 

 

-

 

Payments on term loans and credit facility

 

 

(1.2

)

 

 

-

 

 

 

 

(14.4

)

Payments of promissory note

 

 

-

 

 

 

(4.0

)

 

 

 

-

 

Payment of deferred registration costs

 

 

-

 

 

 

(11.3

)

 

 

 

-

 

Net cash provided by (used in) financing activities

 

 

(1.2

)

 

 

663.1

 

 

 

 

(14.4

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Effect of Exchange Rate Changes on Cash

 

 

0.5

 

 

 

(2.7

)

 

 

 

1.2

 

Net Increase (Decrease) in Cash and Cash Equivalents

 

 

11.6

 

 

 

11.9

 

 

 

 

(7.3

)

Cash and Cash Equivalents, beginning of period

 

 

19.7

 

 

 

1.7

 

 

 

 

17.5

 

Cash and Cash Equivalents, end of period

 

$

31.3

 

 

$

13.6

 

 

 

$

10.2

 

 

See notes to unaudited condensed consolidated financial statements.

 

 

6


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

Note 1 Nature of Operations

Ranpak Holdings Corp. (formerly known as One Madison Corporation) is a leading provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. Through proprietary protective packaging systems and paper consumables, the Company offers a full suite of protective packaging solutions. The Company’s business is global, with a strong presence in the United States and Europe.  Throughout this report, when we refer to “Ranpak,” the “Company,” “we,” “our,” or “us,” we are referring to Ranpak Holdings Corp. and all of our subsidiaries, except where the context indicates otherwise.

One Madison Corporation (“One Madison”) was originally formed as a blank check company incorporated on July 13, 2017 and was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. One Madison units, Class A ordinary shares originally sold as part of the units, and warrants originally sold as part of the units sold in the Company’s initial public offering on January 22, 2018 were listed in the New York Stock Exchange (the “NYSE”) under the symbols “OMAD.U”, “OMAD” and “OMAD.WS”, respectively.  The Class A ordinary shares and warrants comprising the units began separately trading on February 26, 2018.  Upon the closing of the business combination (the “Closing”) as described below, these shares and warrants that were converted as part of the transaction, began trading under the symbols “PACK” and “PACK WS,” respectively.

On June 3, 2019, the Company, consummated a business combination (the “Ranpak Business Combination”) pursuant to the Stock Purchase Agreement dated December 12, 2018 by and among the Company, Rack Holdings L.P., a Delaware limited partnership (“Seller”), and Rack Holdings, Inc., a Delaware corporation and a direct wholly owned subsidiary of Seller (“Rack Holdings”). The Company, through its wholly owned subsidiary, Ranger Packaging LLC (the “Acquiring Entity”), acquired all of the issued and outstanding equity interests of Rack Holdings from Seller, on the terms and subject to the conditions set forth in the Stock Purchase Agreement. Refer to Note 7, “Acquisition” for further discussion of the Ranpak Business Combination. In connection with the Ranpak Business Combination, the Company domesticated to a Delaware corporation on May 31, 2019 and changed its name to Ranpak Holdings Corp.

Note 2 Basis of Presentation and Summary of Significant Accounting Policies

Unaudited Interim Financial Statements These interim unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and accompanying notes for each of the three years ended December 31, 2019, 2018, and 2017 and Rack Holdings’ audited consolidated financial statements and accompanying notes for each of the years ended December 31, 2018, and 2017, which are included in our Annual Report on Form 10-K for the year ended December 31, 2019 (“Form 10-K”) and the Company’s Registration Statement on Form S-4, as amended (File No. 333-230030) (the “Registration Statement”), respectively.  Periods prior to the Ranpak Business Combination are noted as Predecessor periods and periods after the Ranpak Business Combination are noted as Successor periods, both of which are subsequently defined.

The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and with instructions to Form 10-Q and Rule 10-01 of the Securities and Exchange Commission (“SEC”) Regulation S-X as they apply to interim financial information.  Accordingly, the unaudited interim condensed consolidated financial statements do not include all of the information and notes required by GAAP for complete financial statements, although we believe that the disclosures made are adequate to make the information not misleading.

The interim condensed consolidated financial statements are unaudited but, in our opinion, include all adjustments that are necessary for a fair statement of operations and financial position for the periods presented.  The interim financial results are not necessarily indicative of results that may be expected for any other interim period or the fiscal year.

Predecessor and Successor Reporting — On June 3, 2019, the Company consummated the acquisition of all outstanding and issued equity interests of Rack Holdings, pursuant to the Stock Purchase Agreement, and now owns 100% of Rack Holdings Inc. and its wholly owned subsidiaries.  The Ranpak Business Combination is accounted for under the scope of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 805, Business Combinations (“ASC 805”), as One Madison was deemed to be the accounting acquirer while Rack Holdings was deemed the “Predecessor.”  Accordingly, the business combination is accounted for using the acquisition method which requires the Company to record the fair value of assets acquired and liabilities assumed from Rack Holdings (See Note 7, “Acquisition”).

 

7


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

The financial statements separate the Company’s presentation into two distinct periods. The period before the Closing of the Ranpak Business Combination (labeled Predecessor period) depicts the financial statements of Rack Holdings, and the period after the Closing (labeled Successor period) depicts the financial statements of the Company, including the consolidation of One Madison with Rack Holdings and application of acquisition method of accounting.  Further, the period of June 3, 2019 through September 30, 2019 is defined as the “Successor Period” and the period January 1, 2019 through June 2, 2019 is defined as the “1H 2019 Predecessor Period.”  As a result of the application of the acquisition method of accounting as of the Closing, the financial statements for the Predecessor periods and for the Successor periods are presented on a different basis of accounting and are, therefore, not comparable.

Principles of Consolidation — The unaudited interim condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries prepared in conformity with GAAP.  All intercompany balances and transactions have been eliminated in consolidation and certain immaterial prior year amounts have been reclassified consistent with current year presentation.  All amounts are in millions, except share and per share amounts and are approximate due to rounding.

Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from these estimates and such differences could be material.

Foreign Currency — The nature of business activities involves the management of various financial and market risks, including those related to changes in foreign currency exchange rates.  The functional currency of our operating subsidiaries outside the U.S. is the applicable local currency.  For those operations, assets and liabilities are translated into U.S. dollars at period-end exchange rates and revenues and expenses are translated into U.S. dollars using average monthly exchange rates.

Emerging Growth Company (“EGC”) — Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (“JOBS Act”) exempts EGCs from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act of 1933, as amended, registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended) are required to comply with the new or revised financial accounting standards.  The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable.  We have elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an EGC, can adopt the new or revised standard at the time private companies adopt the new or revised standard.  This may make comparison of our financial statements with another public company, which is neither an EGC nor an EGC which has opted out of using the extended transition period, difficult or impossible because of the potential differences in accounting standards used.

Recently Adopted Accounting Standards — In August 2018, the FASB issued Accounting Standards Update (“ASU”) No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”).  ASU 2018-13 modifies the disclosure requirements on fair value measurements.  We adopted ASU 2018-13 on January 1, 2020.  The adoption of ASU 2018-13 did not have an impact on our fair value disclosures.

Recently Issued Accounting Standards — In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) (“ASC 842”).  The amendments in this ASU require an entity to recognize a right-of-use asset and lease liability for all leases with terms of more than 12 months.  Recognition, measurement and presentation of expenses will depend on classification as a finance or operating lease.  The amendments also require certain quantitative and qualitative disclosures about leasing arrangements.  ASC 842 was originally effective for fiscal years beginning after December 15, 2019, and interim periods beginning after December 15, 2020 with early adoption permitted.  In October 2019, the FASB delayed the implementation of ASC 842 for private companies until fiscal years beginning after December 15, 2020.  In June 2020, the FASB further delayed the implementation of ASC 842 for private companies until fiscal years beginning after December 15, 2021.  Given our status as an EGC, we will adopt ASC 842 in accordance with the private company guidance.  Our implementation team includes personnel from accounting, tax, legal, information technology, and operations departments.  We are in the process of analyzing our lease portfolio and business processes to determine the impact of the new standard on our financial statements and disclosures, however, an estimate of the impact is unavailable at this time.

8


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which amends the FASB’s guidance on the impairment of financial instruments.  ASU 2016-13 adds to GAAP an impairment model (known as the “current expected credit loss model”) that is based on expected losses rather than incurred losses.  ASU 2016-13 was originally effective for annual reporting periods beginning after December 15, 2019, including interim periods within those fiscal years.  On October 16, 2019, the FASB delayed the implementation of ASU 2016-13 for private companies until fiscal years beginning January 1, 2023.  Given our status as an EGC, we will adopt ASU 2016-13 in accordance with the private company guidance.  We are currently evaluating the impact that this new guidance will have on our financial position, results of operations, cash flows and related disclosures.

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848):  Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”).  The amendments in ASU 2020-04 provide optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform.  These expedients and exceptions do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022, except for hedging relationships existing as of December 31, 2022, for which an entity has elected certain optional expedients and that are retained through the end of the hedging relationship.  ASU 2020-04 is effective for all entities as of March 12, 2020 (the date of the issuance of ASU 2020-04) through December 31, 2022.  An entity may elect to apply the amendments for contract modifications as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or prospectively from a date within an interim period that includes or is subsequent to March 12, 2020, up to the date that the financial statements are available to be issued.  We are evaluating the impact of ASU 2020-04 on our financial statements and disclosures.

Note 3 Supplemental Balance Sheet Data and Cash Flow Information

Accounts Receivable, net — The components of accounts receivable, net was follows:

 

 

 

September 30, 2020

 

 

December 31, 2019

 

Accounts receivable

 

$

42.9

 

 

$

36.3

 

Allowance for doubtful accounts

 

 

(0.5

)

 

 

(0.2

)

Accounts receivable, net

 

$

42.4

 

 

$

36.1

 

 

Inventories, net — The components of inventories, net were as follows:

 

 

 

September 30, 2020

 

 

December 31, 2019

 

Raw materials

 

$

9.1

 

 

$

7.2

 

Finished goods

 

 

5.6

 

 

 

4.7

 

Total inventories

 

 

14.7

 

 

 

11.9

 

Reserve for obsolescence

 

 

(1.2

)

 

 

(0.3

)

Inventories, net

 

$

13.5

 

 

$

11.6

 

 

Property, Plant and Equipment, net — The following table details our property, plant and equipment, net:

 

 

 

September 30, 2020

 

 

December 31, 2019

 

Land

 

$

4.1

 

 

$

4.1

 

Buildings and improvements

 

 

8.8

 

 

 

8.1

 

Machinery and equipment

 

 

14.3

 

 

 

13.0

 

Computer and office equipment

 

 

8.8

 

 

 

6.7

 

Converting machines

 

 

129.1

 

 

 

105.9

 

Total property, plant, and equipment

 

 

165.1

 

 

 

137.8

 

Accumulated depreciation

 

 

(39.1

)

 

 

(15.3

)

Property, plant, and equipment, net

 

$

126.0

 

 

$

122.5

 

 

9


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

Depreciation expense recorded in cost of sales and depreciation and amortization in the unaudited condensed consolidated statements of operations and comprehensive income (loss) was as follows:

 

 

 

Successor

 

 

 

Predecessor

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

June 3, 2019 –

 

 

 

January 1, 2019

 

 

 

2020

 

 

2019

 

 

2020

 

 

September 30, 2019

 

 

 

– June 2, 2019

 

Depreciation expense included in cost of goods sold

 

$

8.0

 

 

$

5.1

 

 

$

22.4

 

 

$

6.9

 

 

 

$

8.9

 

Depreciation expense included in depreciation and amortization expense

 

 

0.6

 

 

 

0.4

 

 

 

1.6

 

 

 

0.5

 

 

 

 

0.7

 

Total depreciation expense

 

$

8.6

 

 

$

5.5

 

 

$

24.0

 

 

$

7.4

 

 

 

$

9.6

 

 

Supplemental Cash Flow Information — Supplemental cash flow information is as follows:

 

 

 

Successor

 

 

 

Predecessor

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

June 3, 2019 –

 

 

 

January 1, 2019

 

 

 

2020

 

 

2019

 

 

2020

 

 

September 30, 2019

 

 

 

– June 2, 2019

 

Interest paid

 

$

5.5

 

 

$

7.9

 

 

$

17.0

 

 

$

7.9

 

 

 

$

12.5

 

Taxes paid

 

 

1.2

 

 

 

2.2

 

 

 

2.7

 

 

 

2.4

 

 

 

 

4.0

 

Capital leases

 

$

-

 

 

$

-

 

 

$

0.3

 

 

$

-

 

 

 

$

-

 

 

Note 4 Segment and Geographic Information

In accordance with ASC 280, Segment Reporting (“ASC 280”), we determined we have two operating segments which are aggregated into one reportable segment, Ranpak.  The chief operating decision maker assesses the Company’s performance and allocates resources based on the Company’s consolidated financial information.  The aggregation of the two operating segments is based on the Company’s determination that, per ASC 280, the operating segments have similar economic characteristics, and are similar in all of the following areas: the nature of products and services, the nature of production processes, the type or class of customer for their products or services, and the methods used to distribute their products or provide their services.  In addition, the operating segments were aggregated for purposes of determining whether segments meet the quantitative threshold for separate reporting.

We attribute revenue to individual countries based on the selling location.  Our products are primarily sold from North America and Europe.  The following table presents a summary of total net revenue to external customers by geographic location:

 

 

 

Successor

 

 

 

Predecessor

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

June 3, 2019 –

 

 

 

January 1, 2019

 

 

 

2020

 

 

2019

 

 

2020

 

 

September 30, 2019

 

 

 

– June 2, 2019

 

North America

 

$

33.3

 

 

$

32.9

 

 

$

88.6

 

 

$

42.2

 

 

 

$

50.1

 

Europe/Asia

 

 

43.5

 

 

 

36.2

 

 

 

117.7

 

 

 

43.2

 

 

 

 

56.3

 

Net revenue

 

$

76.8

 

 

$

69.1

 

 

$

206.3

 

 

$

85.4

 

 

 

$

106.4

 

 

Our customers are not concentrated in any specific geographic region.  During the nine months ended September 30, 2020 and the 1H 2019 Predecessor Period, no customers exceeded 10% of net revenue.  During the Successor Period, one customer accounted for approximately 10.1% of net revenue.

10


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

Note 5 Revenue Recognition, Contracts with Customers

Revenue is recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration expected to be received in exchange for those goods or services.  Revenue for paper consumables is recognized based on shipping terms, which is the point in time the customer obtains control of the promised goods.  Revenue for equipment sales is recognized based on an input method, based on percentage of completion of cost and effort incurred.  Maintenance revenue is recognized straight-line on the basis that the level of effort is consistent over the term of the contract.  Lease components within contracts with customers are recognized in accordance with ASC Topic 840, Leases (“ASC 840”).

Sales, value-added, and other taxes collected from customers and remitted to governmental authorities are excluded from revenue.

Our paper consumables, automation equipment, and maintenance services are determined to be distinct performance obligations.  Free on loan and leased equipment is typically identified as a separate lease component in scope of ASC 840.  In association to the sale of automation equipment, we sell other goods and services, such as extended warranties, preventative maintenance services, spare parts and spare part packages, and consulting services.  These other goods and services do not represent performance obligations because they are neither separate nor distinct, or they are not material.

We have forms of variable consideration present in our contracts with customers, including rebates and other discounts.  We estimate variable consideration using either the expected value method or the most likely amount method.  We include in the transaction price some or all of an amount of variable consideration estimated to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.

The time between when a performance obligation is satisfied and when billing and payment occur is closely aligned and performance obligations do not extend beyond one year.  As the transfer of control of our products results in an unconditional right to receive consideration, we did not record contract assets as of September 30, 2020 and December 31, 2019.

Deferred revenue represents contractual amounts received from customers that exceed percentage of project completion that is in excess of costs incurred for automation equipment sales, as well as prepayments for machine fees that are amortized over the next quarter.  Our enforceable contractual obligations have durations of less than one year and are included in current liabilities on the unaudited condensed consolidated balance sheets.  Changes in deferred revenue were as follows:

 

 

 

Nine Months Ended September 30,

 

 

 

2020

 

Beginning balance

 

$

2.5

 

Deferral of revenue

 

 

1.3

 

Recognition of revenue

 

 

(1.9

)

Adjustment for returns

 

 

(1.1

)

Ending balance

 

$

0.8

 

 

In addition to the disaggregation of revenue between paper, machine lease, and other revenue, we further disaggregate our revenue by segment geography to assist in evaluating the nature, timing, and uncertainty of revenue and cash flows that may be impacted by economic factors:

 

 

 

Successor

 

 

 

Predecessor

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

June 3, 2019 –

 

 

 

January 1, 2019

 

 

 

2020

 

 

2019

 

 

2020

 

 

September 30, 2019

 

 

 

– June 2, 2019

 

North America

 

$

29.0

 

 

$

29.0

 

 

$

76.6

 

 

$

38.3

 

 

 

$

43.0

 

Europe/Asia

 

 

37.4

 

 

 

30.8

 

 

 

101.4

 

 

 

35.3

 

 

 

 

49.0

 

Machine lease revenue

 

 

10.4

 

 

 

9.3

 

 

 

28.3

 

 

 

11.8

 

 

 

 

14.4

 

Net revenue

 

$

76.8

 

 

$

69.1

 

 

$

206.3

 

 

$

85.4

 

 

 

$

106.4

 

 

11


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

North America consists of the United States, Canada and Mexico; Europe/Asia consists of European, Asian (including China), Pacific Rim, South American and African countries.

Note 6 Goodwill, Long-Lived and Intangible Assets, Net

Goodwill and Indefinite-Lived Intangible Assets

Goodwill represents the excess of purchase price over the fair value of net assets acquired.  Trademarks and trade names are accounted for as indefinite-lived intangible assets and, accordingly, are not subject to amortization.  We review goodwill on a reporting unit basis and indefinite-lived assets for impairment annually on October 1st and on an interim basis whenever events or changes in circumstances indicate the carrying value of goodwill or indefinite-lived intangible assets may be impaired.

Due to the COVID-19 outbreak, we assessed whether events or circumstances indicate that it was more likely than not that our goodwill and indefinite-lived intangible assets were impaired as of September 30, 2020.  The goodwill and indefinite-lived intangible assets assessments included consideration of key factors such as macroeconomic conditions, industry and market considerations, cost factors, and other relevant entity-and reporting unit-specific events.  While the extent and duration of the economic implications from the COVID-19 pandemic remain unclear, we concluded that it is more likely than not that the fair value of our reporting units and indefinite-lived intangible assets exceeded their carrying values at September 30, 2020.

The following table shows our goodwill balances by operating segment that are aggregated into one reportable segment:

 

 

 

North America

 

 

Europe

 

 

Total

 

Balance at December 31, 2019

 

$

343.0

 

 

$

105.8

 

 

$

448.8

 

Currency translation

 

 

-

 

 

 

4.3

 

 

 

4.3

 

Balance at September 30, 2020

 

$

343.0

 

 

$

110.1

 

 

$

453.1

 

 

Finite-Lived Intangible Assets, net

Finite-lived or amortizable intangible assets consist of patented and unpatented technology and customer/distributor relationships.  In the second quarter of 2020, certain in-process research & development assets were placed in service and transferred into patented/unpatented technology to be amortized over a five-year life.

Impairment of Long-lived Assets

We review our long-lived assets, including amortizable intangible assets and property, plant and equipment, for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable.  For long-lived assets, an impairment loss is indicated when the undiscounted cash flows estimated to be generated by the asset group are not sufficient to recover the unamortized balance of the asset group.  If indicators exist, the loss is measured as the excess of carrying value over the asset group’s fair value, as determined based on discounted future cash flows, asset appraisal and market values of similar assets.  As of September 30, 2020, there were no indicators of impairment present for property, plant and equipment or amortizable intangible assets that required us to test for recoverability.

The following tables summarize our identifiable intangible assets, net with definite and indefinite useful lives:

 

 

 

September 30, 2020

 

 

December 31, 2019

 

 

 

Gross Carrying Amount

 

 

Accumulated Amortization

 

 

Net

 

 

Gross Carrying Amount

 

 

Accumulated Amortization

 

 

Net

 

Customer/distributor relationships

 

$

204.1

 

 

$

(18.3

)

 

$

185.8

 

 

$

199.5

 

 

$

(7.9

)

 

$

191.6

 

Patented/unpatented technology

 

 

168.3

 

 

 

(20.0

)

 

 

148.3

 

 

 

164.5

 

 

 

(8.5

)

 

 

156.0

 

In-process research and development

 

 

1.6

 

 

 

-

 

 

 

1.6

 

 

 

5.0

 

 

 

-

 

 

 

5.0

 

Total definite-lived intangible assets

 

 

374.0

 

 

 

(38.3

)

 

 

335.7

 

 

 

369.0

 

 

 

(16.4

)

 

 

352.6

 

Trademarks/tradenames with indefinite lives

 

 

106.1

 

 

 

-

 

 

 

106.1

 

 

 

106.0

 

 

 

-

 

 

 

106.0

 

Identifiable intangible assets, net

 

$

480.1

 

 

$

(38.3

)

 

$

441.8

 

 

$

475.0

 

 

$

(16.4

)

 

$

458.6

 

 

12


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

The following table shows the remaining estimated amortization expense for our definite-lived intangible assets at September 30, 2020:

Year

 

Amount

 

2020

 

$

7.2

 

2021

 

 

29.0

 

2022

 

 

29.0

 

2023

 

 

29.0

 

2024

 

 

29.0

 

Thereafter

 

 

210.9

 

 

 

$

334.1

 

 

Amortization expense was $7.1 million and $21.3 million in the three and nine months ended September 30, 2020, respectively.  Amortization expense was $9.8 million in the three months ended September 30, 2019, $12.7 million in the Successor Period, and $17.0 million in the 1H 2019 Predecessor Period.

The following table shows the remaining weighted-average useful life of our definite lived intangible assets as of September 30, 2020:

 

 

 

Remaining Weighted-Average Useful Life

Customer/distributor relationships

 

14 years

Patented/unpatented technology

 

10 years

Total identifiable assets, net with definite lives

 

12 years

 

Note 7 Acquisition

Ranpak Business Combination — On June 3, 2019, the Company consummated the acquisition of all outstanding and issued equity interests of Rack Holdings, the Ranpak Business Combination, pursuant to the Stock Purchase Agreement for consideration of $794.9 million and €140.0 million ($160.8 million) in cash, (i) $341.5 million and €140.0 million ($160.8 million) of which was used by the Seller to repay outstanding indebtedness and unpaid transaction expenses as contemplated by the Stock Purchase Agreement and (ii) the remainder of which was paid to Seller.  The purchase price paid at Closing was estimated and subject to customary post-Closing adjustments which included an adjustment of $0.7 million for net working capital and as additional consideration.

The Ranpak Business Combination is accounted for under ASC 805.  Pursuant to ASC 805, the Company has been determined to be the accounting acquirer.  Refer to Note 1, Nature of Operations, for more information.  Rack Holdings constitutes a business with inputs, processes, and outputs.  Accordingly, the acquisition of Rack Holdings constitutes the acquisition of a business for purposes of ASC 805 and, due to the change in control of Rack Holdings, was accounted for using the acquisition method.  The Company recorded the fair value of assets acquired and liabilities assumed from Rack Holdings.

The allocation of the consideration to the assets acquired and liabilities assumed is based on various estimates.  As of December 31, 2019, the Company completed evaluation of net working capital as part of the purchase price paid at Closing and paid additional consideration of $0.7 million.  We finalized the purchase accounting fair value assessment in the second quarter of 2020.

13


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

The following represents the purchase price allocation for the Ranpak Business Combination:

 

 

 

Amount

 

Total consideration

 

$

955.7

 

Cash and cash equivalents

 

 

10.1

 

Accounts receivable

 

 

28.2

 

Inventories

 

 

16.1

 

Property, plant and equipment

 

 

119.5

 

Other assets

 

 

4.8

 

Intangible assets

 

 

473.7

 

Total identifiable assets acquired

 

 

652.4

 

Accounts payable

 

 

8.6

 

Accrued expenses

 

 

7.4

 

Other liabilities

 

 

5.0

 

Deferred tax liabilities

 

 

122.9

 

Net identifiable liabilities acquired

 

 

143.9

 

Goodwill

 

$

447.2

 

 

Intangible assets and property, plant and equipment balances comprise the following:

 

 

 

Fair Value

 

 

Remaining

Useful Lives

Patented/Unpatented Technology

 

$

164.1

 

 

10 years

Customer/Distributor Relationships

 

 

198.6

 

 

15 years

In-Process Research & Development

 

 

5.0

 

 

N/A

Trade Names/Trademarks

 

 

106.0

 

 

Indefinite

Total Fair Value

 

$

473.7

 

 

 

 

 

 

 

 

 

 

Machinery and Equipment

 

$

17.6

 

 

5 years

Converting Machines

 

 

90.4

 

 

3 - 7 years

Buildings and Improvements

 

 

7.4

 

 

15 years

Land

 

 

4.1

 

 

N/A

Total Fair Value

 

$

119.5

 

 

 

 

The fair values for the trade names/trademarks, patented/unpatented technology, and in-process R&D were determined using the Relief-from-Royalty Method, which is a combination of an Income Approach and Market Approach. The fair value for customer/distributor relationships was determined using the Multi-Period Excess Earnings Method, which is an Income-based Approach.  In the second quarter of 2020, certain in-process research & development assets were placed in service and transferred into patented/unpatented technology to be amortized over a five-year life, which was determined using our analysis of feasibility and utility of the assets.

The fair value for land was determined using Sales Comparison and Cost Approaches, depending on location. The fair value for machinery and equipment, and buildings and improvements were determined using a combination of the Cost Approach and Market Approach, considering physical deterioration when determining current reproduction costs.

The estimates of remaining useful lives for the intangible assets and property, plant, and equipment were determined by assessing the period of economic benefit of the assets.

Goodwill represents the excess of the total purchase consideration over the fair value of the underlying net assets, largely arising from the assembled workforce, new customers and the replacement of customers and technology attrition.  Goodwill is not amortized for tax purposes.

14


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

The following unaudited information represents the supplemental pro forma results of the Company’s condensed consolidated statement of operations as if the Ranpak Business Combination occurred on January 1, 2019, for the three and nine months ended September 30, 2019, after giving effect to certain adjustments, including depreciation and amortization of the assets acquired and liabilities assumed based on their estimated fair values and changes in interest expense resulting from changes in debt (in millions):

 

 

 

Three Months Ended

September 30, 2019

 

 

Nine Months Ended

September 30, 2019

 

Net revenue

 

$

70.4

 

 

$

198.2

 

Net loss

 

$

0.8  

 

 

$

(9.8

)

 

These pro forma results were based on estimates and assumptions, which the Company believes are reasonable. They are not the results that would have been realized had the Company been a combined company during the periods presented and are not necessarily indicative of consolidated results of operations in future periods. The pro forma results include adjustments primarily related to purchase accounting adjustments. Acquisition costs and other non-recurring charges incurred are included in the earliest period presented.

Neopack Acquisition — On February 28, 2017, pursuant to the Share Purchase Agreement (“e3NEO Purchase Agreement”) the Predecessor acquired all of the capital stock of Neopack Solutions S.A.S. dba e3NEO.

The e3NEO Purchase Agreement contained a contingent consideration arrangement that required the Company to pay e3NEO a “Next Generation Machine Payment”, which was computed by the Company based on certain criteria established in the e3NEO Purchase Agreement.  The criteria included, but were not limited to, the design and development by e3NEO of a prototype of the “Next Generation Machine” as defined in the e3NEO Purchase Agreement.  The maximum amount payable, $1.1 million, was recorded as contingent consideration, all of which was paid in 2018.

Additionally, the e3NEO Purchase Agreement contains an earn-out provision whereby the seller may be entitled to receive an earn-out payment in an amount up to the greater of (i) $2.6 million (the “Minimum Earn-Out Amount”), and (ii) the trailing twelve (12) month earnings before income taxes, depreciation and amortization of the business calculated as of December 31, 2020 multiplied by forty-eight percent (48%).  In order to be eligible to receive the Minimum Earn-Out Amount pursuant to the purchase agreement, e3NEO must have caused the business to receive purchase orders from customers and receive sign-off from customers upon completion of a successful factory acceptance test related to certain next generation machines on or before December 31, 2019 subject to reasonable approval of the Company. The conditions of the earn-out were not achieved and the Company agreed to a settlement arrangement with the former majority owner of e3NEO, which was approved by French authorities and finalized on April 21, 2020.  The arrangement provides for a payment to the earn-out counterparties in the amount of approximately $1.6 million and also provides the former majority owner of e3NEO severance from the Company, including non-compete and consulting amounts under French law.  Approximately $0.2 million was expensed in the second quarter of 2020 after certain approvals were obtained by French authorities.  Approximately $0.8 million was paid in the second quarter of 2020.  Approximately $0.6 million was accrued for at September 30, 2020 and included in other non-current liabilities in the unaudited condensed consolidated balance sheets.  

Note 8 Long-Term Debt

In connection with the Closing of the Ranpak Business Combination, Ranger Pledgor LLC (“Holdings”), Ranger Packaging LLC (the “U.S. Borrower”), and Ranpak B.V. (the “Dutch Borrower" and together with the US Borrower, the “Borrowers”), entered into a First Lien Credit Agreement that provided for senior secured credit facilities to, in part, (i) fund the business combination, (ii) repay and terminate the existing indebtedness of Rack Holdings, and (iii) pay all fees, premiums, expenses and other transaction costs incurred in connection with the foregoing. The aggregate principal amount of the senior secured credit facilities consists of a $378.2 million dollar-denominated first lien term facility (the “First Lien Dollar Term Facility”), a €140.0 million ($152.6 million equivalent) euro-denominated first lien term facility (the “First Lien Euro Term Facility” and, together with the First Lien Dollar Term Facility, the “First Lien Term Facility”) and a $45.0 million revolving facility (the “Revolving Facility” and together with the First Lien Term Facility, the “Facilities”). The First Lien Term Facility matures seven years after the closing date and the Revolving Facility matures five years after the closing date. In December 2019, the Company closed on a public offering of its Class A common stock generating net proceeds of approximately $107.7 million that was used to pay down the First Lien Dollar Term Facility.  As of September 30, 2020 and December 31, 2019, no amounts were outstanding under the Revolving Facility.

15


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

Long-term debt consisted of the following:

 

 

 

September 30, 2020

 

 

December 31, 2019

 

First Lien Dollar Term Facility

 

$

270.9

 

 

$

270.9

 

First Lien Euro Term Facility

 

 

162.5

 

 

 

157.3

 

Deferred financing costs, net

 

 

(7.0

)

 

 

(7.8

)

Total debt

 

 

426.4

 

 

 

420.4

 

Less: current portion

 

 

(1.6

)

 

 

(1.6

)

Long-term debt

 

$

424.8

 

 

$

418.8

 

 

Borrowings under the Facilities, at the Borrowers’ option, bear interest at either (1) an adjusted eurocurrency rate or (2) a base rate, in each case plus an applicable margin. The applicable margin is 3.75% with respect to eurocurrency borrowings and base rate borrowings as of September 30, 2020 and December 31, 2019, (in each case, assuming a first lien net leverage ratio of less than 5.00:1.00), subject to a leverage-based step-up to an applicable margin equal to 400 basis points for eurocurrency borrowings.  The interest rate for the First Lien Dollar Term Facility as of September 30, 2020 and December 31, 2019 was 3.91% and 5.70%, respectively.  The interest rate for the First Lien Euro Term Facility as of September 30, 2020 and December 31, 2019 was 3.75% and 4.00%, respectively.

The Revolving Facility includes borrowing capacity available for standby letters of credit of up to $5.0 million. Any issuance of letters of credit will reduce the amount available under the Revolving Facility.

The Facilities will provide the Borrowers with the option to increase commitments under the Facilities in an aggregate amount not to exceed the greater of $95.0 million and 100% of trailing-twelve months Consolidated EBITDA (as defined in the definitive documentation with respect to the Facilities), plus any voluntary prepayments of the debt financing (and, in the case of the Revolving Facility, to the extent such voluntary prepayments are accompanied by permanent commitment reductions under the Revolving Facility), plus unlimited amounts subject to the relevant net leverage ratio tests and certain other conditions.

The obligations of (i) the US Borrower under the Facilities and certain of its obligations under hedging arrangements and cash management arrangements are unconditionally guaranteed by Holdings and each existing and subsequently acquired or organized direct or indirect wholly-owned US organized restricted subsidiary of Holdings (together with Holdings, the “US Guarantors”) and (ii) the Dutch Borrower under the Facilities are unconditionally guaranteed by the US Borrower, the US Guarantors and each existing and subsequently acquired or organized direct or indirect wholly-owned Dutch organized restricted subsidiary of Holdings (the “Dutch Guarantors”, and together with the US Guarantors, the “Guarantors”), in each case, other than certain excluded subsidiaries. The Facilities are secured by (i) a first priority pledge of the equity interests of the Borrowers and of each direct, wholly-owned restricted subsidiary of any Borrower or any Guarantor and (ii) a first priority security interest in substantially all of the assets of the Borrowers and the Guarantors (in each case, subject to customary exceptions), provided that obligations of the US Borrower and US Guarantors under the Facilities were not secured by assets of the Dutch Borrower or any Dutch Guarantor.

The Facilities impose restrictions that require the Company to comply with or maintain certain financial tests and ratios. Such agreements restrict our ability to, among other things: (i) declare dividends or redeem or repurchase capital stock, including with respect to Class A common stock; (ii) prepay, redeem or purchase other debt; (iii) incur liens; (iv) make loans, guarantees, acquisitions and other investments; (v) incur additional indebtedness; (vi) engage in sale and leaseback transactions; (vii) amend or otherwise alter debt and other material agreements; (viii) engage in mergers, acquisitions and asset sales; (ix) engage in transactions with affiliates; and (x) enter into arrangements that would prohibit us from granting liens or restrict our ability to pay dividends, make loans or transfer assets among our subsidiaries.  We were in compliance with all financial covenants as of September 30, 2020.

On February 14, 2020, Ranger Packaging LLC, a Delaware limited liability company (“U.S. Borrower”), Ranpak B.V., (the “Dutch Borrower”; the U.S. Borrower and the Dutch Borrower, the “Borrowers”), Ranger Pledgor LLC, a Delaware limited liability company (“Holdings”), certain other subsidiaries of Holdings, certain lenders party to Amendment No. 1 (as defined below) and Goldman Sachs Lending Partners LLC (the “Administrative Agent”) entered into the Amendment No. 1 to First Lien Credit Agreement (“Amendment No. 1”) to amend the First Lien Credit Agreement, dated as of June 3, 2019 among the Borrowers, Holdings, the lenders, the issuing banks and the Administrative Agent (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”).

16


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

Among other things, the Amendment No. 1 amends the Credit Agreement such that (i) the requirement of the Borrowers to apply excess cash flow to mandatorily prepay term loans under the Credit Agreement commences with the fiscal year ending December 31, 2021 (instead of the fiscal year ending December 31, 2020) and (ii) the aggregate amount per fiscal year of capital stock of any parent company of the U.S. Borrower that is held by directors, officers, management, employees, independent contractors or consultants of the U.S. Borrower (or any parent company or subsidiary thereof) that the U.S. Borrower may repurchase, redeem, retire or otherwise acquire or retire for value has been increased to the greater of $10,000,000 and 10% of Consolidated Adjusted EBITDA (as defined in the Credit Agreement) (increased from the greater of $7,000,000 and 7% of Consolidated Adjusted EBITDA) as of the last day of the most recently ended four fiscal quarter period for which financial statements have been delivered.

On July 1, 2020, we entered into a borrower assumption agreement (“Borrower Assumption Agreement”), which provided that, in the following order, (i) Rack Holdings Inc. merged with and into Ranger Packaging LLC, with Ranger Packaging LLC as the surviving entity of such merger and (ii) Ranger Packaging LLC merged with and into Ranpak Corp., with Ranpak Corp. as the surviving entity of such merger (clauses (i) and (ii) collectively, the “Reorganization”).  Contemporaneously with the Reorganization, Ranger Packaging LLC, Ranpak Corp., Ranger Pledgor LLC, certain other subsidiaries of Ranger Pledgor LLC and Goldman Sachs Lending Partners LLC entered into the Borrower Assumption Agreement whereby, among other things, Ranpak Corp. assumed all obligations, liabilities and rights of Ranger Packaging LLC as the “U.S. Borrower” under the New Credit Facilities.

Note 9 Derivative Instruments

We use derivatives as part of the normal business operations to manage our exposure to fluctuations in interest rates associated with variable interest rate debt and decrease the volatility of cash flows affected by changes in interest rates.

On January 31, 2019, the Company entered into a business combination contingent interest rate swap in a notional amount of $200.0 million (the “January 2019 Swap”) to hedge part of the floating interest rate exposure under the First Lien Dollar Term Facility.  The January 2019 Swap became effective on the Closing of the Ranpak Business Combination and will terminate on the third anniversary of the Closing on June 3, 2022.  The January 2019 Swap economically converts a portion of the variable rate debt to fixed rate debt.  The Company receives floating interest payments monthly based on one-month LIBOR and pays a fixed rate of 2.56% to the counterparty.  Prior to September 25, 2019, the Company did not apply hedge accounting to the January 2019 Swap.  Changes in fair value were recorded to interest expense.  

On September 25, 2019, the Company amended the January 2019 Swap to extend its term to mature on June 1, 2023 and lower the rate to 2.31% (the “Amended January 2019 Swap”).  We concurrently entered into an incremental $50.0 million notional swap at 1.5% and maturing on June 1, 2023 (the “September 2019 Swap”).  

Additionally, on September 25, 2019, we designated as cash flow hedges the Amended January 2019 Swap and the September 2019 Swap and applied hedge accounting.  Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for us making fixed-rate payments over the life of the contract agreements without exchange of the underlying notional amount.  Changes in fair value are recorded in accumulated other comprehensive income (loss) and subsequently reclassified into interest expense in the same period during which the hedged transaction affects earnings.

On March 27, 2020, we entered into an interest rate swap that amended the Amended January 2019 Swap to a lower rate of 2.1% and extended the maturity to June 3, 2024 (the “Second Amended January 2019 Swap”).  We designated the Second Amended January 2019 Swap as a cash flow hedge and applied hedge accounting.  

A summary of our interest rate swaps is as follows:

 

Interest Rate Swap Agreements

 

Designation

 

Maturity Date

 

Rate

 

 

Notional Value

 

 

Debt Instrument Hedged

 

Percentage of Debt Instrument Outstanding

 

September 30, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

September 2019 Swap

 

Cash flow hedge

 

June 1, 2023

 

1.50%

 

 

$

50.0

 

 

First Lien Dollar Term Facility

 

18%

 

Second Amended January 2019 Swap

 

Cash flow hedge

 

June 3, 2024

 

2.10%

 

 

 

200.0

 

 

First Lien Dollar Term Facility

 

74%

 

 

 

 

 

 

 

 

 

 

 

$

250.0

 

 

 

 

92%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

September 2019 Swap

 

Cash flow hedge

 

June 1, 2023

 

1.50%

 

 

$

50.0

 

 

First Lien Dollar Term Facility

 

18%

 

Amended January 2019 Swap

 

Cash flow hedge

 

June 1, 2023

 

2.31%

 

 

 

200.0

 

 

First Lien Dollar Term Facility

 

74%

 

 

 

 

 

 

 

 

 

 

 

$

250.0

 

 

 

 

92%

 

17


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

 

The Second Amended January 2019 Swap contains an insignificant financing element that is amortized over the term of the hedging relationship.  We recognized a loss on the interest rate swaps of $1.2 million and $1.6 million in interest expense in the unaudited condensed consolidated statement of operations and comprehensive income (loss) for the three and nine months ended September 30, 2020.

As of September 30, 2020, we anticipate having to reclassify $4.6 million from accumulated other comprehensive income (loss) into earnings during the next twelve months to offset the variability of the hedged items during this period.

The following table summarizes the total fair values of derivative assets and liabilities and the respective classification in the condensed consolidated balance sheets as of September 30, 2020 and December 31, 2019.  The net amount of derivatives can be reconciled to the tabular disclosure of fair value in Note 11:

 

Interest Rate Swap Agreements

 

Balance Sheet Classification

 

September 30, 2020

 

 

December 31, 2019

 

Designated as cash flow hedges

 

Accrued liabilities and other

 

$

4.6

 

 

$

0.4

 

Designated as cash flow hedges

 

Other liabilities

 

 

11.2

 

 

 

4.6

 

 

 

 

 

$

15.8

 

 

$

5.0

 

 

The following table presents the effect of our derivative financial instruments on our unaudited condensed consolidated statement of operations.  The income effects of our derivative activities are reflected in interest expense.  There were no gains or losses recorded prior to June 3, 2019:

 

 

 

Successor

 

 

 

Predecessor

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

June 3, 2019 –

 

 

 

January 1, 2019

 

 

 

2020

 

 

2019

 

 

2020

 

 

September 30, 2019

 

 

 

– June 2, 2019

 

Total interest expense presented in the statement of operations

 

$

4.9

 

 

$

9.5

 

 

$

16.6

 

 

$

17.5

 

 

 

$

20.2

 

Interest rate swap agreements designated as cash flow hedges

 

 

1.2

 

 

 

-

 

 

 

1.6

 

 

 

-

 

 

 

 

-

 

Interest rate swap agreements not designated as cash flow hedges

 

$

-

 

 

$

1.0

 

 

$

-

 

 

$

6.4

 

 

 

$

-

 

 

Note 10 Accumulated Other Comprehensive Income (Loss)

Accumulated other comprehensive income (loss) is a separate line within the unaudited condensed consolidated statements of equity that reports our cumulative income (loss) that has not been reported as part of net income (loss).  The components of accumulated other comprehensive income (loss) at September 30, 2020 and December 31, 2019 were as follows:

 

 

 

September 30, 2020

 

 

 

Gross Balance

 

 

Tax Effect

 

 

Net Balance

 

Foreign currency translation

 

$

9.4

 

 

$

-

 

 

$

9.4

 

Unrealized gain (loss) on interest rate swaps

 

 

(10.6

)

 

 

2.4

 

 

 

(8.2

)

Total

 

$

(1.2

)

 

$

2.4

 

 

$

1.2

 

 

 

 

December 31, 2019

 

 

 

Gross Balance

 

 

Tax Effect

 

 

Net Balance

 

Foreign currency translation

 

$

1.7

 

 

$

-

 

 

$

1.7

 

Unrealized gain (loss) on interest rate swaps

 

 

1.4

 

 

 

0.3

 

 

 

1.7

 

Total

 

$

3.1

 

 

$

0.3

 

 

$

3.4

 

 

18


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

The following table presents the changes in accumulated other comprehensive income (loss) by component for the nine months ended September 30, 2020:

 

 

 

Nine Months Ended September 30, 2020

 

 

 

Foreign currency translation

 

 

Unrealized gain (loss) on interest rate swaps

 

 

Total

 

Beginning balance

 

$

1.7

 

 

$

1.7

 

 

$

3.4

 

Other comprehensive income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

before reclassifications

 

 

7.7

 

 

 

(9.9

)

 

 

(2.2

)

Ending balance

 

$

9.4

 

 

$

(8.2

)

 

$

1.2

 

 

Note 11 Fair Value Measurement

Financial instruments are required to be categorized within a valuation hierarchy based upon the lowest level of input that is significant to the fair value measurement. Assets and liabilities recorded at fair value are measured and classified in accordance with a three-tier fair value hierarchy based on the observability of the inputs available in the market used to measure fair value:

 

Level 1 — Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.

 

Level 2 — Inputs that are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant inputs are observable in the market or can be derived from observable market data. Where applicable, these models project future cash flows and discount the future amounts to a present value using market-based observable inputs including interest rate curves, foreign exchange rates, and credit ratings.

 

Level 3 — Unobservable inputs that are supported by little or no market activities.

The carrying values of cash and cash equivalents (primarily consisting of bank deposits), accounts receivable and accounts payable approximate their fair values due to the short-term nature of these instruments as of September 30, 2020 and December 31, 2019. The carrying value of borrowings under the credit facilities approximates fair value due to the variable interest rates associated with those borrowings.

The following table provides the carrying amounts, estimated fair values and the respective fair value measurements of our financial instruments as of September 30, 2020 and December 31, 2019:

 

 

 

 

 

 

 

Fair Value Measurements

 

 

 

Carrying Amount

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

September 30, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current and long-term debt

 

$

433.4

 

 

$

-

 

 

$

433.4

 

 

$

-

 

Interest rate swap agreements liability

 

$

15.8

 

 

$

-

 

 

$

15.8

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current and long-term debt

 

$

428.2

 

 

$

-

 

 

$

428.2

 

 

$

-

 

Interest rate swap agreements liability

 

$

5.0

 

 

$

-

 

 

$

5.0

 

 

$

-

 

 

The valuation techniques and inputs used for fair value measurements categorized within Level 2 include quoted comparable prices from market inputs. Generally, these fair value measures are model-based valuation techniques such as discounted cash flows or option pricing models using our own estimates and assumptions or those expected to be used by market participants.  We determine our valuation policies and procedures and analyze changes in fair value measurements from period to period by using an industry standard market approach, in which prices and other relevant information are generated by market transactions involving identical or comparable assets or liabilities. No financial instruments were measured using unobservable inputs.

The fair value of outstanding long-term debt is based on prices and other relevant information generated by market transactions involving identical or comparable debt instruments, which represents a Level 2 measurement. Derivative positions are classified within Level 2 of the valuation hierarchy as they are valued using quoted market prices for similar assets and liabilities in active markets.  These Level 2 derivatives are valued utilizing an income approach, which discounts future cash flow based upon current market expectations and adjusts for credit risk.

19


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

Note 12 Income Taxes

For each interim reporting period, we make an estimate of the effective tax rate we expect to be applicable for the full year for our operations.  This estimated effective tax rate is used in providing for income taxes on a year-to-date basis.  Our effective tax rate was as follows:

 

 

 

Successor

 

 

 

Predecessor

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

June 3, 2019 –

 

 

 

January 1, 2019

 

 

 

2020

 

2019

 

 

2020

 

 

September 30, 2019

 

 

 

– June 2, 2019

 

Effective tax rate

 

(15.7)%

 

69.8%

 

 

7.1%

 

 

31.4%

 

 

 

20.5%

 

 

The fluctuation in the effective tax rate over the periods presented above was primarily attributable to a jurisdictional mix of income between periods and discrete tax expense of $1.3 million recorded through the nine months ended September 30, 2020.  The effective tax rate differs from the U.S. federal statutory rate due primarily to benefits derived from the U.S. foreign derived intangible income deduction, tax credits available in the U.S., and income in foreign jurisdictions that are taxed at different rates than the U.S. statutory tax rate.

Pursuant to the Ranpak Business Combination discussed in detail in Note 7, “Acquisition,to the notes to the unaudited condensed consolidated financial statements, the Company has calculated the fair market value of assets and liabilities, including the impact on the deferred tax assets and liabilities in accordance with the guidance under ASC 805.  The deferred tax assets and liabilities are final as the valuation analysis has been completed.  The deferred tax assets and liabilities resulted in a net deferred tax liability of $122.9 million.  

We are subject to taxation in the United States (federal, state, local) and foreign jurisdictions.  As of September 30, 2020, tax years 2017 through 2020 are subject to examination by the tax authorities.  

Pursuant to ASC 740, as of each balance sheet date, the Company assesses its uncertain tax positions to determine whether factors underlying the sustainability assertion have changed.  During the three months ended September 30, 2020, based on new information in an ongoing examination over the 2017-2019 tax years by the tax authorities in the Netherlands, the Company has recognized discrete tax expense for an additional uncertain tax position of $1.3 million relating to positions which are no longer more-likely-than-not sustainable.  The Company anticipates to resolve this matter within the next twelve months.

On March 27, 2020, President Trump signed the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) into law.  The CARES Act includes several significant business tax provisions that, among other things, would eliminate the taxable income limit for certain net operating losses (“NOL”) and allow businesses and individuals to carry back NOLs arising in 2018, 2019, and 2020 to the five prior tax years; suspend the excess business loss rules under section 461(l); accelerate refunds of previously generated corporate AMT credits; generally loosen the business interest limitation under section 163(j) from 30 percent to 50 percent (special partnership rules apply); and fix the “retail glitch” for qualified improvement property in the 2017 tax code overhaul known informally as the Tax Cuts and Jobs Act (the “TCJA”) (TCJA, Public Law 115-97).  ASC 740, Income Taxes, requires that the tax effects of changes in tax laws or rates be recorded discretely as a component of the income tax provision related to continuing operations in the period of enactment.  We recorded any applicable impact from the CARES Act in the first quarter of 2020.  

Note 13 Commitments and Contingencies

Litigation

We are subject to legal proceedings and claims that arise in the ordinary course of our business.  Management evaluates each claim and provides for potential loss when the claim is probable to be paid and reasonably estimable.  While adverse decisions in certain of these litigation matters, claims and administrative proceedings could have a material effect on a particular period’s results of operations, subject to the uncertainties inherent in estimating future costs for contingent liabilities, management believes that any future accruals with respect to these currently known contingencies would not have a material effect on the financial condition, liquidity or cash flows of the Company.  There are no amounts required to be reflected in these unaudited interim condensed consolidated financial statements related to contingencies for the nine months ended September 30, 2020.

20


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

Leases

Certain office and warehouse facilities, transportation vehicles and data processing equipment are leased.  Total rental expense for these leases was $0.6 million and $1.6 million in the three and nine months ended September 30, 2020, respectively.  Total rental expense for these leases was $0.4 million in the three months ended September 30, 2019, $0.5 million in the Successor Period, and $0.9 million in the 1H 2019 Predecessor Period.

Environmental Matters

Our operations are subject to extensive and changing U.S. federal, state and local laws and regulations, as well as the laws of other countries that establish health and environmental quality standards.  These standards, among others, relate to air and water pollutants and the management and disposal of hazardous substances and wastes.  We are exposed to potential liability for personal injury or property damage caused by any release, spill, exposure or other accident involving such pollutants, substances or wastes.  There are no amounts required to be reflected in these unaudited interim consolidated financial statements related to environmental contingencies.

Management believes the Company is in compliance, in all material respects, with environmental laws and regulations and maintains insurance coverage to mitigate exposure to environmental liabilities.  Management does not believe any environmental matters will have a material adverse effect on the Company’s future consolidated results of operations, financial position or cash flows.  

Guarantees

We issue bank guarantees from time to time for various purposes that arise out of the normal course of business.  These amounts are immaterial for all periods presented.  

Note 14 Stock-Based Compensation

We expense the fair value of grants of various stock-based compensation programs over the vesting period of the awards.  Stock compensation expense is recorded in selling, general, and administrative expenses in the condensed consolidated statements of operations.  Awards granted are recognized as compensation expense based on the grant date fair value, estimated in accordance with ASC 718, Compensation - Stock Compensation.  The grant date fair value is the closing price of our stock on the grant date.  Failure to satisfy the threshold service or performance conditions results in the forfeiture of shares.  Forfeiture of share awards with service conditions or performance-based restrictions results in a reversal of previously recognized share-based compensation expense so long as the awards were probable of vesting.

The table below summarizes certain data for our stock-based compensation plans:

 

 

 

Successor

 

 

 

Predecessor

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

June 3, 2019 –

 

 

 

January 1, 2019

 

 

 

2020

 

 

2019

 

 

2020

 

 

September 30, 2019

 

 

 

– June 2, 2019

 

Stock-based compensation expense

 

$

1.7

 

 

$

1.6

 

 

$

5.9

 

 

$

1.8

 

 

 

$

-

 

Tax (expense) benefit for stock-based compensation

 

 

0.4

 

 

 

0.4

 

 

 

1.1

 

 

 

0.4

 

 

 

 

-

 

Fair value of vested awards

 

$

2.1

 

 

$

2.0

 

 

$

7.0

 

 

$

2.2

 

 

 

$

-

 

 

Our shareholders approved the Ranpak Holdings Corp. 2019 Omnibus Incentive Plan (the “2019 Plan”) at the Annual Meeting of Shareholders on February 20, 2019.  The purpose of the 2019 Plan is to motivate and reward employees and other individuals to perform at their highest level and contribute significantly to the success of the Company.  The 2019 Plan is an omnibus plan that may provide these incentives through grants of stock options, stock appreciation rights, restricted stock, restricted stock units (“RSU” or “RSUs”), performance awards, other cash-based awards and other stock-based awards to employees, directors, or consultants of the Company.

21


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

As of September 30, 2020, the pool of shares in the 2019 Plan is summarized as follows:

 

2019 Plan

 

Quantity

 

Maximum allowed for issuance

 

 

4,118,055

 

Awards granted

 

 

(2,331,736

)

Awards forfeited

 

 

734,913

 

Available for future awards

 

 

2,521,232

 

 

 

 

 

 

Awards vested

 

 

288,394

 

 

Restricted Stock Units RSUs represent a right to receive one share of our common stock that is both nontransferable and forfeitable unless and until certain conditions are satisfied.  Certain RSUs vest ratably over a two-year period while others vest over a one-year period.  The fair value of RSUs is determined on the grant date and is amortized over the vesting period on a ratable basis.

Performance-Based Restricted Stock Units Performance-based restricted stock units (“PRSU”) vest over a three-year period.  However, the level of the awards to be earned is determined at the end of the initial one-year performance period, based upon attainment of specific business performance goals during such initial one-year performance period.  If certain minimum performance levels are not attained in the initial one-year performance period, the awards will be automatically forfeited before vesting.  The awards are variable in that compensation could range from zero to 150% of the award agreement’s target contingent on the performance level attained.  The fair value of performance-based restricted stock units is determined on the grant date.  Compensation cost for these awards is recognized based on the probability of achievement of the performance-based conditions.

Activity of our RSUs and PRSUs is as follows:

 

 

 

RSUs

 

 

PRSUs

 

 

 

Quantity

 

 

Weighted Average Grant Date Fair Value

 

 

Quantity

 

 

Weighted Average Grant Date Fair Value

 

Restricted at December 31, 2019

 

 

483,299

 

 

$

9.30

 

 

 

-

 

 

$

-

 

Granted

 

 

501,141

 

 

 

8.08

 

 

 

667,196

 

 

 

8.09

 

Vested

 

 

(248,392

)

 

 

8.61

 

 

 

-

 

 

 

-

 

Forfeited

 

 

(58,329

)

 

 

9.04

 

 

 

(116,700

)

 

 

8.07

 

Outstanding at September 30, 2020

 

 

677,719

 

 

$

8.67

 

 

 

550,496

 

 

$

8.09

 

 

Director Stock Units Members of the Company’s Board of Directors (“Director(s)”) may elect to receive their quarterly retainer fees in the form of Class A common shares that are covered by an active shelf registration statement.  The retainers are paid quarterly, in arrears, and vest upon issuance.  These shares are priced at the closing price of the last business day of the calendar quarter.  Additionally, Directors are granted an annual award of RSUs of $0.1 million, paid or granted quarterly in arrears in the form of cash or stock at the Director’s election, on the date of the annual shareholder meeting.  The number of RSUs is determined by the closing price of Ranpak stock on that date.  These RSUs vest at the earlier of the (i) anniversary of the grant date or (ii) the following annual shareholder meeting.  The following table includes the number of shares granted and vested for Directors electing to receive retainer payments in shares:

 

Director Stock Units

 

Quantity

 

 

Weighted Average Grant Date Fair Value

 

Balance at December 31, 2019

 

 

-

 

 

$

-

 

Granted

 

 

107,184

 

 

 

7.41

 

Vested

 

 

(26,970

)

 

 

7.18

 

Balance at September 30, 2020

 

 

80,214

 

 

$

7.49

 

 

Note 15 Shareholders’ Equity

Capital Stock — The Company is authorized to issue 426,000,000 shares of capital stock, consisting of (i) 200,000,000 shares of Class A common stock, par value $0.0001 per share, (ii) 25,000,000 shares of Class B common stock, par value $0.0001 per share,

22


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

and (iii) 200,000,000 shares of Class C common stock, par value $0.0001 per share and (iv) 1,000,000 shares of preferred stock, par value $0.0001 per share.

Common Shares Each holder of Class A Common Stock (“Class A”) is entitled to one vote for each Class A share held of record. Holders of shares of Class C Common Stock (“Class C”) have no such voting rights and, as such, shall not have the right to receive notice of, attend at or vote on any matters on which stockholders generally are entitled to vote. Class C shares have a right of conversion that upon sale or other transfer convert to Class A shares.

Upon the closing of the Ranpak Business Combination, 3,854,664 of Class B shares were canceled and 7,395,336 of Class B shares were converted to 6,663,953 of Class A shares and 731,383 of Class C shares.  Certain of the Class B shares were subject to forfeiture conditions that carried over to the Class A shares.  At December 31, 2019, Ranpak had 6,847,836 Class A and Class C shares outstanding subject to forfeiture unless certain provisions are met as described below.  These shares will not participate in cash dividends or other cash distributions payable prior to the date the conditions have been satisfied.  Upon satisfaction, shareholders will be entitled to all cash dividends and other cash distributions from the closing of the Ranpak Business Combination.  As of December 31, 2019, there were no such cash dividends or other cash distributions potentially payable upon these conditions.

157,500 shares of Class A common stock will be surrendered for no consideration unless, prior to the fifth anniversary of the Ranpak Business Combination, either (i) the closing price of our Class A common stock equals or exceeds $12.25 per share (in each case as adjusted for share splits, dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 consecutive trading day period or (ii) the Company completes a liquidation, merger, stock exchange or other similar transaction that results in all ordinary shareholders having the right to exchange their common stock for consideration in cash, securities or other property which equals or exceeds $12.25 per share (in each case as adjusted for share splits, dividends, reorganizations, recapitalizations and the like).

2,940,336 shares of Class A common stock will be surrendered for no consideration unless, prior to the tenth anniversary of the Ranpak Business Combination, (i) the closing price of the Company’s Class A common stock equals or exceeds $15.00 per share (in each case as adjusted for share splits, dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 consecutive trading day period or (ii) the Company completes a liquidation, merger, stock exchange or other similar transaction that results in all or substantially all of its shareholders having the right to exchange their shares or the Company otherwise undergoes a change of control.

A total of 3,750,000 shares of Class A and Class C common stock will be surrendered for no consideration unless, prior to the tenth anniversary of the closing of the Ranpak Business Combination, (i) the closing price of the Company’s Class A shares equals or exceeds $12.50 per share (in each case as adjusted for share splits, dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 consecutive trading day period or (ii) the Company completes a liquidation, merger, stock exchange or other similar transaction that results in all or substantially all of its shareholders having the right to exchange their shares or the Company otherwise undergoes a change of control.

Preferred Shares The Company’s charter authorizes 1,000,000 shares of preferred stock and provides that shares of preferred stock may be issued from time to time in one or more series.  The Board of Directors is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series.  The Board of Directors is able, without stockholder approval, to issue preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders of the common stock and could have anti-takeover effects.  As of September 30, 2020, the Company had no preferred stock outstanding.

Warrants — On August 6, 2020, we commenced (i) an offer to each holder of our outstanding public warrants, forward purchase warrants, and private placement warrants (collectively, the “Warrants”), each to purchase shares of Class A common stock, par value $0.0001 per share (“Class A common stock”), the opportunity to receive 0.22 shares of Class A common stock in exchange for each outstanding warrant tendered by the holder and exchanged pursuant to the offer (the “Offer”), and (ii) the solicitation of consents (the “Consent Solicitation”) from holders of the public warrants and the forward purchase warrants to amend the Warrant Agreement, dated as of January 17, 2018, by and between the Company and Continental Stock Transfer & Trust Company, which governs all of the Warrants (the “Warrant Amendment”).  The approved Warrant Amendment permitted the Company to require that each warrant that is outstanding subsequent to the expiration of the Offer be converted into 0.198 shares of Class A common stock.  Further, the Warrant Amendment and its expiration on September 2, 2020 resulted in a valid tendering of 20,048,251 Warrants, or approximately 99.7% of the Warrants, resulting in 4,410,587 shares of Class A common stock issued in exchange for said Warrants.  As a result of the low number of Warrants remaining outstanding following the Offer, the NYSE delisted the remaining Warrants.  The remaining

23


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

60,493 Warrants were exchanged at the 0.198 ratio for 11,977 shares of Class A common stock on September 21, 2020.  We paid an immaterial amount for fractional shares converted to cash.  No Warrants remained after the exchanges.

Registration Rights — Certain investors were entitled to registration rights pursuant to the forward purchase agreements, subscription agreements, private placement warrant agreements, and the registration rights agreement entered into concurrently with the closing of the IPO. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a business combination. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company bore the expenses incurred in connection with the filing of any such registration statements.

Follow-On Offering — On December 13, 2019, the Company closed on a public offering of 16,923,077 shares of its Class A common stock at an offering price of $6.50 per share, generating gross proceeds of approximately $110.0 million ($107.7 million net of expenses).  These shares were registered pursuant to the Form S-3 declared effective on July 31, 2019.  The proceeds from this offering were used to pay down outstanding debt.

Outstanding Shares — At September 30, 2020 and December 31, 2019, the Company had the following shares of common stock outstanding:

 

 

 

September 30, 2020

 

 

December 31, 2019

 

 

 

Class A

 

 

Class C

 

 

Total Common

 

 

Class A

 

 

Class C

 

 

Total Common

 

Shares outstanding not subject to an earn-out agreement

 

 

62,874,702

 

 

 

5,779,910

 

 

 

68,654,612

 

 

 

58,177,288

 

 

 

5,779,910

 

 

 

63,957,198

 

Shares subject to $15.00 earn-out

 

 

2,940,336

 

 

 

-

 

 

 

2,940,336

 

 

 

2,940,336

 

 

 

-

 

 

 

2,940,336

 

Shares subject to $12.50 earn-out

 

 

3,018,617

 

 

 

731,383

 

 

 

3,750,000

 

 

 

3,018,617

 

 

 

731,383

 

 

 

3,750,000

 

Shares subject to $12.25 earn-out

 

 

157,500

 

 

 

-

 

 

 

157,500

 

 

 

157,500

 

 

 

-

 

 

 

157,500

 

Total

 

 

68,991,155

 

 

 

6,511,293

 

 

 

75,502,448

 

 

 

64,293,741

 

 

 

6,511,293

 

 

 

70,805,034

 

 

Translation adjustment—Translation adjustments recorded are a component of accumulated other comprehensive income (loss) in shareholders’ equity. The effects of translating financial statements of foreign operations into the Company’s reporting currency are recognized as a cumulative translation adjustment in accumulated other comprehensive income (loss) which is net of tax, where applicable.

Note 16 — Earnings (Loss) per Share

Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted-average number of shares of common stock outstanding during the period, excluding the effects of any potentially dilutive securities.  Diluted EPS gives effect to the potential dilution, if any, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock, using the more dilutive of the two-class method or if-converted method.  Diluted EPS excludes potential shares of common stock if their effect is anti-dilutive.  If there is a net loss in any period, basic and diluted EPS are computed in the same manner.

The two-class method determines net income (loss) per common share for each class of common stock and participating securities according to dividends declared or accumulated and participation rights in undistributed earnings.  The two-class method requires income available to common shareholders for the period to be allocated between different classes of common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. We apply the two-class method for EPS when computing net income (loss) per Class A and Class C common shares.

The Predecessor had one class of shares outstanding.  As of September 30, 2020, we have not issued any instruments that were considered to be participating securities.  The Successor’s weighted average shares of Class A and Class C common stock have been combined in the denominator of basic and diluted earnings (loss) per share because they have equivalent economic rights.  The following tables set forth the computation of our loss per share:

24


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

 

 

 

Successor

 

 

 

Predecessor

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

June 3, 2019 –

 

 

 

January 1, 2019

 

 

 

2020

 

 

2019

 

 

2020

 

 

September 30, 2019

 

 

 

– June 2, 2019

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(6.1

)

 

$

(1.6

)

 

$

(18.2

)

 

$

(13.9

)

 

 

$

(19.0

)

Net loss attributable to common stockholders for basic and diluted EPS

 

$

(6.1

)

 

$

(1.6

)

 

$

(18.2

)

 

$

(13.9

)

 

 

$

(19.0

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted average common shares outstanding

 

 

72,396,183

 

 

 

53,871,068

 

 

 

71,401,580

 

 

 

53,870,568

 

 

 

 

995

 

Dilutive effect of assumed vesting of RSUs and PRSUs

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

Diluted weighted average common shares outstanding

 

 

72,396,183

 

 

 

53,871,068

 

 

 

71,401,580

 

 

 

53,870,568

 

 

 

 

995

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss per share attributable to common stockholders

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.08

)

 

$

(0.03

)

 

$

(0.25

)

 

$

(0.26

)

 

 

$

(19,195.40

)

Diluted

 

$

(0.08

)

 

$

(0.03

)

 

$

(0.25

)

 

$

(0.26

)

 

 

$

(19,195.40

)

 

The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because milestones were not yet achieved for awards contingent on the achievement of performance milestones:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

June 3, 2019 –

 

 

 

2020

 

 

2019

 

 

2020

 

 

September 30, 2019

 

Warrants on common stock

 

 

-

 

 

 

20,108,744

 

 

 

-

 

 

 

20,108,744

 

RSUs and PRSUs

 

 

1,230,024

 

 

 

951,475

 

 

 

982,473

 

 

 

951,475

 

Total antidilutive securities

 

 

1,230,024

 

 

 

21,060,219

 

 

 

982,473

 

 

 

21,060,219

 

 

Note 17 Transactions with Related Parties

Shared Services Agreement

On June 3, 2019, upon the closing of Ranpak’s business combination with One Madison Corporation, Ranpak entered into a shared services agreement (the “Shared Services Agreement”) with One Madison Group LLC (the “Sponsor”), pursuant to which the Sponsor may provide, or cause to be provided, certain services to Ranpak. The Shared Services Agreement provides for a broad array of potential services, including administrative and “back office” or corporate-type services and requires Ranpak to indemnify the Sponsor in connection with the services provided by the Sponsor to Ranpak.  Total fees under the agreement amounted to approximately $0.1 million and $0.3 million for the three and nine months ended September 30, 2020, respectively.  Totals under the agreements were $0.2 million in the three months ended September 30, 2019 and $0.3 million in the Successor Period.

Advisory Relationship

A director of the Company, prior to being elected as a director, served in an advisory role to Rhône Capital IV L.P., the former majority shareholder of Rack Holdings, Inc., on the sale of Rack Holdings, Inc. The director was compensated for the advisory role through an increase to his indirect equity interest in Rack Holdings, Inc., and reported to Ranpak that the compensation was not significant (less than $50 thousand).

Registration Rights Agreement

As a result of the Ranpak Business Combination, Ranpak is a party to a registration rights agreement with certain security holders. The agreement requires Ranpak to maintain an effective resale shelf registration statement for the benefit of such security holders until they are permitted by law to freely sell their securities without registration or no longer hold Ranpak securities.

Subscription Agreements and Reallocation Agreement

One Madison Corporation entered into a subscription agreement, pursuant to which, as amended, certain shareholders, including our Chairman & CEO, another of our directors, our chief financial officer and one of our significant shareholders may be required to surrender to Ranpak certain of their shares (referred to as founder shares) if the closing price of the Class A common stock (or any successor class of listed common shares) equals or exceeds $12.50 per share (as adjusted for share splits, dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 consecutive trading day period or Ranpak completes a liquidation,

25


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

merger, share exchange or other similar transaction that results in all of its common shareholders having the right to exchange their common equity for consideration in cash, securities or other property which equals or exceeds $12.50 per share (as adjusted for share splits, dividends, reorganizations, recapitalizations and the like) in the five year period following the consummation of the Ranpak Business Combination (the “Earnout”).

One Madison Corporation also entered into a reallocation agreement with certain investors, including our Chairman & CEO, another of our directors and one of our significant shareholders, who provided equity financing for the Ranpak Business Combination under the forward purchase agreements and the subscription agreements, pursuant to which the shares subject to the Earnout and the rights to acquire 5,000,000 warrants to purchase Class A shares arising under the forward purchase agreements were reallocated among all equity financing investors pro rata based on the aggregate amount of equity financing provided by such equity financing investors under the forward purchase agreements and the subscription agreements. The Class B ordinary shares owned by each party to the reallocation agreement following the reallocation are subject to the provisions in the forward purchase agreement relating to Class B ordinary shares, including with respect to the voting of, transfer and forfeiture and waiver of redemption rights with respect to such Class B ordinary shares, or, for the parties to the reallocation agreement that are not party to a forward purchase agreement, the provisions substantially similar to such forward purchase agreement provisions that are set forth on an exhibit to the reallocation agreement.

Stock Purchase Agreement

Ranpak is subject to certain continuing obligations to indemnify the former directors and officers of Rack Holdings Inc. for certain costs, damages and liabilities pursuant to the Stock Purchase Agreement dated December 12, 2018, pursuant to which One Madison Corporation purchased Rack Holdings Inc.

Monitoring Fee Arrangement

Rack Holdings had a monitoring fee agreement, with Rhône Capital IV L.P., a related party, which required Rack Holdings to pay 1% of projected annual earnings before interest, taxes and depreciation and amortization in advance of each semi-annual period, adjusted retroactively up or down, plus reimbursement of other expenses.  As of June 3, 2019, upon the Closing of the Ranpak Business Combination and change in control, this monitoring fee was eliminated.  Monitoring fee and reimbursement expenses are immaterial but are included in selling, general and administrative expense in the unaudited condensed consolidated statements of operations and comprehensive income (loss) for the 1H 2019 Predecessor Period.

Note 18 Restatement of Previously Issued Unaudited Condensed Consolidated Interim Financial Statements

As disclosed in Note 21 in our Annual Report on Form 10-K for the year ended December 31, 2019, subsequent to the issuance of our unaudited condensed consolidated interim financial statements as of June 30, 2019 (Successor) and for the Predecessor Period January 1, 2019 through June 2, 2019 and April 1, 2019 through June 2, 2019 and the Successor Period June 3, 2019 through June 30, 2019 and September 30, 2019 (Successor) and for the Predecessor Period January 1, 2019 through June 2, 2019 and the Successor period for the three months ended September 30, 2019 and the period June 3, 2019 through September 30, 2019, management identified several errors related to presentation of the Predecessor Period (January 1, 2019 through June 2, 2019) resulting from incorrect accounting and reporting related to the Ranpak Business Combination. The foreign currency translation adjustments line item in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) was misstated by ($27.6 million) and the Unaudited Condensed Consolidated Statement of Changes in Shareholders’ Equity was also misstated as a result of all of the errors identified as noted in the below table. Additionally, it was determined that the Unaudited Condensed Consolidated Statement of Cash Flows included several misclassified amounts in the Predecessor Period, resulting in a ($7.8 million) misstatement of net cash flows provided by operating activities, a ($1.1 million) misstatement of net cash flows used in financing activities, and a $8.9 million misstatement in the effect of exchange rate changes on cash. The Company has corrected the errors in the comparable Q3 2019 unaudited condensed consolidated interim financial statements that are presented in the Q3 2020 unaudited condensed consolidated interim Form 10-Q filing.  

In addition, management also identified several errors in the unaudited condensed consolidated interim financial statements for the Successor Period (June 3, 2019 through June 30, 2019 for Q2 2019 and June 3, 2019 through September 30, 2019 for Q3 2019) resulting from incorrect accounting and reporting related to the Ranpak Business Combination. These Successor Period errors resulted in multiple misstatements in the Unaudited Condensed Consolidated Statement of Cash Flows including $3.4 million of net cash provided by financing activities and $7.9 million of effects of exchange rate changes on cash. We also misclassified (1) $308.1 million, relating to the cash withdrawn from trust account, between net cash used in investing activities and beginning cash and (2) $11.3 million, relating to One Madison Corporation’s deferred initial public offering underwriting fees, between net cash used in operating activities and net cash from financing activities. Ending cash balance for both the second and third quarter remain

26


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

unchanged. Goodwill was also misstated by $10.0 million. The foreign currency gain line item in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) was misstated by $2.5 million and the Unaudited Condensed Consolidated Statement of Changes in Shareholders’ Equity was also misstated as a result of the errors identified as noted in the below table. The Company has corrected the errors in the comparable Q3 2019 unaudited condensed consolidated interim financial statements that are presented in the Q3 2020 unaudited condensed consolidated interim Form 10-Q filing.

Management has evaluated the materiality of these misstatements and concluded that the Predecessor Period and Successor Period misstatements were not material to the unaudited condensed consolidated interim financial statements as of June 30, 2019 (Successor) and for the Predecessor Period January 1, 2019 through June 2, 2019 and April 1, 2019 through June 2, 2019 and the Successor Period June 3, 2019 through June 30, 2019 and September 30, 2019 (Successor) and for the Predecessor Period January 1, 2019 through June 2, 2019 and the Successor period for the three months ended September 30, 2019 and the period June 3, 2019 through September 30, 2019, respectively.

The impact of the necessary adjustments on the total amounts previously reported for the Predecessor Period in our unaudited condensed consolidated interim financial statements (included in our quarterly report on Form 10-Q for the three and nine months ended September 30, 2019) is summarized in the following tables:

 

 

 

Predecessor Period (January 1, 2019 – June 2, 2019)

 

 

 

As previously reported

 

 

Adjustment

 

 

As restated

 

Unaudited Condensed Consolidated Statement of Cash Flows

 

 

 

 

 

 

 

 

 

 

 

 

Deferred income taxes

 

$

0.6

 

 

$

(7.8

)

 

$

(7.2

)

Net cash provided by (used in) operating activities

 

 

24.5

 

 

 

(7.8

)

 

 

16.7

 

Payments on term loans and credit facility

 

 

(13.3

)

 

 

(1.1

)

 

 

(14.4

)

Net cash provided by (used in) financing activities

 

 

(13.3

)

 

 

(1.1

)

 

 

(14.4

)

Effect of exchange rate changes on cash

 

$

(7.7

)

 

$

8.9

 

 

$

1.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

$

23.6

 

 

$

(27.6

)

 

$

(4.0

)

Comprehensive income (loss)

 

$

4.6

 

 

$

(27.6

)

 

$

(23.0

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Unaudited Condensed Consolidated Statement of Changes in Shareholders' Equity

 

 

 

 

 

 

 

 

 

 

 

 

Additional paid-in capital

 

$

-

 

 

$

291.4

 

 

$

291.4

 

Accumulated deficit

 

 

-

 

 

 

(88.9

)

 

 

(88.9

)

Treasury stock

 

 

-

 

 

 

(1.5

)

 

 

(1.5

)

Accumulated other comprehensive loss

 

 

-

 

 

 

(27.6

)

 

 

(27.6

)

Total shareholders' equity

 

$

-

 

 

$

173.4

 

 

$

173.4

 

 

 

27


Ranpak Holdings Corp.

Notes to Unaudited Condensed Consolidated Financial Statements

(in millions, except share and per share data)

 

The impact of the necessary adjustments on the total amounts previously reported for the Successor Period from June 3, 2019 through September 30, 2019 in our unaudited condensed consolidated interim financial statements (included in our quarterly report on Form 10-Q for the three and nine months ended September 30, 2019) is summarized in the following table:

 

 

 

Successor Period (June 3, 2019 – September 30, 2019)

 

 

 

As previously reported

 

 

Adjustment

 

 

As restated

 

Unaudited Condensed Consolidated Statement of Cash Flows

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(12.0

)

 

$

(1.9

)

 

$

(13.9

)

Increase (decrease) in accounts payable

 

 

(25.4

)

 

 

11.3

 

 

 

(14.1

)

Increase (decrease) in accrued liabilities

 

 

2.9

 

 

 

(0.6

)

 

 

2.3

 

Currency gain on foreign denominated notes payable

 

 

(3.3

)

 

 

2.5

 

 

 

(0.8

)

Net cash provided by (used in) operating activities

 

 

(11.6

)

 

 

11.3

 

 

 

(0.3

)

Cash withdrawn from trust account

 

 

-

 

 

 

308.1

 

 

 

308.1

 

Net cash provided by (used in) investing activities

 

 

(956.3

)

 

 

308.1

 

 

 

(648.2

)

Proceeds from issuance of term loans and credit facility

 

 

539.0

 

 

 

(4.4

)

 

 

534.6

 

Proceeds from sale of common stock

 

 

302.4

 

 

 

12.3

 

 

 

314.7

 

Payments of deferred registration costs

 

 

-

 

 

 

(11.3

)

 

 

(11.3

)

Net cash provided by (used in) financing activities

 

 

666.5

 

 

 

(3.4

)

 

 

663.1

 

Effect of exchange rate changes on cash

 

 

5.2

 

 

 

(7.9

)

 

 

(2.7

)

Net increase (decrease) in cash and cash equivalents

 

 

(296.2

)

 

 

308.1

 

 

 

11.9

 

Cash and cash equivalents, beginning of period

 

$

309.8

 

 

$

(308.1

)

 

$

1.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency (gain) loss

 

$

(4.1

)

 

$

2.5

 

 

$

(1.6

)

Loss before income tax benefit

 

 

(17.5

)

 

 

(2.5

)

 

 

(20.0

)

Income tax benefit

 

 

(5.5

)

 

 

(0.6

)

 

 

(6.1

)

Net income (loss)

 

 

(12.0

)

 

 

(1.9

)

 

 

(13.9

)

Comprehensive income (loss)

 

$

(18.3

)

 

$

(1.9

)

 

$

(20.2

)

Net income (loss) per share

 

$

(0.22

)

 

$

(0.04

)

 

$

(0.26

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Unaudited Condensed Consolidated Statement of Changes in Shareholders' Equity

 

 

 

 

 

 

 

 

 

 

 

 

Additional paid-in capital

 

$

429.8

 

 

$

15.1

 

 

$

444.9

 

Accumulated other comprehensive loss

 

 

(6.3

)

 

 

(2.5

)

 

 

(8.8

)

Accumulated deficit

 

 

(23.9

)

 

 

(2.0

)

 

 

(25.9

)

Total shareholders' equity

 

$

399.6

 

 

$

10.6

 

 

$

410.2

 

 

 

28


 

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Our forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future. Statements that are not historical facts, including statements about the parties, perspectives and expectations, are forward-looking statements. In addition, any statements that refer to estimates, projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this Quarterly Report on Form 10-Q may include, for example, statements about: our expectations around the performance of the business; our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business; our public securities’ potential liquidity and trading; the lack of a market for our securities.

The forward-looking statements contained in this Quarterly Report on Form 10-Q are based on our current expectations and beliefs concerning future developments and their potential effects on us taking into account information currently available to us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks include, but are not limited to: (1) our inability to secure a sufficient supply of paper to meet our production requirements; (2) the impact of the price of kraft paper on our results of operations; (3) our reliance on third party suppliers; (4) the COVID-19 pandemic and associated response; (5) the high degree of competition in the markets in which we operate; (6) consumer sensitivity to increases in the prices of our products; (7) changes in consumer preferences with respect to paper products generally; (8) continued consolidation in the markets in which we operate; (9) the loss of significant end-users of our products or a large group of such end-users; (10) our failure to develop new products that meet our sales or margin expectations; (11) our future operating results fluctuating, failing to match performance or to meet expectations; (12) our ability to fulfill our public company obligations; and (13) other risks and uncertainties indicated from time to time in filings made with the SEC.

Should one or more of these risks or uncertainties materialize, they could cause our actual results to differ materially from the forward-looking statements. We are not undertaking any obligation to update or revise any forward looking statements whether as a result of new information, future events or otherwise. You should not take any statement regarding past trends or activities as a representation that the trends or activities will continue in the future. Accordingly, you should not put undue reliance on these statements.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis is intended to help the reader understand our business, financial condition, results of operations, liquidity and capital resources.  You should read this discussion in conjunction with the sections entitled “Risk Factors” and “Forward-Looking Statements,” and our financial statements and related notes included in this Quarterly Report on Form 10-Q as well as the section entitled, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of Ranpak included in our Annual Report on Form 10-K, filed with the SEC on March 17, 2020.  For purposes of this section, “Ranpak,” “the Company,” “we,” or “our” refer to (i) Rack Holdings and its subsidiaries (the “Predecessor”) for the periods from January 1, 2019 through June 2, 2019 (referred to herein as the “1H 2019 Predecessor Period”) prior to the consummation of the Ranpak Business Combination and (ii) Ranpak Holdings Corp. and its subsidiaries (the “Successor”) for all periods subsequent to June 3, 2019 after the consummation of the Ranpak Business Combination, unless the context otherwise requires.  Capitalized terms used and not defined herein have the meanings disclosed elsewhere in the Quarterly Report on Form 10-Q.

The following discussion and analysis has been revised for the effects of certain restatements, as detailed in Note 18 to the unaudited condensed consolidated financial statements in this Quarterly Report on Form 10-Q.  

The following discussion contains forward-looking statements that reflect future plans, estimates, beliefs and expected performance. The forward-looking statements are dependent upon events, risks and uncertainties that may be outside of the Company's control.  The Company’s actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed in the sections titled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” included elsewhere in this Quarterly Report on Form 10-Q.

29


 

Overview

Ranpak is a leading provider of environmentally sustainable, systems-based, product protection solutions for e-commerce and industrial supply chains. Since its inception in 1972, Ranpak has delivered high quality protective packaging solutions, while maintaining its commitment to environmental sustainability. Ranpak assembles its protective packaging systems and provides the systems and paper consumables to customers, which include direct end-users and its network of exclusive paper packaging solution distributors, who in turn place the systems with and sell paper to commercial and industrial users for the conversion of paper into packaging materials. Ranpak operates manufacturing facilities in Concord Township, Ohio; Kansas City, Missouri; Raleigh, North Carolina; and Reno, Nevada in the United States, in Heerlen, the Netherlands and Nyrany, Czech Republic.  In the second quarter of 2020, we opened a new production facility for our automation business in Kerkrade, the Netherlands, located approximately three miles from our Heerlen location, to enhance our production capacity in our automation business.  Ranpak also maintains sales and administrative offices in Shanghai, China; Tokyo, Japan; and Singapore.  Ranpak is a global business that generated approximately 54.8% of its net revenue for the fiscal year 2019 outside of the United States.

As of September 30, 2020, Ranpak had an installed base of approximately 113.1 thousand protective packaging systems serving a diverse set of distributors and end-users.  Ranpak generated net revenue of $206.3 million in the nine months ended September 30, 2020.  Additionally, Ranpak generated net revenue of $85.4 million in the Successor Period and $106.4 million in the 1H 2019 Predecessor Period.

The Ranpak Business Combination

On June 3, 2019, we consummated the acquisition of all outstanding and issued equity interests of Rack Holdings, Inc. (“Rack Holdings”) pursuant to a stock purchase agreement for consideration of $794.9 million, which reflects a post-closing adjustment of $0.7 million for net working capital and additional consideration, and €140.0 million ($160.8 million) in cash, (A) $341.5 million and €140.0 million  of which, respectively, was used by the Seller to repay outstanding indebtedness and unpaid transaction expenses as contemplated by the stock purchase agreement and (B) the remainder of which was paid to Rack Holdings L.P. (“Seller”).

The Company (then One Madison Corporation) was deemed to be the accounting acquirer in the Ranpak Business Combination, as a result of which the Company allocated its purchase price to Rack Holdings’ assets and liabilities at fair value, which created a new basis of accounting.  Until the consummation of the Ranpak Business Combination, Rack Holdings operated as a separate business holding all of the historical assets and liabilities related to our business.

The Ranpak Business Combination was financed, in part, with debt of approximately $534.6 million, which became Ranpak’s direct obligation upon the consummation of the Ranpak Business Combination.  Upon the consummation of the Ranpak Business Combination on June 3, 2019, Rack Holdings' then-existing debt, which amounted to approximately $487.6 million as of such date, was repaid in full.  In December 2019, the Company closed a public offering of its Class A common stock generating net proceeds of approximately $107.7 million that was used to pay down the First Lien Dollar Term Facility.

Following the Ranpak Business Combination, we have hired, and expect to hire additional staff and implement procedures and processes to address regulatory and other customary requirements applicable to operating public companies. We have incurred additional annual expenses for, among other things, directors’ and officers’ liability insurance, director fees, and additional internal and external accounting, legal and administrative resources, including increased audit and legal fees.  We estimated that these incremental costs on an annual basis would amount to approximately $2.0 million or more per year, resulting in higher operating expenses in future periods.  The closing of the Ranpak Business Combination also resulted in the elimination of certain non-recurring expenses incurred prior to the Ranpak Business Combination, which amounted to $35.4 million for the year ended December 31, 2019.

The following factors may have affected the comparability of Ranpak’s results of operations between the periods presented in this Quarterly Report on Form 10-Q and may affect the comparability of its results of operations in future periods.

Effect of Currency Fluctuations.  As a result of the geographic diversity of Ranpak’s operations, it is exposed to the effects of currency translation. Currency transaction exposure results when Ranpak generates net sales in one currency at one time and incurs expenses in another currency at another time, or when it realizes gain or loss on intercompany transfers. While Ranpak seeks to limit its currency transaction exposure by matching the currencies in which it incurs sales and expenses, it may not always be able to do so.

In addition, Ranpak is subject to currency translation exposure because the operations of its subsidiaries are measured in their functional currency which is the currency of the primary economic environment in which the subsidiary operates. Any currency balances that are denominated in currencies other than the functional currency of the subsidiary are re-measured into the functional currency, with the resulting gain or loss recorded in the foreign currency (gains) losses line-item in Ranpak’s income statement.  In turn, subsidiary income statement balances that are denominated in currencies other than the U.S. dollar are translated into U.S.

30


 

dollars, Ranpak’s functional currency, in consolidation using the average exchange rate in effect during each fiscal month during the period, with any related gain or loss recorded as foreign currency translation adjustments in other comprehensive income (loss). The assets and liabilities of subsidiaries that use functional currencies other than the U.S. dollar are translated into U.S. dollars in consolidation using period end exchange rates, with the effects of foreign currency translation adjustments included in accumulated other comprehensive income (loss).

Ranpak does not currently hedge its foreign currency transaction or translation exposure. As a result, significant currency fluctuations could impact the comparability of its results between periods, while such fluctuations coupled with material mismatches in net revenues and expenses could also adversely impact its cash flows. See “Qualitative and Quantitative Disclosures About Market Risk.

Acquisitions.  On February 28, 2017, Ranpak acquired e3NEO for total consideration of $3.3 million, including contingent consideration of $1.1 million which was paid in full in 2018, plus an earn-out opportunity, which was not earned and, in April 2020, we entered into a settlement arrangement with the former majority owner of e3NEO to provide, among other things, for a payment to the earn-out counterparties in the amount of approximately $1.6 million.  Approximately $0.2 million was expensed in the second quarter of 2020 after certain approvals were obtained by French authorities.  Approximately $0.8 million was paid in the second quarter of 2020.  Approximately $0.6 million was accrued for at September 30, 2020.  See Note 7, “Acquisition” to the condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.  While recent acquisitions, such as e3NEO, have been relatively small, any significant future business acquisitions may impact the comparability of Ranpak’s results in future periods with those for prior periods.

Seasonality.  Ranpak estimates that approximately one-third of its net revenue, either directly or to distributors, are destined for end-users in the e-commerce sectors, whose businesses frequently follow traditional retail seasonal trends, including a concentration of sales in the holiday period in the fourth quarter.  Ranpak’s results tend to follow similar patterns, with the highest net revenue typically recorded in its fourth fiscal quarter and the slowest sales in its first fiscal quarter of each fiscal year.  Ranpak expects this seasonality to continue in the future, as a result of which its results of operations between fiscal quarters in a given year may not be directly comparable.

Impact of the COVID-19 Pandemic.  The COVID-19 pandemic has resulted in rapid changes in market and economic conditions around the world as COVID-19 continues to spread.  We derive a significant portion of our revenue from sales of Void-fill, Cushioning and Wrapping products to e-commerce end-users and demand from these end-users has been strong, offsetting reductions in demand for these products from customers in other industries.  However, social distancing and similar measures adopted in many jurisdictions around the world have impacted our ability to demonstrate and install our protective packaging systems and Automation products and, as a result, such demonstrations and installations have been delayed.  If social distancing measures continue for an extended period of time, growth in our protective packaging system base, acquisition of new customers and sales of Automation products may be adversely affected.  We believe that these impacts are not unique to us and that our industry competitors have been impacted in a similar fashion.  We are deemed an essential business under the Memorandum on Identification of Essential Critical Infrastructure Workers During COVID-19 Response issued by the United States Cybersecurity and Infrastructure Security Agency and pursuant to state decisions in states where our domestic production and distribution facilities are located.  We continue to operate our production and distribution facilities, both domestically and internationally, albeit subject to social distancing and other measures to promote a safe operating environment.  While we have experienced limited delays in receiving certain supplies we use to assemble our packaging systems, to date, these measures have not materially impacted the cost of producing and distributing our products, the cost and availability of raw materials and components, and we have encountered minimal disruption in our ability to fulfill customer orders.  We continue to monitor our liquidity position closely and have extended payment terms to certain of our customers when necessary, while correspondingly seeking extended terms from our key suppliers.  While we do not currently expect COVID-19 to have a material impact on our business, results of operations, financial condition or liquidity, at the time of this filing, we cannot predict the extent to which we will ultimately be impacted due to the evolving and highly uncertain nature and duration of the COVID-19 pandemic.  We will continue to evaluate the nature and extent of the impact to our business, results of operations, financial condition, and cash flows.

Key Performance Indicators and Other Factors Affecting Performance

Ranpak uses the following key performance indicators and monitors the following other factors to analyze its business performance, determine financial forecasts, and help develop long-term strategic plans:

31


 

Protective Packaging Systems Base — Ranpak closely tracks the number of protective packaging systems installed with end-users as it is a leading indicator of underlying business trends and near-term and ongoing net sales expectations. Ranpak’s installed base of protective packaging systems also drives its capital expenditure budgets.  The following table presents Ranpak’s installed base of protective packaging systems by product line as of September 30, 2020 and 2019:

 

 

 

September 30, 2020

 

 

September 30, 2019

 

 

Change

 

 

% Change

 

Protective Packaging Systems

 

(in thousands)

 

 

 

 

 

Cushioning machines

 

 

33.2

 

 

 

32.1

 

 

 

1.1

 

 

 

3.4

 

Void-fill machines

 

 

65.5

 

 

 

59.5

 

 

 

6.0

 

 

 

10.1

 

Wrapping machines

 

 

14.4

 

 

 

10.7

 

 

 

3.7

 

 

 

34.6

 

Total

 

 

113.1

 

 

 

102.3

 

 

 

10.8

 

 

 

10.6

 

 

Paper Costs.  Paper is a key component of Ranpak’s cost of sales and paper costs can fluctuate significantly between periods. Ranpak purchases both 100% virgin and 100% recycled paper, as well as blends, from various suppliers for conversion into the paper consumables it sells. The cost of paper supplies is Ranpak’s largest input cost, and it negotiates supply and pricing arrangements with most of its paper suppliers annually, with a view towards mitigating fluctuations in paper cost. Nevertheless, as paper is a commodity, its price on the open market, and in turn the prices Ranpak negotiates with suppliers at a given point in time, can fluctuate significantly, and is affected by several factors outside of Ranpak’s control, including supply and demand and the cost of other commodities that are used in the manufacture of paper, including wood, energy and chemicals. The market for Ranpak’s solutions is competitive and it may be difficult for Ranpak to pass on increases in paper prices to its customers immediately, or at all, which has in the past and could in the future adversely affect its operating results.

Results of Operations

The following tables set forth Ranpak’s results of operations for the three and nine month periods ended September 30, 2020, the three months ended September 30, 2019, the Successor Period, and the 1H 2019 Predecessor Period, with line items presented in millions of dollars.

The Ranpak Business Combination is accounted for under the scope of business combination guidance in ASC 805 as One Madison Corporation was deemed to be the accounting acquirer while Rack Holdings was deemed the “Predecessor.”  Accordingly, the business combination is accounted for using the acquisition method which requires the Company to record the fair value of assets acquired and liabilities assumed from Rack Holdings (see Note 7, “Acquisition”).

The financial statements separate the Company’s presentation into distinct periods.  The periods before the Closing of the Ranpak Business Combination (labeled Predecessor) depict the financial statements of Rack Holdings, and the period after the Closing (labeled Successor) depicts the financial statements of the Company, including the consolidation of One Madison Corporation with Rack Holdings and application of acquisition method of accounting.  As a result of the application of the acquisition method of accounting as of the Closing, the financial statements for the Predecessor periods and for the Successor periods are presented on a different basis of accounting and are, therefore not comparable.  

Our condensed consolidated financial statements are prepared in accordance with GAAP.  We have, however, also disclosed below Earnings Before Interest, Taxes, Depreciation and Amortization (“EBITDA”) and adjusted EBITDA, which are non-GAAP financial measures.  We have included EBITDA and adjusted EBITDA because they are key measures used by our management and Board of Directors to understand and evaluate our operating performance and trends, to prepare and approve our annual budget and to develop short- and long-term operational plans.  In particular, the exclusion of certain expenses in calculating EBITDA and adjusted EBITDA can provide a useful measure for period-to-period comparisons of our primary business operations.  Accordingly, we believe that EBITDA and adjusted EBITDA provide useful information to investors and others in understanding and evaluating the Company’s operating results in the same manner as our management and Board of Directors.

EBITDA and adjusted EBITDA have limitations as analytical tools, and you should not consider them in isolation or as substitutes for analysis of our results as reported under GAAP.  In particular, EBITDA and adjusted EBITDA should not be viewed as substitutes for, or superior to, net income (loss) prepared in accordance with GAAP as a measure of profitability or liquidity. Some of these limitations are:

 

although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and EBITDA and adjusted EBITDA do not reflect all cash capital expenditure requirements for such replacements or for new capital expenditure requirements;

 

EBITDA and adjusted EBITDA do not reflect changes in, or cash requirements for, our working capital needs;

32


 

 

adjusted EBITDA does not consider the potentially dilutive impact of equity-based compensation;

 

EBITDA and adjusted EBITDA do not reflect the impact of the recording or release of valuation allowances or tax payments that may represent a reduction in cash available to us;

 

adjusted EBITDA does not take into account any restructuring and integration costs; and

 

other companies, including companies in our industry, may calculate EBITDA and adjusted EBITDA differently, which reduces their usefulness as comparative measures.

EBITDA — EBITDA is a non-GAAP financial measure that we calculate as net income (loss), adjusted to exclude: benefit from (provision for) income taxes; interest expense; and depreciation and amortization.

Adjusted EBITDA — Adjusted EBITDA is a non-GAAP financial measure that we calculate as net income (loss), adjusted to exclude: benefit from (provision for) income taxes; interest expense; depreciation and amortization; stock-based compensation expense; expenses related to the Ranpak Business Combination and, in certain periods, certain other income and expense items.

We also believe that adjusting these non-GAAP measures for comparability between the Predecessor, Successor and Pro Forma periods is useful to the user of our financial statements.

In addition, in our discussion below, we include certain unaudited, non-GAAP pro forma data for the three and nine month periods ended September 30, 2020, the three months ended September 30, 2019, the Successor Period, and the 1H 2019 Predecessor Period.  This data is based on our historical financial statements included elsewhere in this Quarterly Report on Form 10-Q, adjusted (where applicable) to remove the effect of costs incurred to consummate the Ranpak Business Combination, other one-time costs incurred due to the Company entering into the Ranpak Business Combination and for purchase accounting adjustments related to the Ranpak Business Combination as well as to reflect a constant currency presentation between periods for the convenience of readers. We refer to these data as pro forma data in our discussion.  However, such pro forma data have not been prepared in accordance with Article 11 of Regulation S-X.  We reconcile this data to our GAAP data for the same period under “Presentation and Reconciliation of GAAP to Non-GAAP Measures” for the three and nine months ended September 30, 2020 and 2019.

Comparison of Three Months Ended September 30, 2020 to Three Months Ended September 30, 2019

 

 

 

Three Months Ended September 30,

 

 

 

2020

 

 

% Net revenue

 

 

2019

 

 

% Net revenue

 

Net revenue

 

$

76.8

 

 

 

 

$

69.1

 

 

 

Cost of goods sold

 

 

46.6

 

 

 

60.7

 

 

 

39.6

 

 

 

57.3

 

Gross profit

 

 

30.2

 

 

 

39.3

 

 

 

29.5

 

 

 

42.7

 

Selling, general and administrative expenses

 

 

17.8

 

 

 

23.2

 

 

 

17.7

 

 

 

25.6

 

Depreciation and amortization expense

 

 

7.7

 

 

 

10.0

 

 

 

10.3

 

 

 

14.9

 

Other operating expense, net

 

 

1.9

 

 

 

2.5

 

 

 

0.5

 

 

 

0.7

 

Income (loss) from operations

 

 

2.8

 

 

 

3.6

 

 

 

1.0

 

 

 

1.4

 

Interest expense

 

 

4.9

 

 

 

6.4

 

 

 

9.5

 

 

 

13.7

 

Foreign currency (gain) loss

 

 

3.2

 

 

 

4.2

 

 

 

(3.2

)

 

 

(4.6

)

Loss before income tax expense

 

 

(5.3

)

 

 

(6.9

)

 

 

(5.3

)

 

 

(7.7

)

Income tax expense (benefit)

 

 

0.8

 

 

 

1.0

 

 

 

(3.7

)

 

 

(5.4

)

Net loss

 

$

(6.1

)

 

 

(7.9

)

 

$

(1.6

)

 

 

(2.3

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBITDA

 

$

15.2

 

 

 

 

 

 

$

22.9

 

 

 

 

 

Adjusted EBITDA

 

$

23.7

 

 

 

 

 

 

$

22.0

 

 

 

 

 

33


 

 

 

 

Pro Forma

 

 

 

Three Months Ended September 30,

 

 

 

2020

 

 

% Net revenue

 

 

2019

 

 

% Net revenue

 

 

$ Change

 

 

% Change

 

Net revenue

 

$

76.1

 

 

 

 

$

70.4

 

 

 

 

$

5.7

 

 

 

8.1

 

Cost of goods sold

 

 

46.2

 

 

 

60.7

 

 

 

39.3

 

 

 

55.8

 

 

 

6.9

 

 

 

17.6

 

Gross profit

 

 

29.9

 

 

 

39.3

 

 

 

31.1

 

 

 

44.2

 

 

 

(1.2

)

 

 

(3.9

)

Selling, general and administrative expenses

 

 

17.7

 

 

 

23.3

 

 

 

15.8

 

 

 

22.4

 

 

 

1.9

 

 

 

12.0

 

Depreciation and amortization expense

 

 

7.7

 

 

 

10.1

 

 

 

10.5

 

 

 

14.9

 

 

 

(2.8

)

 

 

(26.7

)

Other operating expense, net

 

 

1.8

 

 

 

2.4

 

 

 

0.7

 

 

 

1.0

 

 

 

1.1

 

 

 

157.1

 

Income (loss) from operations

 

 

2.7

 

 

 

3.5

 

 

 

4.1

 

 

 

5.8

 

 

 

(1.4

)

 

 

(34.1

)

Interest expense

 

 

4.9

 

 

 

6.4

 

 

 

9.6

 

 

 

13.6

 

 

 

(4.7

)

 

 

(49.0

)

Foreign currency (gain) loss

 

 

3.2

 

 

 

4.2

 

 

 

(3.2

)

 

 

(4.5

)

 

 

6.4

 

 

 

(200.0

)

Loss before income tax expense

 

 

(5.4

)

 

 

(7.1

)

 

 

(2.3

)

 

 

(3.3

)

 

 

(3.1

)

 

 

134.8

 

Income tax expense (benefit)

 

 

0.8

 

 

 

1.1

 

 

 

(3.1

)

 

 

(4.4

)

 

 

3.9

 

 

 

(125.8

)

Net loss

 

$

(6.2

)

 

 

(8.1

)

 

$

0.8

 

 

 

1.1

 

 

$

(7.0

)

 

 

(875.0

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBITDA

 

$

15.2

 

 

 

 

 

 

$

22.9

 

 

 

 

 

 

$

(7.7

)

 

 

(33.6

)

Adjusted EBITDA

 

$

23.7

 

 

 

 

 

 

$

22.0

 

 

 

 

 

 

$

1.7

 

 

 

7.7

 

Net Revenue

The following tables and the discussion that follows compare Ranpak’s net revenue by geographic region and by product line for the three months ended September 30, 2020 and 2019 on a GAAP basis and on a non-GAAP, pro forma basis as described above and in the discussion below.  See also “Presentation and Reconciliation of GAAP to Non-GAAP Measures” for further:

 

 

 

Three Months Ended September 30,

 

 

 

2020

 

 

% Net revenue

 

 

2019

 

 

% Net revenue

 

North America

 

$

33.3

 

 

 

43.4

 

 

$

32.9

 

 

 

47.6

 

Europe/Asia

 

 

43.5

 

 

 

56.6

 

 

 

36.2

 

 

 

52.4

 

Net revenue

 

$

76.8

 

 

 

100.0

 

 

$

69.1

 

 

 

100.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cushioning machines

 

$

31.8

 

 

 

41.4

 

 

$

31.3

 

 

 

45.3

 

Void-fill machines

 

 

33.3

 

 

 

43.4

 

 

 

28.4

 

 

 

41.1

 

Wrapping machines

 

 

10.1

 

 

 

13.2

 

 

 

6.6

 

 

 

9.6

 

Other

 

 

1.6

 

 

 

2.0

 

 

 

2.8

 

 

 

4.0

 

Net revenue

 

$

76.8

 

 

 

100.0

 

 

$

69.1

 

 

 

100.0

 

 

 

 

Pro Forma

 

 

 

Three Months Ended September 30,

 

 

 

2020

 

 

% Net revenue

 

 

2019

 

 

% Net revenue

 

 

$ Change

 

 

% Change

 

North America

 

$

33.3

 

 

 

43.8

 

 

$

33.0

 

 

 

46.9

 

 

$

0.3

 

 

 

0.9

 

Europe/Asia

 

 

42.8

 

 

 

56.2

 

 

 

37.4

 

 

 

53.1

 

 

 

5.4

 

 

 

14.4

 

Net revenue

 

$

76.1

 

 

 

100.0

 

 

$

70.4

 

 

 

100.0

 

 

$

5.7

 

 

 

8.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cushioning machines

 

$

31.4

 

 

 

41.3

 

 

$

31.9

 

 

 

45.3

 

 

$

(0.5

)

 

 

(1.6

)

Void-fill machines

 

 

33.0

 

 

 

43.4

 

 

 

28.8

 

 

 

40.9

 

 

 

4.2

 

 

 

14.6

 

Wrapping machines

 

 

10.1

 

 

 

13.3

 

 

 

6.8

 

 

 

9.7

 

 

 

3.3

 

 

 

48.5

 

Other

 

 

1.6

 

 

 

2.0

 

 

 

2.9

 

 

 

4.1

 

 

 

(1.3

)

 

 

(44.8

)

Net revenue

 

$

76.1

 

 

 

100.0

 

 

$

70.4

 

 

 

100.0

 

 

$

5.7

 

 

 

8.1

 

 

34


 

Net revenue for the three months ended September 30, 2020 was $76.8 million.  Net revenue was $69.1 million in the three months ended September 30, 2019.  Net revenue increased $7.7 million or 11.1% as a result of an increase in the volume of Ranpak’s paper consumable products of approximately 15.1 pp, partially offset by a decrease of approximately 1.8 pp in sales of automated box sizing equipment and a 5.6 pp decrease in the price of Ranpak’s paper consumable products.  Net revenue was positively impacted by increases in cushioning, void-fill, and wrapping, partially offset by decreases in automation.  Cushioning increased $0.5 million, or 1.6%, to $31.8 million from $31.3 million, void-fill increased $4.9 million, or 17.3%, to $33.3 million from $28.4 million, wrapping increased $3.5 million, or 53.0%, to $10.1 million from $6.6 million, while other sales decreased $1.2 million, or 42.9%, to $1.6 million from $2.8 million, for the three months ended September 30, 2020 compared to the three months ended September 30, 2019. Other net revenue includes automated box sizing equipment and non-paper revenue from packaging systems installed in the field.  Pro forma net revenue was $76.1 million for the three months ended September 30, 2020, a $5.7 million, or 8.1%, increase on a constant currency basis from pro forma net revenue of $70.4 million for the three months ended September 30, 2019.

Net revenue in North America for the three months ended September 30, 2020 totaled $33.3 million.  Net revenue in North America was $32.9 million in the three months ended September 30, 2019.  Net revenue in North America increased $0.4 million, or 1.2% attributable to an increase in wrapping sales, partially offset by a decline in cushioning and void-fill volumes. Pro forma net revenue in North America was $33.3 million for the three months ended September 30, 2020, a $0.3 million, or 0.9%, increase from pro forma net revenue of $33.0 million for the three months ended September 30, 2019 after purchase accounting adjustments.

Net revenue in Europe/Asia for the three months ended September 30, 2020 totaled $43.5 million. Net revenue in Europe/Asia was $36.2 million in the three months ended September 30, 2019.  Net revenue in Europe/Asia increased $7.3 million or 20.2% driven primarily by increases in void-fill and wrapping product categories, partially offset by a decline in automation revenue.  Pro forma net revenue in Europe/Asia was $42.8 million for the three months ended September 30, 2020, a $5.4 million, or 14.4%, increase from pro forma net revenue of $37.4 million for the three months ended September 30, 2019 after adjusting for constant currency.  

Cost of Sales

Cost of sales for the three months ended September 30, 2020 totaled $46.6 million. Cost of sales was $39.6 million in the three months ended September 30, 2019.  Cost of sales increased $7.0 million or 17.7% due to higher sales of consumables, an increase in depreciation of $2.9 million over the prior year due to the Ranpak Business Combination fair value adjustments, increased converter placement, increases in labor and freight costs, and an increase in non-recurring operating costs in automation, offset by lower price of paper.  Pro forma cost of sales increased by $6.9 million, or 17.6%, to $46.2 million in the three months ended September 30, 2020 from $39.3 million for the three months ended September 30, 2019 after adjusting to a constant currency in both periods.  As a result, on a pro forma basis, net sales minus cost of sales as a percentage of net sales decreased by 4.9 pp to 39.3% in the three months ended September 30, 2020 from 44.2% for the comparable period in 2019.

Selling, General and Administrative Expenses (SG&A)

SG&A expenses for the three months ended September 30, 2020 was $17.8 million and nearly flat to SG&A of $17.7 million in the three months ended September 30, 2019.  Pro forma SG&A expenses increased by $1.9 million, or 12.0%, to $17.7 million in the three months ended September 30, 2020 from $15.8 million for the comparable period in 2019 after adjusting to a constant currency in both periods, largely due to support of growth initiatives and $1.2 million in costs associated with the Warrant Exchange.  As a percentage of pro forma net sales, pro forma SG&A increased to 23.2% in the three months ended September 30, 2020 from 22.4% in the three months ended September 30, 2019 on a constant currency basis.

Depreciation and Amortization

Depreciation and amortization expenses for the three months ended September 30, 2020 were $7.7 million.  Depreciation and amortization expenses were $10.3 million in the three months ended September 30, 2019.  Depreciation and amortization expenses decreased $2.6 million, or 25.2% due to the Ranpak Business Combination fair value adjustments, their related amortizable lives and changes in currency rates.  Pro forma depreciation and amortization expenses decreased by $2.8 million, or 26.7%, to $7.7 million in the three months ended September 30, 2020 from $10.5 million for the three months ended September 30, 2019 on a constant currency basis.  As a percentage of pro forma net sales, pro forma depreciation and amortization expenses decreased to 10.1% in the three months ended September 30, 2020 from 14.9% in the three months ended September 30, 2019 on a constant currency basis.

Other Operating Expense, Net

Other operating expense, net, for the three months ended September 30, 2020 was $1.9 million. Other operating expense, net was $0.5 million in the three months ended September 30, 2019.  Other operating expense increased $1.4 million.  Pro forma other operating expense, net was $1.8 million in the three months ended September 30, 2020 compared to $0.7 million for the three months ended September 30, 2019 on a constant currency basis, largely driven by increases in research and development.  As a percentage of pro

35


 

forma net sales, pro forma other operating expense, net, increased to 2.4% in the three months ended September 30, 2020 from 1.0% in the three months ended September 30, 2019 on a constant currency basis.  

Interest Expense

Interest expense for the three months ended September 30, 2020 was $4.9 million.  Interest expense was $9.5 million in the three months ended September 30, 2019.  Interest expense decreased $4.6 million, or 48.4%.  Interest expense decreased due to decreased debt levels and deferred financing costs, as well as lower interest rates.  Pro forma interest expense decreased by $4.7 million, or 49.0%, to $4.9 million in the three months ended September 30, 2020 compared to $9.6 million for the three months ended September 30, 2019 on a constant currency basis due to decreased debt levels and deferred financing costs, as well as lower interest rates.  As a percentage of pro forma net sales, pro forma interest expense decreased to 6.4% in the three months ended September 30, 2020 from 13.6% in the three months ended September 30, 2019.

Foreign Currency (Gain) Loss

Foreign currency loss for the three months ended September 30, 2020 was $3.2 million.  Foreign currency gain was $3.2 million in the three months ended September 30, 2019.  Foreign currency loss increased $6.4 million due to favorable movements in Euro exchange rates.  Pro forma foreign currency loss was $3.2 million in the three months ended September 30, 2020 compared to gain of $3.2 million for the three months ended September 30, 2019 on a constant currency basis.  As a percentage of pro forma net sales, pro forma foreign currency loss decreased to 4.2% in the three months ended September 30, 2020 from 4.5% in the three months ended September 30, 2019 on a constant currency basis.  

Income Tax Expense (Benefit)

Income tax expense for the three months ended September 30, 2020 was $0.8 million, or an effective tax rate of negative 15.7%.  Income tax benefit was $3.7 million in the three months ended September 30, 2019, or an effective tax rate of 69.8%.  The fluctuation in the effective tax rate between periods was primarily attributable to a jurisdictional mix of income between periods and discrete tax expense of $1.3 million recorded in the third quarter of 2020.  The effective tax rate differs from the U.S. federal statutory rate due primarily to benefits derived from the U.S. foreign derived intangible income deduction, tax credits available in the United States, and income in foreign jurisdictions that are taxed at different rates than the U.S. statutory tax rate.

Net Loss

Net loss for the three months ended September 30, 2020 increased $4.5 million to $6.1 million from a net loss of $1.6 million in the three months ended September 30, 2019.  Pro forma net loss was $6.2 million in the three months ended September 30, 2020 compared to pro forma net income of $0.8 million for the three months ended September 30, 2019 on a constant currency basis. The change was due to the reasons discussed above.

EBITDA and Adjusted EBITDA

EBITDA for the three months ended September 30, 2020 was $15.2 million.  EBITDA was $22.9 million in the three months ended September 30, 2019.  Adjusting for constant currency and other one-time costs, pro forma Adjusted EBITDA for the three months ended September 30, 2020 and 2019 totaled $23.7 million and $22.0 million, respectively, an increase of $1.7 million, or 7.7% on a constant currency basis.

36


 

Comparison of Nine Months Ended September 30, 2020 to the Successor Period and 1H 2019 Predecessor Period  

 

 

 

Successor

 

 

 

Predecessor

 

 

 

Nine Months Ended September 30,

June 3, 2019 – September 30, 2019

 

 

 

January 1, 2019 – June 2, 2019

 

 

 

2020

 

 

% Net revenue

 

 

2019

 

 

% Net revenue

 

 

 

2019

 

 

% Net revenue

 

Net revenue

 

$

206.3

 

 

 

 

$

85.4

 

 

 

 

 

$

106.4

 

 

 

Cost of goods sold

 

 

122.3

 

 

 

59.3

 

 

 

52.6

 

 

 

61.6

 

 

 

 

61.2

 

 

 

57.5

 

Gross profit

 

 

84.0

 

 

 

40.7

 

 

 

32.8

 

 

 

38.4

 

 

 

 

45.2

 

 

 

42.5

 

Selling, general and administrative expenses

 

 

58.1

 

 

 

28.2

 

 

 

22.5

 

 

 

26.3

 

 

 

 

23.8

 

 

 

22.4

 

Transaction costs

 

 

-

 

 

 

-

 

 

 

0.3

 

 

 

0.4

 

 

 

 

7.4

 

 

 

7.0

 

Depreciation and amortization expense

 

 

22.9

 

 

 

11.1

 

 

 

13.3

 

 

 

15.6

 

 

 

 

17.7

 

 

 

16.6

 

Other operating expense, net

 

 

2.9

 

 

 

1.4

 

 

 

0.8

 

 

 

0.9

 

 

 

 

2.2

 

 

 

2.1

 

Income (loss) from operations

 

 

0.1

 

 

 

0.0

 

 

 

(4.1

)

 

 

(4.8

)

 

 

 

(5.9

)

 

 

(5.5

)

Interest expense

 

 

16.6

 

 

 

8.0

 

 

 

17.5

 

 

 

20.5

 

 

 

 

20.2

 

 

 

19.0

 

Foreign currency (gain) loss

 

 

3.1

 

 

 

1.5

 

 

 

(1.6

)

 

 

(1.9

)

 

 

 

(2.2

)

 

 

(2.1

)

Loss before income tax expense

 

 

(19.6

)

 

 

(9.5

)

 

 

(20.0

)

 

 

(23.4

)

 

 

 

(23.9

)

 

 

(22.5

)

Income tax benefit

 

 

(1.4

)

 

 

(0.7

)

 

 

(6.1

)

 

 

(7.1

)

 

 

 

(4.9

)

 

 

(4.6

)

Net loss

 

$

(18.2

)

 

 

(8.8

)

 

$

(13.9

)

 

 

(16.3

)

 

 

$

(19.0

)

 

 

(17.9

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBITDA

 

$

42.2

 

 

 

 

 

 

$

20.1

 

 

 

 

 

 

 

$

22.9

 

 

 

 

 

Adjusted EBITDA

 

$

60.8

 

 

 

 

 

 

$

-

 

 

 

 

 

 

 

$

-

 

 

 

 

 

 

 

 

Pro Forma

 

 

 

Nine Months Ended September 30,

 

 

 

2020

 

 

% Net revenue

 

 

2019

 

 

% Net revenue

 

 

$ Change

 

 

% Change

 

Net revenue

 

$

208.7

 

 

 

 

$

198.2

 

 

 

 

$

10.5

 

 

 

5.3

 

Cost of goods sold

 

 

123.7

 

 

 

59.3

 

 

 

113.0

 

 

 

57.0

 

 

 

10.7

 

 

 

9.5

 

Gross profit

 

 

85.0

 

 

 

40.7

 

 

 

85.2

 

 

 

43.0

 

 

 

(0.2

)

 

 

(0.2

)

Selling, general and administrative expenses

 

 

58.7

 

 

 

28.1

 

 

 

43.1

 

 

 

21.7

 

 

 

15.6

 

 

 

36.2

 

Depreciation and amortization expense

 

 

23.1

 

 

 

11.1

 

 

 

30.8

 

 

 

15.5

 

 

 

(7.7

)

 

 

(25.0

)

Other operating expense, net

 

 

3.2

 

 

 

1.5

 

 

 

3.6

 

 

 

1.8

 

 

 

(0.4

)

 

 

(11.1

)

Income (loss) from operations

 

 

-

 

 

 

-

 

 

 

7.7

 

 

 

3.9

 

 

 

(7.7

)

 

 

(100.0

)

Interest expense

 

 

16.6

 

 

 

8.0

 

 

 

26.1

 

 

 

13.2

 

 

 

(9.5

)

 

 

(36.4

)

Foreign currency (gain) loss

 

 

3.1

 

 

 

1.5

 

 

 

(3.8

)

 

 

(1.9

)

 

 

6.9

 

 

 

(181.6

)

Loss before income tax expense

 

 

(19.7

)

 

 

(9.4

)

 

 

(14.6

)

 

 

(7.4

)

 

 

(5.1

)

 

 

34.9

 

Income tax benefit

 

 

(1.3

)

 

 

(0.6

)

 

 

(4.8

)

 

 

(2.4

)

 

 

3.5

 

 

 

(72.9

)

Net loss

 

$

(18.4

)

 

 

(8.8

)

 

$

(9.8

)

 

 

(4.9

)

 

$

(8.6

)

 

 

87.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBITDA

 

$

42.2

 

 

 

 

 

 

$

58.1

 

 

 

 

 

 

$

(15.9

)

 

 

(27.4

)

Adjusted EBITDA

 

$

60.8

 

 

 

 

 

 

$

58.4

 

 

 

 

 

 

$

2.4

 

 

 

4.1

 

 

Net Revenue

The following table and the discussion that follows compares Ranpak’s net revenue by geographic region and by product line for the nine months ended September 30, 2020 and 2019 on a GAAP basis and on a non-GAAP, pro forma basis as described above and in the discussion below. See also “Presentation and Reconciliation of GAAP to Non-GAAP Measures” for further:

 

 

 

Successor

 

 

 

Predecessor

 

 

 

Nine Months Ended September 30,

June 3, 2019 – September 30, 2019

 

 

 

January 1, 2019 – June 2, 2019

 

 

 

2020

 

 

% Net revenue

 

 

2019

 

 

% Net revenue

 

 

 

2019

 

 

% Net revenue

 

North America

 

$

88.6

 

 

 

42.9

 

 

$

42.2

 

 

 

49.4

 

 

 

$

50.1

 

 

 

47.1

 

Europe/Asia

 

 

117.7

 

 

 

57.1

 

 

 

43.2

 

 

 

50.6

 

 

 

 

56.3

 

 

 

52.9

 

Net revenue

 

$

206.3

 

 

 

100.0

 

 

$

85.4

 

 

 

100.0

 

 

 

$

106.4

 

 

 

100.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cushioning machines

 

$

86.1

 

 

 

41.7

 

 

$

39.3

 

 

 

46.0

 

 

 

$

46.4

 

 

 

43.6

 

Void-fill machines

 

 

86.8

 

 

 

42.1

 

 

 

36.4

 

 

 

42.6

 

 

 

 

42.7

 

 

 

40.1

 

Wrapping machines

 

 

25.9

 

 

 

12.6

 

 

 

8.0

 

 

 

9.4

 

 

 

 

8.8

 

 

 

8.3

 

Other

 

 

7.5

 

 

 

3.6

 

 

 

1.7

 

 

 

2.0

 

 

 

 

8.5

 

 

 

8.0

 

Net revenue

 

$

206.3

 

 

 

100.0

 

 

$

85.4

 

 

 

100.0

 

 

 

$

106.4

 

 

 

100.0

 

37


 

 

 

 

Pro Forma

 

 

 

Nine Months Ended September 30,

 

 

 

2020

 

 

% Net revenue

 

 

2019

 

 

% Net revenue

 

 

$ Change

 

 

% Change

 

North America

 

$

88.6

 

 

 

42.5

 

 

$

92.7

 

 

 

46.8

 

 

$

(4.1

)

 

 

(4.4

)

Europe/Asia

 

 

120.1

 

 

 

57.5

 

 

 

105.5

 

 

 

53.2

 

 

 

14.6

 

 

 

13.8

 

Net revenue

 

$

208.7

 

 

 

100.0

 

 

$

198.2

 

 

 

100.0

 

 

$

10.5

 

 

 

5.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cushioning machines

 

$

87.3

 

 

 

41.8

 

 

$

93.6

 

 

 

47.2

 

 

$

(6.3

)

 

 

(6.7

)

Void-fill machines

 

 

87.5

 

 

 

41.9

 

 

 

81.9

 

 

 

41.3

 

 

 

5.6

 

 

 

6.8

 

Wrapping machines

 

 

26.1

 

 

 

12.5

 

 

 

17.7

 

 

 

8.9

 

 

 

8.4

 

 

 

47.5

 

Other

 

 

7.8

 

 

 

3.8

 

 

 

5.0

 

 

 

2.6

 

 

 

2.8

 

 

 

56.0

 

Net revenue

 

$

208.7

 

 

 

100.0

 

 

$

198.2

 

 

 

100.0

 

 

$

10.5

 

 

 

5.3

 

 

Net revenue for the nine months ended September 30, 2020 was $206.3 million.  Net revenue for the Successor Period was $85.4 million, and $106.4 million in the 1H 2019 Predecessor Period, for a combined $191.8 million in the nine months ended September 30, 2019.  Net revenue increased $14.5 million or 7.6% as a result of an increase in the volume of Ranpak’s paper consumable products of approximately 9.6 pp and an increase of approximately 0.1 pp in sales of automated box sizing equipment, partially offset by a decrease in the price of Ranpak’s paper consumable products which contributed a 4.6 pp decrease in sales.  Net revenue was positively impacted by increases in cushioning, void-fill, and wrapping, partially offset by decreases in other sales.  Cushioning increased $0.4 million, or 0.5%, to $86.1 million from $85.7 million, void-fill increased $7.7 million, or 9.7%, to $86.8 million from $79.1 million, wrapping increased $9.1 million, or 54.2%, to $25.9 million from $16.8 million, while other sales decreased $2.7 million, or 26.5% to $7.5 million from $10.2 million, in each case for the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019.  Other net revenue includes automated box sizing equipment and non-paper revenue from packaging systems installed in the field.  Pro forma net revenue was $208.7 million for the nine months ended September 30, 2020, a $10.5 million, or 5.3%, increase on a constant currency basis pro forma net revenue of $198.2 million for the nine months ended September 30, 2019 after adjusting to a constant currency in both periods and purchase accounting adjustments related to revenue recognition in the nine months ended September 30, 2019.

Net revenue in North America for the nine months ended September 30, 2020 totaled $88.6 million.  Net revenue in North America was $42.2 million in the Successor Period and $50.1 million in the 1H 2019 Predecessor Period for a combined $92.3 million in the nine months ended September 30, 2019.  Net revenue in North America decreased $3.7 million, or 4.0% attributable to a decline in cushioning and void-fill volumes, partially offset by an increase in wrapping sales.  Pro forma net revenue in North America was $88.6 million for the nine months ended September 30, 2020, a $4.1 million, or 4.4%, decrease from pro forma net revenue in North America of $92.7 million for the nine months ended September 30, 2019 after purchase accounting adjustments.

Net revenue in Europe/Asia for the nine months ended September 30, 2020 totaled $117.7 million.  Net revenue in Europe/Asia was $43.2 million in the Successor Period and $56.3 million in the 1H 2019 Predecessor Period, for a combined $99.5 million in the nine months ended September 30, 2019.  Net revenue in Europe/Asia increased $18.2 million or 18.3% driven primarily by growth in wrapping and void-fill sales, partially offset by a decline in cushioning.  Pro forma net revenue in Europe/Asia was $120.1 million for the nine months ended September 30, 2020, a $14.6 million, or 13.8%, increase from pro forma net revenue of $105.5 million for the nine months ended September 30, 2019 after purchase accounting adjustments and adjusting for constant currency.

Cost of Sales

Cost of sales for the nine months ended September 30, 2020 totaled $122.3 million.  Cost of sales was $52.6 million in the Successor Period and $61.2 million in the 1H 2019 Predecessor Period, for a combined $113.8 million in the nine months ended September 30, 2019.  Cost of sales increased $8.5 million or 7.5% due to increases in sales year over year and higher depreciation expense of $6.6 million due to the Ranpak Business Combination fair value adjustments, an increase in non-recurring operating costs in automation, offset by a decrease in the price of paper.  Pro forma cost of sales increased by $10.7 million, or 9.5%, to $123.7 million in the nine months ended September 30, 2020 from $113.0 million for the nine months ended September 30, 2019 after adjusting to a constant currency in both periods and purchase accounting adjustments of $2.1 million for the nine months ended September 30, 2019.  As a result, on a pro forma basis, net sales minus cost of sales as a percentage of net sales decreased by 2.3 pp to 40.7% in the nine months ended September 30, 2020 from 43.0% for the nine months ended September 30, 2019.

Selling, General, and Administrative Expenses

SG&A expenses for the nine months ended September 30, 2020 was $58.1 million.  SG&A was $22.5 million in the Successor Period and $23.8 million in the 1H 2019 Predecessor Period, for a combined $46.3 million in the nine months ended September 30, 2019.  SG&A expenses increased $11.8 million or 25.5% due to $1.2 million of costs associated with the Warrant Exchange, severance costs, non-cash equity compensation costs, increased support of growth initiatives, and increased costs associated with being a public

38


 

company.  Pro forma SG&A expenses increased by $15.6 million, or 36.2%, to $58.7 million in the nine months ended September 30, 2020 from $43.1 million for the nine months ended September 30, 2019 after adjusting to a constant currency in both periods.  As a percentage of pro forma net sales, pro forma SG&A increased to 28.1% in the nine months ended September 30, 2020 from 21.7% in the nine months ended September 30, 2019 on a constant currency basis.

Transaction Costs

We incurred transaction costs related to the Ranpak Business Combination of approximately $0.3 million in the Successor Period and $7.4 million in the 1H 2019 Predecessor Period for a combined $7.7 million. All of these costs were related to the Ranpak Business Combination.

Depreciation and Amortization

Depreciation and amortization expenses for the nine months ended September 30, 2020 were $22.9 million.  Depreciation and amortization expenses were $13.3 million in the Successor Period and $17.7 million in the 1H 2019 Predecessor Period, for a combined $31.0 million in the nine months ended September 30, 2019.  Depreciation and amortization expenses decreased $8.1 million, or 26.1% due to the Ranpak Business Combination fair value adjustments, their related amortizable lives and changes in currency rates.  Pro forma depreciation and amortization expenses decreased by $7.7 million, or 25.0%, to $23.1 million in the nine months ended September 30, 2020 from $30.8 million for the nine months ended September 30, 2019 on a constant currency basis.  As a percentage of pro forma net sales, pro forma depreciation and amortization expenses decreased to 11.1% in the nine months ended September 30, 2020 from 15.5% in the nine months ended September 30, 2019 on a constant currency basis.

Other Operating Expense, Net

Other operating expense, net for the nine months ended September 30, 2020 was $2.9 million. Other operating expense, net was $0.8 million in the Successor Period and $2.2 million in the 1H 2019 Predecessor Period, for a combined $3.0 million in the nine months ended September 30, 2019, nearly flat to the current year.  Pro forma other operating expense, net, was $3.2 million in the nine months ended September 30, 2020 compared to $3.6 million for the nine months ended September 30, 2019 on a constant currency basis.  As a percentage of pro forma net sales, pro forma other operating expense, net, decreased to 1.5% in the nine months ended September 30, 2020 from 1.8% in the nine months ended September 30, 2019 on a constant currency basis.

Interest Expense

Interest expense for the nine months ended September 30, 2020 was $16.6 million.  Interest expense was $17.5 million in the Successor Period and $20.2 million in the 1H 2019 Predecessor Period, for a combined $37.7 million in the nine months ended September 30, 2019.  Interest expense decreased $21.1 million, or 56.0%.  Interest expense decreased due to decreased debt levels and lower interest rates, as well as transaction-related expenses in June 2019, which included a write-off of deferred financing fees and the termination of an interest rate swap.  Pro forma interest expense decreased by $9.5 million, or 36.4%, to $16.6 million in the nine months ended September 30, 2020 compared to $26.1 million for the nine months ended September 30, 2019 on a constant currency basis.  As a percentage of pro forma net sales, pro forma interest expense decreased to 8.0% in the nine months ended September 30, 2020 from 13.2% in the nine months ended September 30, 2019.

Foreign Currency (Gain) Loss

Foreign currency loss for the nine months ended September 30, 2020 was $3.1 million.  Foreign currency gain was $1.6 million in the Successor Period and $2.2 million in the 1H 2019 Predecessor Period, for a combined gain of $3.8 million in the nine months ended September 30, 2019.  Foreign currency loss increased $6.9 million due to favorable movements in Euro exchange rates, as well as the net impact of the re-measurement of Ranpak’s Euro-denominated term facility and its Euro-denominated intercompany note to a Dutch subsidiary in the Predecessor periods.  Pro forma foreign currency loss was $3.1 million in the nine months ended September 30, 2020 compared to a gain of $3.8 million for the nine months ended September 30, 2019 on a constant currency basis.  As a percentage of pro forma net sales, pro forma foreign currency (gain) loss decreased to 1.5% in the nine months ended September 30, 2020 from 1.9% in the nine months ended September 30, 2019.

Income Tax Benefit

Income tax benefit for the nine months ended September 30, 2020 was $1.4 million, or an effective tax rate of 7.1%.  Income tax benefit was $6.1 million in the Successor Period and $4.9 million in the 1H 2019 Predecessor Period, for a combined benefit of $11.0 million in the nine months ended September 30, 2019.  The fluctuation in the effective tax rate between periods was primarily attributable to a jurisdictional mix of income between periods and discrete tax expense of $1.3 million recorded in the third quarter of 2020.  The effective tax rate differs from the U.S. federal statutory rate due primarily to benefits derived from the U.S. foreign derived intangible income deduction, tax credits available in the United States, and income in foreign jurisdictions that are taxed at different rates than the U.S. statutory tax rate.

39


 

Net Loss

Net loss for the nine months ended September 30, 2020 was $18.2 million.  Net loss was $13.9 million in the Successor Period and $19.0 million in the 1H 2019 Predecessor Period, for a combined net loss of $32.9 million in the nine months ended September 30, 2019.  Net loss decreased $14.7 million, or 44.7%.  Pro forma net loss was $18.4 million in the nine months ended September 30, 2020 compared to pro forma net loss of $9.8 million for the nine months ended September 30, 2019 on a constant currency basis.  The change was primarily due to the reasons discussed above.

EBITDA and Adjusted EBITDA

EBITDA for the nine months ended September 30, 2020 was $42.2 million compared to a combined $58.1 million in the nine months ended September 30, 2019.  Adjusting for transaction costs associated with the Ranpak Business Combination, constant currency and other one-time costs, pro forma Adjusted EBITDA for the nine months ended September 30, 2020 totaled $60.8 million, an increase of $2.4 million, or 4.1% on a constant currency basis from $58.4 million in the nine months ended September 30, 2019.

Presentation and Reconciliation of GAAP to Non-GAAP Measures

As noted above, we believe that in order to better understand the performance of the Company, providing non-GAAP financial measures to users of our financial information is helpful.  Ranpak believes presentation of these non-GAAP measures is useful because they are many of the key measures that allow management to evaluate more effectively its operating performance and compare the results of its operations from period to period and against its peers without regard to financing methods or capital structure.  Management does not consider these non-GAAP measures in isolation or as an alternative to similar financial measures determined in accordance with GAAP.  Additionally, as a result of the Ranpak Business Combination, we believe that users of our financial information will find that non-GAAP, pro forma data for the three and nine months ended September 30, 2020 is useful when comparing the current and prior periods.  The computations of EBITDA and adjusted EBITDA may not be comparable to other similarly titled measures of other companies.  These non-GAAP financial measures should not be considered as alternatives to, or more meaningful than, measures of financial performance as determined in accordance with GAAP or as indicators of operating performance.

40


 

The following tables and related notes reconcile certain non-GAAP measures including the non-GAAP pro forma measures, to GAAP information presented in this Quarterly Report on Form 10-Q for the three and nine months ended September 30, 2020 and 2019:

 

 

 

Successor

 

 

 

Three Months Ended September 30, 2020

 

 

 

As reported

 

 

Adjustments(6)

 

 

Pro Forma

 

Net revenue

 

$

76.8

 

 

$

(0.7

)

 

$

76.1

 

Cost of goods sold

 

 

46.6

 

 

 

(0.4

)

 

 

46.2

 

Gross profit

 

 

30.2

 

 

 

(0.3

)

 

 

29.9

 

Selling, general and administrative expenses

 

 

17.8

 

 

 

(0.1

)

 

 

17.7

 

Depreciation and amortization expense

 

 

7.7

 

 

 

-

 

 

 

7.7

 

Other operating expense, net

 

 

1.9

 

 

 

(0.1

)

 

 

1.8

 

Income (loss) from operations

 

 

2.8

 

 

 

(0.1

)

 

 

2.7

 

Interest expense

 

 

4.9

 

 

 

-

 

 

 

4.9

 

Foreign currency (gain) loss

 

 

3.2

 

 

 

-

 

 

 

3.2

 

Loss before income tax expense

 

 

(5.3

)

 

 

(0.1

)

 

 

(5.4

)

Income tax benefit

 

 

0.8

 

 

 

-

 

 

 

0.8

 

Net loss

 

$

(6.1

)

 

$

(0.1

)

 

 

(6.2

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Add(4):

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization expense - COS

 

 

 

 

 

 

 

 

 

 

8.0

 

Depreciation and amortization expense - SG&A

 

 

 

 

 

 

 

 

 

 

7.7

 

Interest expense

 

 

 

 

 

 

 

 

 

 

4.9

 

Income tax benefit

 

 

 

 

 

 

 

 

 

 

0.8

 

EBITDA

 

 

 

 

 

 

 

 

 

 

15.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments(5):

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized (gain) loss translation

 

 

 

 

 

 

 

 

 

 

3.3

 

Constant currency

 

 

 

 

 

 

 

 

 

 

(0.2

)

Non-cash impairment losses

 

 

 

 

 

 

 

 

 

 

0.7

 

M&A, restructuring, severance

 

 

 

 

 

 

 

 

 

 

1.2

 

Amortization of restricted stock units

 

 

 

 

 

 

 

 

 

 

1.7

 

Warrant Exchange costs

 

 

 

 

 

 

 

 

 

 

1.2

 

Other non-core and non-cash adjustments

 

 

 

 

 

 

 

 

 

 

0.6

 

Adjusted EBITDA

 

 

 

 

 

 

 

 

 

$

23.7

 

41


 

 

 

 

Successor

 

 

 

Three Months Ended September 30, 2019

 

 

 

As reported

 

 

Adjustments(6)

 

 

Pro Forma

 

Net revenue

 

$

69.1

 

 

$

1.3

 

(1)

$

70.4

 

Cost of goods sold

 

 

39.6

 

 

 

(0.3

)

(2)

 

39.3

 

Gross profit

 

 

29.5

 

 

 

1.6

 

 

 

31.1

 

Selling, general and administrative expenses

 

 

17.7

 

 

 

(1.9

)

 

 

15.8

 

Depreciation and amortization expense

 

 

10.3

 

 

 

0.2

 

 

 

10.5

 

Other operating expense, net

 

 

0.5

 

 

 

0.2

 

 

 

0.7

 

Income (loss) from operations

 

 

1.0

 

 

 

3.1

 

 

 

4.1

 

Interest expense

 

 

9.5

 

 

 

0.1

 

 

 

9.6

 

Foreign currency (gain) loss

 

 

(3.2

)

 

 

-

 

 

 

(3.2

)

Loss before income tax expense

 

 

(5.3

)

 

 

3.0

 

 

 

(2.3

)

Income tax benefit

 

 

(3.7

)

 

 

0.6

 

(3)

 

(3.1

)

Net loss

 

$

(1.6

)

 

$

2.4

 

 

 

0.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Add(4):

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization expense - COS

 

 

 

 

 

 

 

 

 

 

5.1

 

Depreciation and amortization expense - SG&A

 

 

 

 

 

 

 

 

 

 

10.5

 

Interest expense

 

 

 

 

 

 

 

 

 

 

9.6

 

Income tax benefit

 

 

 

 

 

 

 

 

 

 

(3.1

)

EBITDA

 

 

 

 

 

 

 

 

 

 

22.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments(5):

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized (gain) loss translation

 

 

 

 

 

 

 

 

 

 

(3.2

)

Non-cash impairment losses

 

 

 

 

 

 

 

 

 

 

0.4

 

Amortization of restricted stock units

 

 

 

 

 

 

 

 

 

 

1.6

 

Other non-core and non-cash adjustments

 

 

 

 

 

 

 

 

 

 

0.3

 

Adjusted EBITDA

 

 

 

 

 

 

 

 

 

$

22.0

 

42


 

 

 

 

Pro Forma

 

 

 

Three Months Ended September 30,

 

 

 

 

 

 

 

 

 

 

 

2020

 

 

2019

 

 

$ Change

 

 

% Change

 

Net revenue

 

$

76.1

 

 

$

70.4

 

 

$

5.7

 

 

 

8.1

 

Cost of goods sold

 

 

46.2

 

 

 

39.3

 

 

 

6.9

 

 

 

17.6

 

Gross profit

 

 

29.9

 

 

 

31.1

 

 

 

(1.2

)

 

 

(3.9

)

Selling, general and administrative expenses

 

 

17.7

 

 

 

15.8

 

 

 

1.9

 

 

 

12.0

 

Depreciation and amortization expense

 

 

7.7

 

 

 

10.5

 

 

 

(2.8

)

 

 

(26.7

)

Other operating expense, net

 

 

1.8

 

 

 

0.7

 

 

 

1.1

 

 

 

157.1

 

Income (loss) from operations

 

 

2.7

 

 

 

4.1

 

 

 

(1.4

)

 

 

(34.1

)

Interest expense

 

 

4.9

 

 

 

9.6

 

 

 

(4.7

)

 

 

(49.0

)

Foreign currency (gain) loss

 

 

3.2

 

 

 

(3.2

)

 

 

6.4

 

 

 

(200.0

)

Loss before income tax expense

 

 

(5.4

)

 

 

(2.3

)

 

 

(3.1

)

 

 

134.8

 

Income tax benefit

 

 

0.8

 

 

 

(3.1

)

 

 

3.9

 

 

 

(125.8

)

Net loss

 

 

(6.2

)

 

 

0.8

 

 

 

(7.0

)

 

 

(875.0

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Add(4):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization expense - COS

 

 

8.0

 

 

 

5.1

 

 

 

2.9

 

 

 

56.9

 

Depreciation and amortization expense - SG&A

 

 

7.7

 

 

 

10.5

 

 

 

(2.8

)

 

 

(26.7

)

Interest expense

 

 

4.9

 

 

 

9.6

 

 

 

(4.7

)

 

 

(49.0

)

Income tax benefit

 

 

0.8

 

 

 

(3.1

)

 

 

3.9

 

 

 

(125.8

)

EBITDA

 

 

15.2

 

 

 

22.9

 

 

 

(7.7

)

 

 

(33.6

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments(5):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized (gain) loss translation

 

 

3.3

 

 

 

(3.2

)

 

 

6.5

 

 

 

(203.1

)

Constant currency

 

 

(0.2

)

 

 

-

 

 

 

(0.2

)

 

 

Non-cash impairment losses

 

 

0.7

 

 

 

0.4

 

 

 

0.3

 

 

 

75.0

 

M&A, restructuring, severance

 

 

1.2

 

 

 

-

 

 

 

1.2

 

 

 

Amortization of restricted stock units

 

 

1.7

 

 

 

1.6

 

 

 

0.1

 

 

 

6.2

 

Warrant Exchange costs

 

 

1.2

 

 

 

-

 

 

 

1.2

 

 

 

Other non-core and non-cash adjustments

 

 

0.6

 

 

 

0.3

 

 

 

0.3

 

 

 

100.0

 

Adjusted EBITDA

 

$

23.7

 

 

$

22.0

 

 

$

1.7

 

 

 

7.7

 

43


 

 

 

 

Successor

 

 

 

Nine Months Ended September 30, 2020

 

 

 

As reported

 

 

Adjustments(6)

 

 

Pro Forma

 

Net revenue

 

$

206.3

 

 

$

2.4

 

 

$

208.7

 

Cost of goods sold

 

 

122.3

 

 

 

1.4

 

 

 

123.7

 

Gross profit

 

 

84.0

 

 

 

1.0

 

 

 

85.0

 

Selling, general and administrative expenses

 

 

58.1

 

 

 

0.6

 

 

 

58.7

 

Depreciation and amortization expense

 

 

22.9

 

 

 

0.2

 

 

 

23.1

 

Other operating expense, net

 

 

2.9

 

 

 

0.3

 

 

 

3.2

 

Income (loss) from operations

 

 

0.1

 

 

 

(0.1

)

 

 

-

 

Interest expense

 

 

16.6

 

 

 

-

 

 

 

16.6

 

Foreign currency (gain) loss

 

 

3.1

 

 

 

-

 

 

 

3.1

 

Loss before income tax expense

 

 

(19.6

)

 

 

(0.1

)

 

 

(19.7

)

Income tax benefit

 

 

(1.4

)

 

 

0.1

 

 

 

(1.3

)

Net loss

 

$

(18.2

)

 

$

(0.2

)

 

 

(18.4

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Add(4):

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization expense - COS

 

 

 

 

 

 

 

 

 

 

22.4

 

Depreciation and amortization expense - SG&A

 

 

 

 

 

 

 

 

 

 

23.0

 

Interest expense

 

 

 

 

 

 

 

 

 

 

16.6

 

Income tax benefit

 

 

 

 

 

 

 

 

 

 

(1.4

)

EBITDA

 

 

 

 

 

 

 

 

 

 

42.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments(5):

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized (gain) loss translation

 

 

 

 

 

 

 

 

 

 

3.1

 

Constant currency

 

 

 

 

 

 

 

 

 

 

0.4

 

Non-cash impairment losses

 

 

 

 

 

 

 

 

 

 

1.5

 

M&A, restructuring, severance

 

 

 

 

 

 

 

 

 

 

4.8

 

Amortization of restricted stock units

 

 

 

 

 

 

 

 

 

 

5.9

 

Warrant Exchange costs

 

 

 

 

 

 

 

 

 

 

1.2

 

Other non-core and non-cash adjustments

 

 

 

 

 

 

 

 

 

 

1.7

 

Adjusted EBITDA

 

 

 

 

 

 

 

 

 

$

60.8

 

 

 

 

Successor

 

 

Predecessor

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

June 3, 2019 –

 

 

January 1, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

September 30, 2019

 

 

– June 2, 2019

 

 

Nine Months Ended September 30, 2019

 

 

 

As reported

 

 

As reported

 

 

Combined

 

 

Adjustments(6)

 

 

Pro Forma

 

Net revenue

 

$

85.4

 

 

$

106.4

 

 

$

191.8

 

 

$

6.4

 

(1)

$

198.2

 

Cost of goods sold

 

 

52.6

 

 

 

61.2

 

 

 

113.8

 

 

 

(0.8

)

(2)

 

113.0

 

Gross profit

 

 

32.8

 

 

 

45.2

 

 

 

78.0

 

 

 

7.2

 

 

 

85.2

 

Selling, general and administrative expenses

 

 

22.5

 

 

 

23.8

 

 

 

46.3

 

 

 

(3.2

)

 

 

43.1

 

Transaction costs

 

 

0.3

 

 

 

7.4

 

 

 

7.7

 

 

 

(7.7

)

 

 

-

 

Depreciation and amortization expense

 

 

13.3

 

 

 

17.7

 

 

 

31.0

 

 

 

(0.2

)

 

 

30.8

 

Other operating expense, net

 

 

0.8

 

 

 

2.2

 

 

 

3.0

 

 

 

0.6

 

 

 

3.6

 

Income (loss) from operations

 

 

(4.1

)

 

 

(5.9

)

 

 

(10.0

)

 

 

17.7

 

 

 

7.7

 

Interest expense

 

 

17.5

 

 

 

20.2

 

 

 

37.7

 

 

 

(11.6

)

 

 

26.1

 

Foreign currency (gain) loss

 

 

(1.6

)

 

 

(2.2

)

 

 

(3.8

)

 

 

-

 

 

 

(3.8

)

Loss before income tax expense

 

 

(20.0

)

 

 

(23.9

)

 

 

(43.9

)

 

 

29.3

 

 

 

(14.6

)

Income tax benefit

 

 

(6.1

)

 

 

(4.9

)

 

 

(11.0

)

 

 

6.2

 

(3)

 

(4.8

)

Net loss

 

$

(13.9

)

 

$

(19.0

)

 

$

(32.9

)

 

$

23.1

 

 

 

(9.8

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Add(4):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization expense - COS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15.8

 

Depreciation and amortization expense - SG&A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

30.8

 

Interest expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

26.1

 

Income tax benefit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(4.8

)

EBITDA

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

58.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments(5):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized (gain) loss translation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3.8

)

Non-cash impairment losses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1.2

 

Amortization of restricted stock units

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1.8

 

PE monitoring fees

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.6

 

Other non-core and non-cash adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.5

 

Adjusted EBITDA

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

58.4

 

44


 

 

 

 

Pro Forma

 

 

 

Nine Months Ended September 30,

 

 

 

 

 

 

 

 

 

 

 

2020

 

 

2019

 

 

$ Change

 

 

% Change

 

Net revenue

 

$

208.7

 

 

$

198.2

 

 

$

10.5

 

 

 

5.3

 

Cost of goods sold

 

 

123.7

 

 

 

113.0

 

 

 

10.7

 

 

 

9.5

 

Gross profit

 

 

85.0

 

 

 

85.2

 

 

 

(0.2

)

 

 

(0.2

)

Selling, general and administrative expenses

 

 

58.7

 

 

 

43.1

 

 

 

15.6

 

 

 

36.2

 

Depreciation and amortization expense

 

 

23.1

 

 

 

30.8

 

 

 

(7.7

)

 

 

(25.0

)

Other operating expense, net

 

 

3.2

 

 

 

3.6

 

 

 

(0.4

)

 

 

(11.1

)

Income (loss) from operations

 

 

-

 

 

 

7.7

 

 

 

(7.7

)

 

 

(100.0

)

Interest expense

 

 

16.6

 

 

 

26.1

 

 

 

(9.5

)

 

 

(36.4

)

Foreign currency (gain) loss

 

 

3.1

 

 

 

(3.8

)

 

 

6.9

 

 

 

(181.6

)

Loss before income tax expense

 

 

(19.7

)

 

 

(14.6

)

 

 

(5.1

)

 

 

34.9

 

Income tax benefit

 

 

(1.3

)

 

 

(4.8

)

 

 

3.5

 

 

 

(72.9

)

Net loss

 

 

(18.4

)

 

 

(9.8

)

 

 

(8.6

)

 

 

87.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Add(4):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization expense - COS

 

 

22.4

 

 

 

15.8

 

 

 

6.6

 

 

 

41.8

 

Depreciation and amortization expense - SG&A

 

 

23.0

 

 

 

30.8

 

 

 

(7.8

)

 

 

(25.3

)

Interest expense

 

 

16.6

 

 

 

26.1

 

 

 

(9.5

)

 

 

(36.4

)

Income tax benefit

 

 

(1.4

)

 

 

(4.8

)

 

 

3.4

 

 

 

(70.8

)

EBITDA

 

 

42.2

 

 

 

58.1

 

 

 

(15.9

)

 

 

(27.4

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments(5):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized (gain) loss translation

 

 

3.1

 

 

 

(3.8

)

 

 

6.9

 

 

 

(181.6

)

Constant currency

 

 

0.4

 

 

 

-

 

 

 

0.4

 

 

 

Non-cash impairment losses

 

 

1.5

 

 

 

1.2

 

 

 

0.3

 

 

 

25.0

 

M&A, restructuring, severance

 

 

4.8

 

 

 

-

 

 

 

4.8

 

 

 

Amortization of restricted stock units

 

 

5.9

 

 

 

1.8

 

 

 

4.1

 

 

 

227.8

 

Warrant Exchange costs

 

 

1.2

 

 

 

-

 

 

 

1.2

 

 

 

PE monitoring fees

 

 

-

 

 

 

0.6

 

 

 

(0.6

)

 

 

(100.0

)

Other non-core and non-cash adjustments

 

 

1.7

 

 

 

0.5

 

 

 

1.2

 

 

 

240.0

 

Adjusted EBITDA

 

$

60.8

 

 

$

58.4

 

 

$

2.4

 

 

 

4.1

 

(see subsequent footnotes)

(1)

Adjust for percentage of completion revenue recognition change.

(2)

Adjust for percentage of completion revenue recognition change for cost of sales.

(3)

Adjust tax provision at 21.0% corporate rate for items adjusted above.

(4)

Reconciliations of EBITDA and Adjusted EBITDA for each period presented are to net (loss) income, the nearest GAAP equivalent, and accordingly include the adjustments shown in the “Adj.” column to net (loss) income of each table.

(5)

Adjustments are related to non-recurring costs such as: unrealized non-cash (gains) losses on translation of the Predecessor debt, private equity monitoring fees, non-cash (gain) loss on the disposal of machines, acquisition costs, severance and a revenue recognition adjustment related to e3NEO acquisition. Certain costs related to being a public company, such as additional staff, legal and accounting costs that were not included in the Predecessor are also included in Adjusted EBITDA.

(6)

Effect of Euro constant currency adjustment to a rate of $1.15 US Dollar to €1.00 as follows:

45


 

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Net revenue

 

$

(0.7

)

 

$

1.2

 

 

$

2.4

 

 

$

2.4

 

Cost of goods sold

 

 

(0.4

)

 

 

0.7

 

 

 

1.4

 

 

 

1.4

 

Gross profit

 

 

(0.3

)

 

 

0.5

 

 

 

1.0

 

 

 

1.0

 

Selling, general and administrative expenses

 

 

(0.1

)

 

 

0.3

 

 

 

0.6

 

 

 

0.5

 

Transaction costs

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Depreciation and amortization expense

 

 

-

 

 

 

0.2

 

 

 

0.2

 

 

 

0.3

 

Other operating expense, net

 

 

(0.1

)

 

 

0.2

 

 

 

0.3

 

 

 

0.3

 

Income (loss) from operations

 

 

(0.1

)

 

 

(0.2

)

 

 

(0.1

)

 

 

(0.1

)

Interest expense

 

 

-

 

 

 

0.1

 

 

 

-

 

 

 

0.1

 

Foreign currency loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Loss before income tax expense

 

 

(0.1

)

 

 

(0.3

)

 

 

(0.1

)

 

 

(0.2

)

Income tax benefit

 

 

-

 

 

 

-

 

 

 

0.1

 

 

 

-

 

Net loss

 

$

(0.1

)

 

$

(0.3

)

 

$

(0.2

)

 

$

(0.2

)

 

Liquidity and Capital Resources

Liquidity describes the ability of a company to generate sufficient cash flows to meet the cash requirements of its business operations, including working capital needs, capital expenditures, debt service, acquisitions, other commitments and contractual obligations.  We evaluate liquidity in terms of cash flows from operations and other sources and the sufficiency of such cash flows to fund our operating, investing and financing activities.

We believe that our estimated cash from operations together with borrowing capacity under the revolving portion of the Facilities will provide us with sufficient resources to cover our current requirements.  Our main liquidity needs relate to capital expenditures and expenses for the production and maintenance of protective packaging systems placed at end-user facilities, working capital, including the purchase of paper raw materials, and payments of principal and interest on our outstanding debt.  We expect our capital expenditures to increase as we continue to grow our business.  Our future capital requirements and the adequacy of available funds will depend on many factors, and if we are unable to obtain needed additional funds, we may have to reduce our operating costs or incur additional debt, which could impair our growth prospects and/or otherwise negatively impact our business.  Further, volatility in the equity and credit markets resulting from the COVID-19 pandemic could make obtaining new equity or debt financing more difficult or expensive.

We had $31.3 million in cash and cash equivalents as of September 30, 2020 and $19.7 million as of December 31, 2019.  We also had $426.4 million in debt, $1.6 million of which was classified as short-term, as of September 30, 2020, compared to $420.4 million in debt, $1.6 million of which was classified as short-term, as of December 31, 2019.  In December 2019, we closed a public offering of our Class A common stock generating net proceeds of approximately $107.7 million that was used to pay down long-term debt.  At September 30, 2020, we did not have amounts outstanding under our $45.0 million revolving credit facility, and we had no borrowings under such facility through November 6, 2020.

Debt Profile

Ranpak’s previous credit facilities were repaid in connection with the consummation of the Ranpak Business Combination, and were replaced with the following facilities: (i) a $378.2 million dollar-denominated first lien term facility (the “First Lien Dollar Term Facility”) and a €140.0 million euro-denominated first lien term facility (the “First Lien Euro Term Facility” and, together with the First Lien Dollar Term Facility, the “First Lien Term Facility”), and (ii) a $45.0 million revolving facility (together, the “New Credit Facilities”). The material terms of the New Credit Facilities are summarized in Note 8, Long-Term Debt to the condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

Debt Before the Ranpak Business Combination

Prior to the Ranpak Business Combination, the Company had two first lien credit facilities, a United States Dollar Tranche (“US$ Tranche”) and a Euro Tranche (“Euro Tranche”), a revolving credit facility and a second lien credit facility. The first lien credit facilities included: (1) a seven-year Term Loan (US$ Tranche) facility in the amount of $233.4 million, (2) a seven-year Term Loan (Euro Tranche) facility in the amount of €157.0 million, and (3) a five-year $30.0 million revolving credit facility, of which the equivalent of $13.0 million may be denominated in Euros (collectively, the “Old Credit Facilities”). In March 2017, Ranpak raised $45 million of incremental First Lien (US$ Tranche) debt and used the proceeds to pay down a portion of the Second Lien (US$ Tranche), the results of which saved Ranpak 400 basis points on the applicable interest rate on $45 million of its outstanding debt. Borrowings under the US$ Tranche bore interest in an amount based on either the Adjusted Eurodollar rate (the greater of 1.00% or

46


 

LIBOR) plus 3.25% or a Base Rate plus 2.75% (the higher of the Federal Funds effective rate plus ½ of 1%, prime, or the Adjusted Eurodollar rate plus 1%). Borrowings under the Euro Tranche bore interest in an amount based on the Adjusted EURIBOR rate (the greater of 1.00% or EURIBOR) plus 3.25%. Interest on LIBOR and EURIBOR rate loans were payable at the end of the applicable interest periods.

Borrowings under the revolving credit facility bore interest in an amount based on either the base rate or Adjusted Eurodollar rate plus a variable margin that is dependent on the First Lien Net Leverage Ratio. The first lien credit facilities were secured by a first priority security interest in substantially all of the Company’s assets.  Principal payments on the first lien term loan facilities were due quarterly and were based on 1% of the annual outstanding balances. Additionally, per the credit agreement, Ranpak was required to make additional annual pre-payments, based on consolidated excess cash flow calculation results.

The second lien credit facility was an eight-year US$ Tranche in the amount of $135.0 million. Borrowings under the US$ Tranche bore interest in an amount based on either the Adjusted Eurodollar rate (the greater of 1.00% or LIBOR) plus 7.25% or a base rate plus 6.25%. The second lien credit agreement was secured by a second priority security interest in substantially all of Ranpak’s assets and includes default provisions and contained a covenant similar to the first lien credit facility described above.

The Old Credit Facilities were repaid in full upon the consummation of the Ranpak Business Combination and replaced with the New Credit Facilities.

Debt After the Ranpak Business Combination

In connection with the stock purchase agreement related to the Ranpak Business Combination, One Madison obtained a debt commitment letter (as amended and restated, supplemented or otherwise modified, the “debt commitment letter”), pursuant to which the Goldman Sachs Lending Partners LLC and certain affiliated investment entities thereof (collectively, the “Lenders”) committed to provide senior secured credit facilities to, in part, (i) fund the Ranpak Business Combination, (ii) repay and terminate the existing indebtedness of Ranpak (the “debt refinancing”) and (iii) pay all fees, premiums, expenses and other transaction costs incurred in connection with the foregoing. The aggregate commitment of the senior secured credit facilities consists of a $289.2 million dollar-denominated first lien term facility and a €140.0 million euro-denominated first lien term facility (with the ability to reduce the dollar-denominated first lien term facility and correspondingly increase the euro-denominated first lien term facility in an amount of up to €60.0 million), a $45.0 million revolving facility (including the right to bring in additional lenders to provide commitments with respect to the revolving facility in an amount of up to $30.0 million and additional borrowing capacity available for letters of credit in an amount of up to $5.0 million), a $100.0 million first lien contingency term facility and a $100.0 million second lien contingency term facility. Upon the consummation of the Ranpak Business Combination, the New Credit Facilities became the direct obligations of certain subsidiaries of Ranpak (collectively, the “borrowers”) and were secured by substantially all of Ranpak’s assets.

Each of the First Lien Term Facility, and the first lien contingency term facility accrue interest at a rate of LIBOR plus 3.75% (assuming a first lien net leverage ratio of less than 5.00:1.00). The second lien contingency term facility accrues interest at a rate of LIBOR plus 7.50%.  No amounts have been drawn on under the second lien contingency.  The first lien term facility and first lien contingency term facility mature on the seventh anniversary of the date of the closing of the Ranpak Business Combination, June 3, 2026. The revolving facility matures on the fifth anniversary of the date of the Closing June 3, 2024. The second lien contingency term facility matures on the eighth anniversary of the date of the Closing, June 3, 2027 but was not available for us to borrow against at September 30, 2020.

The revolving facility includes borrowing capacity available for letters of credit of up to $5 million. Any issuance of letters of credit will reduce the amount available under the revolving facility.

In addition, the debt financing provides the borrowers with the option to increase commitments under the debt financing in an aggregate amount not to exceed the greater of $95 million and 100% of trailing-twelve months consolidated EBITDA, plus any voluntary prepayments of the debt financing (and, in the case of the revolving facility, to the extent such voluntary prepayments are accompanied by permanent commitment reductions under the revolving facility), plus unlimited amounts subject to the relevant net leverage ratio tests and certain other conditions.

The obligations of the borrowers under the debt financing and certain of their respective obligations under hedging arrangements and cash management arrangements are unconditionally guaranteed by the direct parent of each borrower and each existing and subsequently acquired or organized direct or indirect wholly-owned US or Dutch restricted subsidiary (collectively, the “guarantors”), in each case, other than certain excluded subsidiaries and subject to other customary limitations set forth in the definitive documentation with respect to the debt financing. The debt financing is secured by a security interest in substantially all of the assets of the borrowers and the guarantors (and including a pledge of the equity interests of each borrower and of each guarantor and of their respective direct, wholly-owned restricted subsidiaries), in each case subject to customary exceptions.

47


 

The revolving facility requires the borrowers to maintain a maximum first lien net leverage ratio 9.10:1.00 based on the amount of the initial first lien term loans under the debt financing actually borrowed on the closing date based on providing at least a 35% cushion to consolidated EBITDA for the most recent four fiscal quarter periods ending prior to the date of the closing. This “springing” financial covenant is tested on the last day of each fiscal quarter, but only if on such date the sum of (i) the principal amount of outstanding revolving loans under the revolving facility, (ii) drawings on letters of credit under the revolving facility and (iii) the face amount of non-cash collateralized letters of credit under the revolving facility in excess of an amount to be set forth in the definitive documentation with respect to the debt financing exceeds 35% of the total revolving commitments under the revolving facility.

The senior secured credit facilities also contain a number of customary negative covenants. Such covenants, among other things, will limit or restrict the ability of each of the borrowers, their restricted subsidiaries, and where applicable, the direct parent holding companies of the borrowers, to:

 

incur additional indebtedness, issue disqualified stock and make guarantees;

 

incur liens on assets;

 

engage in mergers or consolidations or fundamental changes;

 

sell assets;

 

pay dividends and distributions or repurchase capital stock;

 

make investments, loans and advances, including acquisitions;

 

amend organizational documents;

 

enter into certain agreements that would restrict the ability to pay dividends;

 

repay certain junior indebtedness;

 

engage in transactions with affiliates; and

 

in the case of the direct parent holding companies of the borrowers, engage in activities other than passively holding the equity interests in the borrowers.

The aforementioned restrictions are subject to certain exceptions including (i) the ability to incur additional indebtedness, liens, investments, dividends and distributions, and prepayments of junior indebtedness subject, in each case, to compliance with certain financial metrics and certain other conditions and (ii) a number of other traditional exceptions that grant the borrowers continued flexibility to operate and develop their businesses. The senior secured credit facilities also contain certain customary representations and warranties, affirmative covenants and events of default.

Amendment to First Lien Credit Facilities

On February 14, 2020, Ranger Packaging LLC, a Delaware limited liability company (“U.S. Borrower”), Ranpak B.V., a private limited liability company under the laws of the Netherlands (the “Dutch Borrower”; the U.S. Borrower and the Dutch Borrower, the “Borrowers”), Ranger Pledgor LLC, a Delaware limited liability company (“Holdings”), certain other subsidiaries of Holdings, certain lenders party to Amendment No. 1 (as defined below) and Goldman Sachs Lending Partners LLC (the “Administrative Agent”) entered into the Amendment No. 1 to First Lien Credit Agreement (“Amendment No. 1”) to amend the New Credit Facilities.

Among other things, the Amendment No. 1 amends the New Credit Facilities such that (x) the requirement of the Borrowers to apply a percentage of excess cash flow to mandatorily prepay term loans under the New Credit Facilities commences with the fiscal year ending December 31, 2021 (instead of the fiscal year ending December 31, 2020) and (y) the aggregate amount per fiscal year of capital stock of any parent company of the U.S. Borrower that is held by directors, officers, management, employees, independent contractors or consultants of the U.S. Borrower (or any parent company or subsidiary thereof) that the U.S. Borrower may repurchase, redeem, retire or otherwise acquire or retire for value has been increased to the greater of $10,000,000 and 10% of Consolidated Adjusted EBITDA (as defined in the New Credit Facilities) (increased from the greater of $7,000,000 and 7% of Consolidated Adjusted EBITDA) as of the last day of the most recently ended quarter for which financial statements have been delivered.

48


 

Borrower Assumption Agreement

On July 1, 2020, in the following order, (i) Rack Holdings Inc. merged with and into Ranger Packaging LLC, with Ranger Packaging LLC as the surviving entity of such merger and (ii) Ranger Packaging LLC merged with and into Ranpak Corp., with Ranpak Corp. as the surviving entity of such merger (clauses (i) and (ii) collectively, the “Reorganization”).  Contemporaneously with the Reorganization, Ranger Packaging LLC, Ranpak Corp., Ranger Pledgor LLC, certain other subsidiaries of Ranger Pledgor LLC and Goldman Sachs Lending Partners LLC entered into the Borrower Assumption Agreement whereby, among other things, Ranpak Corp. assumed all obligations, liabilities and rights of Ranger Packaging LLC as the “U.S. Borrower” under the New Credit Facilities.

Cash Flows

The following table sets forth Ranpak’s summary cash flow information for the periods indicated:

 

 

 

Successor

 

 

 

Predecessor

 

 

 

Nine Months Ended September 30,

 

 

June 3, 2019

 

 

 

January 1, 2019

 

 

 

2020

 

 

– September 30, 2019

 

 

 

– June 2, 2019

 

Net cash provided by (used in) operating activities

 

$

37.8

 

 

$

(0.3

)

 

 

$

16.7

 

Net cash used in investing activities

 

 

(25.5

)

 

 

(648.2

)

 

 

 

(10.8

)

Net cash provided by (used in) financing activities

 

 

(1.2

)

 

 

663.1

 

 

 

 

(14.4

)

Effect of Exchange Rate Changes on Cash

 

 

0.5

 

 

 

(2.7

)

 

 

 

1.2

 

Net Increase (Decrease) in Cash and Cash Equivalents

 

 

11.6

 

 

 

11.9

 

 

 

 

(7.3

)

Cash and Cash Equivalents, beginning of period

 

 

19.7

 

 

 

1.7

 

 

 

 

17.5

 

Cash and Cash Equivalents, end of period

 

$

31.3

 

 

$

13.6

 

 

 

$

10.2

 

 

Cash Flows Provided (Used in) by Operating Activities

Net cash provided by operating activities was $37.8 million in the nine months ended September 30, 2020.  Cash used in operating activities in the Successor Period of $0.3 million and cash provided by operating activities in the 1H 2019 Predecessor Period of $16.7 million combined for $16.4 million in cash provided by operating activities in the nine months ended September 30, 2019.  The changes in operating cash flows are due to cash earnings and increases in working capital.

Cash Flows Used in Investing Activities

Net cash used in investing activities was $25.5 million in the nine months ended September 30, 2020.  Cash used in investing activities in the Successor Period of $648.2 million and $10.8 million in the 1H 2019 Predecessor Period combined for $659.0 million in cash used by investing activities in the nine months ended September 30, 2019.  The changes are due to cash used for the Ranpak Business Combination and capital expenditures related to our protective packaging systems.

Cash Flows Provided (Used in) by Financing Activities

Net cash used in financing activities was $1.2 million in the nine months ended September 30, 2020 and reflects payment of debt.  Net cash provided by financing activities in the Successor Period of $663.1 million and cash used in financing activities in the 1H 2019 Predecessor Period of $14.4 million combined for $648.7 million in cash provided by financing activities in the nine months ended September 30, 2019, primarily related to the debt and stock transactions relative to the Ranpak Business Combination.

Contractual Obligations and Other Commitments

Ranpak has leased production facilities in Reno, Nevada, Kansas City, Missouri and Raleigh, North Carolina, in the United States and in Nyrany, Czech Republic, as well as several leased sales and administrative offices. The leases for the four leased production facilities expire in September 2023, July 2025, December 2024 and April 2026, respectively.  Ranpak recognizes rent expense on a straight-line basis over the relevant lease period.

Ranpak has various contractual obligations and commercial commitments that are recorded as liabilities in its audited consolidated financial statements. Other items, such as purchase obligations and other executory contracts, are not recognized as liabilities, but are required to be disclosed.  There have been no significant changes outside the ordinary course of business to our “Contractual Obligations” table in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of the Form 10-K.

49


 

Off-Balance Sheet Arrangements

Ranpak did not have any off-balance sheet arrangements as of September 30, 2020.

Critical Accounting Policies

Our unaudited condensed consolidated financial statements have been prepared in conformity with GAAP, which requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of our financial statements and the reported amounts of revenues and expenses during the reporting period.  While we do not believe that the reported amounts would be materially different, application of these policies involves the exercise of judgment and the use of assumptions as to future uncertainties and, as a result, actual results could differ from these estimates.  We evaluate our estimates and judgments on an ongoing basis.  We base our estimates on experience and various other assumptions that we believe are reasonable under the circumstances.  All of our significant accounting policies, including certain critical accounting policies and estimates, are disclosed in our Form 10-K.

Recently Issued and Adopted Accounting Pronouncements

For recently issued and adopted accounting pronouncements, see Note 2, Basis of Presentation and Summary of Significant Accounting Policies to the unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

 

50


 

Item 3.  Quantitative and Qualitative Disclosures About Market Risk

Interest Rate Risk

Changes in interest rates affect the amount of interest income we earn on cash, cash equivalents and short-term investments and the amount of interest expense we pay on borrowings under the floating rate portions of our credit facilities.  A hypothetical 100 basis point increase or decrease in the applicable base interest rates under our credit facilities would have resulted in a $3.3 million impact on our cash interest expense for the nine months ended September 30, 2020.  We use interest rate swap agreements to manage this exposure.

In March 2020, we entered into the Second Amended January 2019 Swap, which amended the Amended January 2019 Swap to a lower rate of 2.1% and extend its maturity to June 1, 2024.  In July 2020, we entered into the Borrower Assumption Agreement, which details the Reorganization and the assumption of obligations, liabilities and rights under the New Credit Facilities.  Refer to Note 8, Long-Term Debt and Note 9, Derivative Instruments to the condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for additional information.  There were no other changes to our debt and interest rate swap agreements from those disclosed in the Form 10-K.

Foreign Currency Exchange Rate Risk

We are exposed to foreign currency exchange risk related to our transactions and subsidiaries’ balances that are denominated in currencies other than the U.S. dollar, our functional currency. See “Factors Affecting the Comparability of Ranpak’s Results of Operations - Effect of Currency Fluctuations” for more information about Ranpak’s foreign currency exchange rate exposure.  We seek to naturally hedge our foreign exchange transaction exposure by matching the transaction currencies for our cash inflows and outflows and maintaining access to credit in the principal currencies in which we conduct business.  Currently, we do not hedge our foreign exchange transaction or translation exposure, but may consider doing so in the future.

For the nine months ended September 30, 2020, net revenue denominated in currencies other than U.S. dollars amounted to $117.7 million or 57.1% of our net revenue for the period.  Substantially all of this amount was denominated in Euro.  A 10% increase or decrease in the value of the Euro to the U.S. dollar would have caused our reported net revenue for the nine months ended September 30, 2020 to increase or decrease by approximately $11.8 million.

Commodity Price Risk

While our business is significantly impacted by price fluctuations related to the purchase, production and sale of paper products, we are not directly exposed to market price fluctuations in paper purchase or sale prices as we negotiate prices with suppliers on an annual basis and negotiate prices with distributors reflecting competitive market terms.  Our strategy has generally been to obtain competitive prices for our products and services and allow operating results to reflect market price movements dictated by supply and demand.

Item 4.  Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.  Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our management, with the participation of the Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2020. Based on this evaluation of our disclosure controls and procedures, our management, with the participation of the Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were not effective as of September 30, 2020 because of material weaknesses in our internal control over financial reporting, as described under “Item 9A. Controls and Procedures—Internal Control Over Financial Reporting” in the Form 10-K.

Changes in Internal Control Over Financial Reporting

Other than the ongoing steps being taken to remediate the material weaknesses described under “Item 9A. Controls and Procedures—Internal Control Over Financial Reporting” in the Form 10-K, there were no changes during the nine months ended September 30, 2020 in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

51


 

PART II – OTHER INFORMATION

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Our forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future. Statements that are not historical facts, including statements about the parties, perspectives and expectations, are forward-looking statements. In addition, any statements that refer to estimates, projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this Quarterly Report on Form 10-Q may include, for example, statements about: our expectations around the performance of the business; our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business; our public securities’ potential liquidity and trading; the lack of a market for our securities.

The forward-looking statements contained in this Quarterly Report on Form 10-Q are based on our current expectations and beliefs concerning future developments and their potential effects on us taking into account information currently available to us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks include, but are not limited to: (1) our inability to secure a sufficient supply of paper to meet our production requirements; (2) the impact of the price of kraft paper on our results of operations;(3) our reliance on third party suppliers; (4) the COVID-19 pandemic and associated response (5) the high degree of competition in the markets in which we operate; (6) consumer sensitivity to increases in the prices of our products; (7) changes in consumer preferences with respect to paper products generally; (8) continued consolidation in the markets in which we operate; (9) the loss of significant end-users of our products or a large group of such end-users; (10) our failure to develop new products that meet our sales or margin expectations; (11) our future operating results fluctuating, failing to match performance or to meet expectations; (12) our ability to fulfill our public company obligations; and (13) other risks and uncertainties indicated from time to time in filings made with the SEC.

Should one or more of these risks or uncertainties materialize, they could cause our actual results to differ materially from the forward-looking statements. We are not undertaking any obligation to update or revise any forward looking statements whether as a result of new information, future events or otherwise. You should not take any statement regarding past trends or activities as a representation that the trends or activities will continue in the future. Accordingly, you should not put undue reliance on these statements.

None.

Item 1A.  Risk Factors

Information about our risk factors is contained in Item 1A of the Form 10-K.  A supplemental risk factor was included in the Quarterly Report on Form 10-Q for the period ended March 31, 2020 (the “Q1-20 10-Q”).  There are no other material changes in our risk factors from those disclosed in the Form 10-K or Q1-20 10-Q.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3.  Defaults Upon Senior Securities

None.

Item 4.  Mine Safety Disclosures

Not applicable.

Item 5.  Other Information

None.

52


 

Item 6.  Exhibits

 

Exhibit No.

 

Description

 

 

 

2.1

 

Stock Purchase Agreement, dated December 12, 2018, among One Madison Corporation, Rack Holdings L.P. and Rack Holdings Inc. (incorporated by reference to the corresponding exhibit to the Company’s Current Report on Form 8-K (File No. 001-38348), filed with the SEC on December 13, 2018)

 

 

 

2.2

 

Amendment to Stock Purchase Agreement, dated January 24, 2019, among One Madison Corporation, Rack Holdings L.P. and Rack Holdings Inc. (incorporated by reference to the corresponding exhibit to the Company’s Current Report on Form 10-K (File No. 001-38348), filed with the SEC on March 1, 2019)

 

 

 

2.3

 

Amendment No. 2 to Stock Purchase Agreement, dated May 14, 2019, among One Madison Corporation, Rack Holdings L.P. and Rack Holdings Inc. (incorporated by reference to the corresponding exhibit to the Company’s Current Report on Form 8-K (File No. 001-38348), filed with the SEC on May 15, 2019)

 

 

 

3.1

 

Certificate of Incorporation of the Company (incorporated by reference to the corresponding exhibit to the Company’s Current Report on Form 8-K (File No. 001-38348), filed with the SEC on June 6, 2019)

 

 

 

3.2

 

Bylaws of the Company (incorporated by reference to the corresponding exhibit to the Company’s Current Report on Form 8-K (File No. 001-38348), filed with the SEC on June 6, 2019)

 

 

 

4.1

 

Specimen Common Stock Certificate (incorporated by reference to the corresponding exhibit to the Company’s Registration Statement on Form S-3, as amended (File No. 333-232105), filed with the SEC on July 26, 2019

 

 

 

4.2

 

Form of Specimen Warrant Certificate (incorporated by reference to the corresponding exhibit to the Company’s Registration Statement on Form S-1, as amended (File No. 333-220956), filed with the SEC on January 5, 2018)

 

 

 

4.3

 

Warrant Agreement, dated January 17, 2018, between the Company and Continental Stock Transfer & Trust Company, as warrant agent (incorporated by reference to the corresponding exhibit to the Company’s Current Report on Form 8-K (File No. 001-38348), filed with the SEC on January 22, 2018)

 

 

 

4.4

 

Amendment No. 1 to Warrant Agreement, dated as of September 3, 2020, by and among the Company and Continental Stock Transfer & Trust Company (incorporated by reference to the corresponding exhibit to the Company’s Current Report on Form 8-K (File No. 001-38348), filed with the SEC on September 3, 2020)

 

 

 

31.1*

 

Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

31.2*

 

Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

32*

 

Certificate of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. § 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

101.INS

 

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document*

 

 

 

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document*

 

 

 

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document*

 

 

 

101.DEF

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document*

 

 

 

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document*

 

 

 

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document*

 

 

 

104*

 

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

 

*

Filed herewith

 

53


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

Ranpak Holdings Corp.

 

 

 

 

 

Date:

November 6, 2020

 

By:

/s/ William Drew

 

 

 

 

William Drew

 

 

 

 

Senior Vice President and Chief Financial Officer

 

54